data_2lae_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lae _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.749 0.309 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 82.9 t -124.99 130.79 73.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.168 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -121.28 156.17 33.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.192 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.6 t -91.72 140.68 29.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.99 179.77 8.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.24 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -128.89 148.0 50.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.163 172.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 42.5 p30 -85.06 -170.02 2.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.209 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.01 -24.17 67.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.213 -171.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 61.6 p -97.34 -1.51 44.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.182 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.91 18.18 60.11 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.7 mt -91.46 157.28 42.48 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 0.0 111.192 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -55.07 134.86 66.12 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.667 1.578 . . . . 0.0 111.261 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 67.9 ttp -148.81 149.04 30.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.222 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 83.2 mt -113.8 144.61 42.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.199 169.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 95.3 t -113.19 119.73 61.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.225 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.4 t -105.33 137.38 35.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.227 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.9 ttt180 -64.77 107.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.459 ' HA2' ' HD3' ' A' ' 247' ' ' PRO . . . 130.76 143.56 5.33 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . 0.459 ' HD3' ' HA2' ' A' ' 246' ' ' GLY . 45.0 Cg_exo -58.55 167.73 4.77 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.732 1.621 . . . . 0.0 111.191 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -48.99 -46.99 44.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -62.99 -26.19 68.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.159 -173.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 81.3 t -85.29 -52.56 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.224 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 255' ' ' LEU . 74.0 t -73.58 -53.81 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.181 -173.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -56.27 -39.87 73.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 -172.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -73.86 -29.75 62.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -107.55 6.01 27.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.177 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.543 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 60.8 tp -65.48 -42.38 56.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.23 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 85.9 Cg_exo -51.75 -35.4 58.25 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.693 1.595 . . . . 0.0 111.188 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.94 79.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.11 -34.91 77.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.213 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.434 HD23 ' SD ' ' A' ' 264' ' ' MET . 81.0 mt -63.48 -41.76 98.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.186 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.56 -25.39 67.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.192 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -80.69 -20.07 43.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.21 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 31.6 m -105.16 9.82 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.204 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.64 20.22 58.63 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' MET . . . . . 0.514 ' SD ' HG22 ' A' ' 278' ' ' VAL . 59.7 ttm -119.09 103.24 9.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.775 0.321 . . . . 0.0 111.213 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -93.65 129.08 40.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.166 -170.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.456 ' HA ' HG12 ' A' ' 278' ' ' VAL . 95.0 t -73.2 127.7 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.213 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 65.3 p -108.84 -27.88 9.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.219 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -162.71 166.31 24.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.237 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 82.8 p -161.41 153.78 20.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.208 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 85.1 m -133.92 112.0 10.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.185 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -72.86 -22.11 60.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 84.9 p -77.99 -12.41 59.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.178 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -116.87 -20.04 9.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.224 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.31 25.94 67.18 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -172.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -110.04 149.99 29.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.776 0.322 . . . . 0.0 111.187 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 56.7 ttm -140.07 136.76 33.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.196 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -110.59 125.6 53.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.197 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.514 HG22 ' SD ' ' A' ' 264' ' ' MET . 34.8 m -134.46 155.4 38.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.19 -169.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.0 m -117.92 125.06 49.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 172.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -113.15 137.61 51.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.209 -171.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -136.69 129.89 17.6 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.181 170.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.98 139.08 79.48 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.687 1.591 . . . . 0.0 111.269 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 64.3 mt -99.79 166.49 11.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.173 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 56.7 p -74.96 164.89 26.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.259 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -58.25 -39.3 78.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.21 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 93.9 p -70.29 -30.53 67.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.208 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.92 -43.58 92.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.215 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -71.63 -28.71 63.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.201 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -66.73 -40.53 88.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.194 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.98 -39.15 87.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.212 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.92 -39.0 90.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.188 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 90.3 39.93 5.89 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 -175.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -141.92 166.36 24.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.775 0.321 . . . . 0.0 111.208 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 82.8 p -99.43 -178.45 3.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.163 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.404 ' HA ' ' HD2' ' A' ' 296' ' ' PRO . 66.0 t0 -64.74 120.66 68.01 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.183 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 295' ' ' ASP . 37.9 Cg_endo -67.04 -22.94 47.05 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.728 1.619 . . . . 0.0 111.21 -177.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.86 19.09 60.15 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 10.8 mp -101.29 140.28 35.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.228 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -99.33 159.56 14.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.184 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.3 t -60.16 139.99 57.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.181 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 153.15 -179.33 29.64 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -86.08 136.36 33.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.748 0.308 . . . . 0.0 111.244 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -121.15 149.05 43.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 319' ' ' ILE . 87.7 tttt -110.72 122.13 47.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.212 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 62.8 mt -103.15 135.85 44.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.241 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -119.65 125.14 48.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.208 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 315' ' ' SER . 57.6 t -122.32 120.31 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -109.34 155.05 16.27 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -88.92 118.76 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 111.194 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.532 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 87.9 mt -95.45 11.41 32.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.225 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 37.1 t0 87.63 -64.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.157 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -101.81 -10.1 20.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.181 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 89.8 mmt-85 -137.69 176.57 8.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.217 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 50.3 m -119.99 136.59 54.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 307' ' ' VAL . 27.8 t -96.71 109.74 22.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 174.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 48.9 tp -111.72 124.0 51.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.182 -176.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -127.02 148.46 50.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.221 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -112.27 125.92 54.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -173.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' A' ' 304' ' ' LYS . 92.5 mt -108.23 124.41 64.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.225 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.452 ' HB2' ' HD2' ' A' ' 321' ' ' PRO . 35.1 p30 -75.13 173.83 6.32 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.241 -174.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 320' ' ' ASP . 51.8 Cg_exo -59.93 -25.18 78.79 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.73 1.62 . . . . 0.0 111.177 -176.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -80.18 -9.75 59.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.167 -173.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.58 17.17 42.97 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -120.42 162.01 20.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.797 0.332 . . . . 0.0 111.189 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 78.4 p -79.32 153.94 29.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.195 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 68.2 mt -76.47 158.43 31.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.197 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 41.0 p -76.76 167.05 22.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.199 -173.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -61.8 -35.04 77.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.21 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 98.9 p -71.51 -35.78 70.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.21 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -68.82 -41.95 77.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -67.61 -37.49 82.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.214 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -60.69 -37.41 81.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.195 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -66.7 -38.89 87.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.248 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 84.5 mt -68.19 -22.64 64.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.227 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.78 -56.75 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.169 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -67.98 -35.36 78.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.201 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.52 -46.53 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.179 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -79.66 -28.91 40.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.257 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -54.26 -42.07 69.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.221 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -76.17 -34.33 59.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.211 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.05 -40.82 95.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -74.02 -27.61 61.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.215 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 90.5 p -82.78 -27.83 30.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.215 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 49.5 tptt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.237 -179.771 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 . . . . . 0 CA--C 1.523 -0.071 0 CA-C-O 120.845 0.355 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 83.2 t -127.0 125.21 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.186 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -112.51 156.89 21.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.228 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 35.0 t -95.62 136.24 36.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.191 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.28 167.71 29.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.215 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -99.48 145.73 27.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 41.8 p30 -85.85 -169.9 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.35 -25.5 67.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.175 -172.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 68.6 p -97.58 -1.22 44.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.219 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.0 18.53 60.95 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 98.4 mt -94.0 158.09 36.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.753 0.311 . . . . 0.0 111.216 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.06 139.3 80.02 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.696 1.598 . . . . 0.0 111.212 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.421 ' SD ' ' OG ' ' A' ' 315' ' ' SER . 64.5 ttp -156.08 149.88 25.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.172 -175.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 88.6 mt -111.89 143.91 42.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.203 172.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 94.2 t -118.08 120.94 66.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 176.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.01 140.03 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.181 -175.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -74.88 92.51 2.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.179 -174.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 153.59 156.07 7.46 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 173.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.4 157.87 38.79 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.728 1.618 . . . . 0.0 111.207 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -48.18 -47.05 35.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -63.34 -24.07 67.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.202 -174.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 90.2 t -88.44 -51.1 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.207 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 255' ' ' LEU . 72.6 t -74.42 -52.0 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.24 -174.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 87.9 t90 -55.12 -39.92 69.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.239 -174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -75.19 -31.69 61.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.193 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -99.02 -0.71 41.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.201 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.522 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 55.9 tp -69.64 -43.61 22.28 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 -176.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 74.2 Cg_exo -53.2 -35.81 75.02 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.714 1.609 . . . . 0.0 111.147 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.56 -47.47 78.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.216 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.12 73.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.204 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 256' ' ' PRO . 56.0 mt -67.64 -49.85 60.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.181 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.78 -31.75 69.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.171 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -60.76 -31.46 70.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.21 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.3 24.95 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.191 -171.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.65 23.34 50.65 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 170.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' MET . . . . . 0.427 ' HB3' HG22 ' A' ' 278' ' ' VAL . 67.1 mtt -118.87 104.96 11.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.772 0.32 . . . . 0.0 111.227 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -96.7 112.23 24.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 95.7 t -69.62 127.84 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.234 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 79.6 p -103.84 -26.08 12.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.191 -174.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -165.12 162.26 20.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.157 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 86.0 p -159.48 154.34 24.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.191 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 91.6 m -132.08 109.91 10.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.184 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -72.54 -23.32 60.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.219 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 86.3 p -77.69 -12.7 60.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.199 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -119.56 -18.81 8.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.223 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.45 28.92 60.72 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -109.5 150.22 28.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.345 . . . . 0.0 111.196 -173.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 58.9 ttm -142.33 137.31 30.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.219 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -117.54 126.32 52.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.19 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 264' ' ' MET . 10.5 p -138.77 135.65 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.179 -167.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 98.0 m -95.85 125.01 40.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.246 176.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -114.16 137.78 51.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.163 -172.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 282' ' ' PRO . 89.1 tttt -132.62 127.58 20.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.203 169.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 281' ' ' LYS . 77.7 Cg_exo -55.03 137.6 76.71 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.765 1.643 . . . . 0.0 111.212 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 70.4 mt -99.23 163.85 12.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.21 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 58.7 p -71.55 163.26 28.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.174 -176.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.57 -38.69 75.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.194 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 90.9 p -69.64 -30.35 68.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.193 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.63 -43.96 92.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.254 175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -74.28 -26.45 60.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.184 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -67.56 -40.6 84.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.199 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -70.3 -35.1 73.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.21 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.87 -29.14 66.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 77.37 35.28 37.86 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -137.01 154.65 50.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.769 0.318 . . . . 0.0 111.182 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 36.1 t -70.45 142.16 52.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.209 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -64.72 117.21 36.09 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.214 175.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 156.83 62.34 Favored 'Trans proline' 0 C--N 1.327 -0.559 0 C-N-CA 121.696 1.597 . . . . 0.0 111.191 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -89.56 34.33 4.06 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 11.1 mp -100.32 139.92 35.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.762 0.315 . . . . 0.0 111.191 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -103.74 162.73 12.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.209 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.7 t -59.53 134.6 57.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 158.4 -178.97 34.41 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -86.82 133.42 33.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.804 0.335 . . . . 0.0 111.205 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -121.28 153.03 38.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.197 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -112.22 160.63 17.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.171 173.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 53.2 tp -144.98 128.82 17.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.173 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -109.75 122.77 48.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.199 170.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 47.7 t -116.48 126.9 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.199 -172.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -114.37 167.46 12.32 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -107.08 104.4 14.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 111.185 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.1 59.95 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 64.91 -104.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.189 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -93.93 16.02 15.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.234 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -131.6 166.14 22.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.174 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 58.2 m -118.37 138.79 52.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.203 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.421 ' OG ' ' SD ' ' A' ' 241' ' ' MET . 31.2 t -107.01 112.75 25.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.246 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 64.0 mt -101.76 113.59 26.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.193 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -105.72 102.4 11.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.165 170.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -86.97 135.11 33.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.219 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 79.5 mt -124.03 128.63 74.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.18 -172.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.429 ' HB2' ' HD2' ' A' ' 321' ' ' PRO . 30.8 p30 -72.7 173.32 5.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.189 -175.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 320' ' ' ASP . 50.4 Cg_exo -60.45 -24.67 78.55 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.668 1.579 . . . . 0.0 111.24 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -81.69 -8.42 59.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 -175.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 88.75 24.6 32.32 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -121.09 143.82 48.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.809 0.338 . . . . 0.0 111.245 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 87.6 m -62.82 135.0 57.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.23 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 95.5 mt -59.91 155.25 16.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.217 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 69.4 p -83.23 165.97 18.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.247 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.61 -34.96 76.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.229 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 83.1 p -64.89 -25.65 67.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.189 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -90.01 -41.17 11.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -70.0 -36.52 75.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -57.95 -36.58 72.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.241 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -71.57 -35.74 70.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.191 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.07 -19.5 63.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 54.5 t -53.55 -53.78 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.173 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -66.49 -35.4 80.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.214 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 63.0 t -58.26 -50.18 79.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.168 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -86.17 -24.69 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.209 -176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -53.88 -49.55 68.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.181 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -76.53 -46.28 27.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.198 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.12 -36.46 81.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.208 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -72.54 -41.75 65.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.162 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 87.1 p -78.21 -15.33 58.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.194 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.193 -178.974 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.822 0.344 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 97.1 t -130.92 135.17 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -129.99 161.72 30.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 -176.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 31.9 t -101.93 145.98 28.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.201 172.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -154.28 166.96 31.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.203 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.73 139.82 30.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.209 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -81.78 173.04 12.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.25 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -65.31 -23.32 66.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 60.0 p -82.85 -15.43 51.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.197 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.43 -4.52 64.39 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 98.0 mt -81.84 154.15 70.34 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.173 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.14 130.0 38.33 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.655 1.57 . . . . 0.0 111.259 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 63.1 ttp -130.01 139.64 51.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 43.1 tp -104.56 128.45 52.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.23 174.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 31.7 m -123.91 149.95 28.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.222 -173.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.41 145.62 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -74.86 84.33 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.2 -172.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' A' ' 247' ' ' PRO . . . 158.59 156.57 8.07 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 171.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 246' ' ' GLY . 35.4 Cg_exo -61.45 161.14 24.93 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.718 1.612 . . . . 0.0 111.234 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -48.8 -46.16 41.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.192 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -60.35 -30.68 69.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.167 -175.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 81.5 t -83.12 -52.47 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.225 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 255' ' ' LEU . 79.2 t -73.89 -50.17 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.24 -171.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 91.1 t90 -55.81 -37.39 68.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 -173.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -74.88 -30.93 61.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -96.89 -8.07 31.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.212 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.513 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 61.4 tp -67.45 -44.12 44.63 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 -173.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 90.9 Cg_exo -49.34 -40.4 43.85 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.658 1.572 . . . . 0.0 111.192 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.09 -43.25 95.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.252 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.0 -27.46 66.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.205 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.409 HD23 ' SD ' ' A' ' 264' ' ' MET . 93.2 mt -77.1 -39.61 48.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.203 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -63.03 -26.71 68.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.221 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -77.64 -14.86 59.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 35.9 m -113.78 15.8 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.219 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.16 14.45 71.8 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' MET . . . . . 0.482 ' SD ' HG22 ' A' ' 278' ' ' VAL . 57.4 ttm -110.19 100.04 9.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 111.227 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -89.45 127.1 35.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 -171.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.448 ' HA ' HG12 ' A' ' 278' ' ' VAL . 96.3 t -74.31 124.84 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.201 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 64.6 p -107.73 -26.63 10.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.2 -177.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -163.41 158.7 21.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.168 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 87.9 p -159.36 155.4 26.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.175 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 81.3 m -140.11 116.69 10.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.228 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -67.14 -38.73 86.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.24 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 96.6 p -73.54 -21.84 60.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.189 -170.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -113.83 -12.1 12.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.212 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 74.39 36.81 48.95 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -91.03 134.96 34.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 111.24 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 59.9 tpp -135.82 96.65 3.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 174.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -95.29 120.77 36.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.193 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.482 HG22 ' SD ' ' A' ' 264' ' ' MET . 35.2 m -132.32 155.56 41.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.241 -169.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 98.4 m -116.09 123.39 47.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.222 168.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -109.06 132.75 53.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.181 -170.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 282' ' ' PRO . 88.5 tttt -129.01 126.51 23.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.195 170.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 281' ' ' LYS . 75.4 Cg_exo -55.08 141.0 80.52 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.703 1.602 . . . . 0.0 111.171 -177.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 66.3 mt -98.32 164.0 12.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.224 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 59.5 p -75.56 164.79 25.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.193 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.17 -39.36 78.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 91.5 p -70.15 -29.87 66.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.198 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.52 -42.74 91.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.204 174.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -72.32 -29.77 64.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.188 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -65.6 -40.1 92.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.196 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.08 -45.34 85.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 62.8 tp -61.4 -41.01 96.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 97.68 34.57 5.45 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -140.09 172.35 12.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.319 . . . . 0.0 111.247 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 83.1 p -107.73 -175.29 2.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.179 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -60.81 120.39 52.99 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.87 -19.9 39.92 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.707 1.605 . . . . 0.0 111.218 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 85.34 11.76 74.64 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.3 mt -95.14 138.21 33.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 111.229 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -101.88 156.46 17.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.206 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 43.5 t -57.76 138.71 55.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.179 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 149.64 -178.94 26.82 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -81.95 143.06 31.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.775 0.321 . . . . 0.0 111.203 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -126.13 140.1 52.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.202 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -105.19 114.88 29.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.178 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 43.8 tp -110.73 120.62 43.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.23 -176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -98.12 131.17 44.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.232 171.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.15 117.64 54.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.202 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -105.79 154.86 16.97 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -92.17 114.65 27.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.763 0.316 . . . . 0.0 111.16 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.51 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 84.4 mt -93.7 9.92 35.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.232 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 34.5 t0 87.55 -64.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.208 175.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -99.62 -7.28 25.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.186 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -137.76 173.27 11.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 71.0 m -126.88 139.6 52.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 170.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 90.7 p -94.5 154.35 17.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 74.5 mt -129.32 115.63 17.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.184 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -115.08 104.53 11.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 174.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -92.4 133.13 36.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.193 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 85.9 mt -115.96 124.88 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.231 168.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.444 ' HB2' ' HD2' ' A' ' 321' ' ' PRO . 31.2 p30 -76.05 174.37 5.71 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.209 -172.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 320' ' ' ASP . 64.0 Cg_exo -59.47 -25.44 78.65 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.688 1.592 . . . . 0.0 111.212 -175.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -84.34 -6.82 59.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.199 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.43 15.06 59.16 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -108.89 146.35 33.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.805 0.336 . . . . 0.0 111.22 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 74.9 p -67.25 149.97 49.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.419 ' HG ' ' HB2' ' A' ' 330' ' ' GLN . 13.9 tp -69.58 135.58 50.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.23 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 52.8 p -84.43 164.27 18.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.213 -168.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -54.98 -45.44 74.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.223 -174.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 97.3 p -63.02 -24.94 68.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . 0.419 ' HB2' ' HG ' ' A' ' 326' ' ' LEU . 74.7 mt-30 -88.72 -37.94 15.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.225 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -65.15 -37.45 87.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.179 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -72.84 -32.12 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.224 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -64.96 -33.07 75.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 94.3 mt -78.52 -7.94 58.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.24 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.06 -58.66 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.187 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -72.32 -33.45 67.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.239 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 68.5 t -63.95 -51.0 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.196 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -68.79 -41.29 78.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.18 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -54.55 -43.15 71.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -63.79 -41.13 97.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.186 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.79 -31.15 72.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.198 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -76.9 -34.64 57.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.151 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 83.5 p -77.04 -17.79 58.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.274 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.215 174.221 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.848 0.356 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 66.7 t -129.3 130.64 67.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -129.9 160.17 34.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.21 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 34.5 t -101.73 142.24 33.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.215 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -153.04 173.4 15.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.252 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -96.64 141.09 30.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.252 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -79.89 171.4 15.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.229 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.98 -25.62 67.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.166 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 61.7 p -83.55 -15.17 50.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.196 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.77 -5.56 58.31 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 95.3 mt -77.23 157.12 81.24 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.79 0.328 . . . . 0.0 111.19 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.49 133.03 55.71 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.74 1.627 . . . . 0.0 111.211 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 62.2 ttp -133.67 144.56 49.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.254 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 74.5 mt -109.98 145.72 36.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.166 171.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 68.5 t -124.34 127.12 72.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 94.2 t -111.93 134.77 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.223 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -65.82 113.06 4.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.187 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 127.73 142.19 5.45 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -73.31 169.21 22.82 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.738 1.625 . . . . 0.0 111.228 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -48.53 -45.29 37.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.187 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -63.37 -27.09 69.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.236 -173.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 72.9 t -88.26 -56.88 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.177 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 255' ' ' LEU . 76.6 t -67.58 -54.66 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.199 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -55.61 -39.71 71.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.207 -169.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -68.0 -35.95 79.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -107.99 8.81 28.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.211 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.546 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 50.7 tp -68.4 -41.7 25.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.223 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 82.4 Cg_exo -51.17 -38.95 61.87 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.689 1.593 . . . . 0.0 111.18 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.08 -44.91 87.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.222 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.19 -36.0 82.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.185 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.95 -38.2 66.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.203 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -57.67 -36.31 71.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.215 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -64.91 -26.24 68.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.176 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 35.7 m -106.71 18.75 5.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.233 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 85.78 14.57 67.32 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' MET . . . . . 0.442 ' SD ' HG22 ' A' ' 278' ' ' VAL . 58.1 ttm -111.9 99.92 8.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.764 0.316 . . . . 0.0 111.229 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.8 127.1 42.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.206 -171.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.41 ' HA ' HG12 ' A' ' 278' ' ' VAL . 98.0 t -72.61 127.98 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.227 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 73.8 p -108.21 -25.88 10.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.197 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -163.08 158.72 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 89.7 p -159.93 160.73 33.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.218 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 62.0 m -140.84 119.98 12.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 62.9 ttp180 -66.97 -43.52 82.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.182 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 96.9 p -73.33 -20.59 60.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.201 -169.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -112.41 -13.46 13.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 72.84 38.24 56.52 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -89.21 139.12 30.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 0.0 111.157 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 55.7 tpp -139.01 89.96 2.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.237 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -89.37 121.47 31.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.224 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.442 HG22 ' SD ' ' A' ' 264' ' ' MET . 34.6 m -129.99 153.63 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.239 -168.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.6 m -112.92 124.65 53.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.225 167.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -112.71 136.48 52.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.212 -171.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -134.69 128.73 19.07 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.22 171.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.17 140.48 81.0 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.643 1.562 . . . . 0.0 111.164 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 67.1 mt -99.67 163.9 12.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.239 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.3 p -73.47 163.13 28.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.186 -176.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.86 -35.3 72.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.241 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 87.9 p -71.42 -31.64 67.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.69 -43.08 94.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.189 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -72.5 -30.12 64.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.228 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -66.26 -40.2 90.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.172 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.19 -38.67 82.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.224 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.34 -36.28 81.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.214 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 94.72 19.16 32.62 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -174.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -115.71 -156.55 0.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.812 0.339 . . . . 0.0 111.194 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 10.7 t -147.84 -168.45 3.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.218 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -68.43 120.15 73.16 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.223 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.46 -15.03 25.04 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.686 1.591 . . . . 0.0 111.22 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 85.76 8.06 80.4 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.52 141.39 29.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.189 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -99.82 158.7 15.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.2 t -58.0 137.14 57.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.197 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 155.63 -179.65 31.42 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -87.03 138.23 31.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.325 . . . . 0.0 111.188 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -122.63 145.2 48.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.194 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -109.98 112.4 24.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.166 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 39.1 tp -105.73 120.06 40.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.235 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -92.25 128.18 38.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.173 170.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 52.7 t -115.09 122.79 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -116.25 157.2 15.17 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.77 120.28 34.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 0.0 111.165 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.524 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 88.2 mt -96.77 14.57 24.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.213 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 32.0 t0 87.61 -65.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -102.71 -10.42 19.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.213 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -139.16 176.7 8.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.218 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 58.7 m -119.83 138.05 53.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.231 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 23.7 t -100.06 128.59 46.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.182 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 68.4 mt -110.54 126.88 54.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.171 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -125.3 105.01 8.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -90.12 127.96 36.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.204 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 45.5 mm -108.89 127.66 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.253 170.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.427 ' C ' ' OD1' ' A' ' 320' ' ' ASP . 26.3 p30 -75.72 174.17 5.94 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.226 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 320' ' ' ASP . 71.9 Cg_exo -60.02 -26.07 81.43 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.716 1.611 . . . . 0.0 111.182 -173.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -83.29 -8.12 59.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.167 -174.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.73 15.13 58.63 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -105.94 146.9 29.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.799 0.333 . . . . 0.0 111.197 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 89.8 m -60.9 130.11 44.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.216 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 19.7 tp -63.24 134.71 56.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.166 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 56.7 p -81.29 164.75 22.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -166.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.75 -32.04 73.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.206 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 83.8 p -65.67 -18.11 65.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -107.85 -28.28 9.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.199 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -73.89 -42.28 60.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.227 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -62.04 -32.25 72.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.188 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -72.51 -35.02 68.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.238 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 38.5 mt -65.43 -32.39 73.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.195 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 58.0 t -52.6 -45.62 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -62.24 -45.47 93.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.196 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 5.3 m -78.82 -26.08 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -72.97 -43.96 61.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.214 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -55.36 -44.75 76.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -65.38 -41.03 94.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.08 -36.69 85.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.192 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -79.55 -38.83 33.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.239 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 90.0 p -73.06 -25.83 61.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.259 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.223 -177.809 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 48.3 p30 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.82 0.343 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 91.2 t -125.05 137.45 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -149.97 163.01 39.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.199 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 26.3 t -96.33 139.08 32.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.177 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -162.7 157.74 22.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.39 147.15 23.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.227 176.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -85.14 -166.81 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.221 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.97 -25.41 67.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 -172.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 63.0 p -97.41 1.01 48.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 -176.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 86.98 21.28 50.71 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.406 HD12 ' HD2' ' A' ' 240' ' ' PRO . 59.1 tp -99.62 114.44 65.61 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.35 . . . . 0.0 111.205 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.406 ' HD2' HD12 ' A' ' 239' ' ' LEU . 53.6 Cg_exo -54.24 135.74 65.92 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.725 1.617 . . . . 0.0 111.221 177.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.3 163.93 39.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.193 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.7 tp -76.9 127.66 33.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.181 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.1 t -108.36 121.91 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.218 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.5 t -124.34 125.16 69.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.23 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -76.43 91.7 3.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 -172.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 172.46 161.2 22.53 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 172.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.17 156.15 52.11 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.646 1.564 . . . . 0.0 111.191 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -48.91 -45.89 42.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -63.95 -22.27 66.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.249 -175.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 91.8 t -91.22 -50.38 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.163 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 74.3 t -73.01 -46.95 50.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.184 -173.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -60.63 -40.14 90.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.232 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -71.61 -35.38 70.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.169 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -80.16 -25.57 39.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.185 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.564 ' HB3' ' HD3' ' A' ' 256' ' ' PRO . 49.7 tp -53.83 -48.67 92.84 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 -169.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 255' ' ' LEU . 90.0 Cg_exo -47.8 -44.47 26.75 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.671 1.581 . . . . 0.0 111.192 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.42 -40.84 93.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.195 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.42 -35.4 80.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.245 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 81.5 mt -67.39 -37.63 83.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.211 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.56 -26.45 68.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.211 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -92.64 1.59 57.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.201 -173.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 35.5 m -125.34 9.81 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.237 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.97 27.58 33.76 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 172.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 98.3 mtp -117.2 105.96 12.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.757 0.313 . . . . 0.0 111.239 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -87.75 118.11 27.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.218 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 90.9 t -70.28 126.64 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.211 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 67.1 p -106.23 -28.11 10.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.231 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -162.16 160.85 27.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.214 174.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 83.5 p -154.53 152.79 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.207 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 60.6 m -144.53 122.67 12.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -92.69 -19.98 21.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.242 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 88.8 p -75.75 -15.06 60.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.205 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -117.95 -20.64 8.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.245 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.02 48.86 10.48 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -145.96 175.24 10.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.335 . . . . 0.0 111.182 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 50.3 ttm -159.83 148.52 17.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.213 -175.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -116.81 121.22 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.192 174.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 45.4 t -138.53 131.29 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.202 -168.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 97.8 m -92.87 120.13 32.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.2 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -97.85 127.34 43.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.195 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -123.03 120.2 27.56 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.2 172.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.06 134.09 61.77 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.692 1.595 . . . . 0.0 111.188 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 68.5 mt -99.27 163.78 12.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.19 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 60.9 p -81.75 167.48 19.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.217 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -59.16 -32.68 70.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 85.2 p -69.81 -22.54 63.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.179 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -82.13 -39.57 23.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.203 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -74.24 -24.61 59.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.216 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -68.5 -40.2 80.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.203 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.72 -38.7 76.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.209 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 48.0 tp -67.95 -36.25 79.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.204 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 84.75 42.71 7.13 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -139.14 160.13 40.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 111.216 -174.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 87.8 p -94.28 162.62 13.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.212 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -41.26 120.96 1.98 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.247 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.22 -24.93 57.98 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.721 1.614 . . . . 0.0 111.172 -176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 81.86 15.63 74.75 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.37 143.36 26.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 0.0 111.205 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -100.35 145.23 28.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.211 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 46.3 t -54.34 139.08 37.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.204 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 143.65 -171.53 25.28 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -84.56 138.52 32.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 111.221 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -119.25 137.41 53.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.225 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.445 ' HB3' ' HB ' ' A' ' 319' ' ' ILE . 88.1 tttt -94.33 126.34 39.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.19 171.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.408 ' HB3' HD11 ' A' ' 316' ' ' LEU . 63.5 mt -108.13 134.75 50.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.243 -176.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -123.05 124.14 42.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.19 173.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.413 HG23 HD13 ' A' ' 316' ' ' LEU . 70.5 t -115.4 125.09 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.189 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -118.11 156.5 15.62 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 176.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -102.63 108.52 19.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.752 0.311 . . . . 0.0 111.216 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 83.5 mt -87.97 67.66 9.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.198 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 64.93 -102.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.24 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -89.23 -8.19 54.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -118.34 175.05 5.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.194 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 74.5 m -132.24 159.35 39.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.203 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 87.8 p -133.04 149.53 52.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.215 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.413 HD13 HG23 ' A' ' 307' ' ' VAL . 37.1 tp -133.07 118.06 18.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.165 -175.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -100.22 140.21 34.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.233 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . 0.445 ' HB2' ' HB2' ' A' ' 326' ' ' LEU . 46.1 m-85 -108.52 131.25 55.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.233 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 304' ' ' LYS . 85.9 mt -116.48 119.32 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.235 168.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.466 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 30.2 p30 -78.14 175.85 4.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.172 -171.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.466 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 67.9 Cg_exo -59.45 -25.65 79.31 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.748 1.632 . . . . 0.0 111.175 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.88 -6.72 59.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 88.67 14.47 61.31 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -98.96 142.72 30.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.73 0.3 . . . . 0.0 111.242 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 81.4 p -78.67 162.61 26.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.178 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 318' ' ' PHE . 25.3 tp -62.55 131.7 49.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.267 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 66.4 p -87.74 164.92 15.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.18 177.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -61.55 -47.75 84.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 73.8 m -55.9 -42.71 76.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.224 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -64.99 -49.22 71.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -63.48 -34.57 78.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.171 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.84 -40.37 97.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -68.48 -34.12 75.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.216 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.74 -13.73 61.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.206 -175.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 74.1 t -55.83 -58.46 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.226 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -66.28 -34.96 79.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.68 -49.86 82.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.227 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -87.25 -24.52 24.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.213 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -55.22 -49.99 70.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.191 171.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -67.07 -36.55 82.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.213 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -70.17 -42.34 72.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.23 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -75.69 -27.78 58.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.156 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 72.8 m -81.24 -22.37 38.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.218 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 47.1 tptt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.224 178.468 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.795 0.331 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 96.9 t -120.84 138.87 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.193 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -130.29 163.04 27.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.226 176.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 40.7 t -92.85 140.37 29.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.182 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -146.69 175.83 10.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.202 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -119.58 144.32 47.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.238 174.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 42.2 p30 -88.63 -172.04 3.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.177 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -69.0 -19.21 64.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.188 -172.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 59.8 p -95.84 -7.37 37.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.183 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 92.89 6.49 63.5 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 240' ' ' PRO . 99.4 mt -87.43 145.45 37.53 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.783 0.325 . . . . 0.0 111.219 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 239' ' ' LEU . 54.6 Cg_exo -58.99 140.27 94.6 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.724 1.616 . . . . 0.0 111.192 -176.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -148.21 172.05 14.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.2 173.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 92.0 mt -108.89 150.49 27.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.195 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.9 149.43 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.221 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.78 138.71 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.203 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -71.9 74.08 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.169 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 174.94 164.44 29.7 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -76.25 159.83 36.49 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.718 1.612 . . . . 0.0 111.181 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -52.0 -44.28 64.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -63.42 -23.35 67.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.192 -171.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.16 -52.51 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.203 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.15 -52.94 55.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.204 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -57.71 -42.49 83.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.155 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -67.08 -34.7 78.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.185 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -100.0 4.55 44.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.211 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.528 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 46.6 tp -68.73 -43.39 28.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.217 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 85.9 Cg_exo -51.84 -36.91 64.85 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.73 1.62 . . . . 0.0 111.226 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.19 -45.54 91.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -66.27 -36.93 84.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 256' ' ' PRO . 49.0 mt -63.31 -43.82 96.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.158 -177.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.67 -20.19 66.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -93.52 -5.71 48.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.222 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 31.5 m -115.24 2.18 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.199 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 98.44 21.29 17.5 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' MET . . . . . 0.409 ' HG2' ' HB2' ' A' ' 280' ' ' TYR . 67.1 mtt -116.98 104.38 11.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 111.193 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -89.01 120.52 30.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.76 124.91 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.203 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 71.8 p -104.69 -25.37 12.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.216 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -164.99 160.62 19.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.226 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 84.7 p -162.89 157.67 21.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.179 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 68.3 m -143.23 121.06 11.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.217 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -73.26 -45.9 53.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.222 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 87.0 p -66.72 -21.07 66.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.202 -172.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.69 -21.81 12.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.213 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.61 42.59 26.3 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -128.14 160.6 31.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.801 0.334 . . . . 0.0 111.217 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 59.7 ttm -158.27 149.77 21.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.23 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -125.93 128.7 47.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.187 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.59 146.61 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.166 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 97.4 m -102.6 119.29 38.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.221 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . 0.409 ' HB2' ' HG2' ' A' ' 264' ' ' MET . 42.6 t80 -107.52 137.17 46.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.191 -172.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 282' ' ' PRO . 87.6 tttt -136.96 129.08 17.01 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.225 169.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 281' ' ' LYS . 76.0 Cg_exo -55.01 140.4 79.93 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.702 1.602 . . . . 0.0 111.215 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 56.5 mt -100.63 165.32 11.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.155 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.1 p -73.01 163.62 27.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.24 -37.37 74.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.156 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 89.5 p -71.25 -30.95 66.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.53 -42.41 92.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.222 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -71.55 -29.88 65.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.198 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -66.09 -39.95 90.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.206 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.92 -41.16 87.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.199 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.46 -41.88 98.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.213 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 97.48 35.6 5.15 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -143.64 160.27 40.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 111.141 -174.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 88.1 p -85.1 171.47 12.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.237 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -64.92 120.04 63.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.218 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -69.14 -21.03 36.95 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.76 1.64 . . . . 0.0 111.197 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.09 30.22 55.63 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 47.4 tp -106.4 133.44 51.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 111.188 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -86.4 164.75 16.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.236 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.0 p -68.72 164.71 21.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.191 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 145.36 172.12 15.52 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -91.75 109.32 20.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.747 0.308 . . . . 0.0 111.186 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -103.82 146.74 28.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -169.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -90.81 129.81 36.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.201 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.419 HD22 HD22 ' A' ' 255' ' ' LEU . 41.5 tp -123.19 119.93 31.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.219 -176.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -112.19 145.54 39.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 43.5 t -135.12 134.81 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.198 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -134.21 172.66 21.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -115.59 112.78 22.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 0.0 111.182 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.558 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 93.3 mt -83.37 0.52 45.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.177 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 34.0 t0 88.41 -64.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.178 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -76.4 -15.23 59.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.213 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -164.74 173.83 11.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.156 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 38.5 t -100.67 151.64 21.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.218 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 97.6 p -131.87 153.77 49.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.192 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 4.3 pp -150.59 156.47 41.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.218 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -149.21 136.5 20.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.179 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -102.13 138.49 39.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.202 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 85.4 mt -124.33 130.43 73.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.188 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -54.72 157.19 5.6 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.268 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.43 -25.67 49.72 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.681 1.587 . . . . 0.0 111.237 175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.84 0.8 57.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.222 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.83 32.01 10.51 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -124.42 121.6 35.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.802 0.334 . . . . 0.0 111.178 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 6.1 t -49.12 150.99 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 9.7 mp -62.53 151.5 37.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.158 165.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 69.6 p -85.14 161.83 19.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -57.25 -38.8 74.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.219 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 85.5 p -65.15 -26.03 68.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.197 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -88.72 -41.48 12.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.233 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -66.83 -41.22 87.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.242 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -57.52 -34.31 68.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.222 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -73.52 -36.79 65.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.202 173.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 67.9 mt -68.32 -20.11 64.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.182 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 55.9 t -54.13 -55.46 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.194 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -68.74 -34.97 76.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.84 -49.0 86.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.188 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -75.41 -37.95 60.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.211 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -53.57 -44.32 69.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.22 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -65.13 -41.27 94.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.197 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.52 -32.24 73.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.243 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -76.43 -29.33 56.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.209 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 72.2 p -76.99 -16.13 59.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.186 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.198 171.687 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.2 129.51 53.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.204 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -150.54 155.26 39.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 87.6 p -87.21 158.8 19.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.215 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -166.56 155.75 11.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.165 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -93.24 135.25 34.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.212 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 47.9 p30 -86.57 -165.81 1.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.215 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -65.15 -24.58 67.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.202 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 65.9 p -98.13 -2.3 40.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.201 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 86.46 11.28 72.08 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 32.4 tp -78.31 123.88 85.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 0.0 111.218 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.85 120.5 8.24 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.686 1.59 . . . . 0.0 111.223 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.451 ' HE2' ' HB2' ' A' ' 317' ' ' GLN . 67.9 mmm -129.79 160.04 34.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.223 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 33.6 tp -107.79 124.03 49.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.212 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.8 t -106.39 125.3 62.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 89.3 t -107.97 133.77 51.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.186 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -68.71 102.08 1.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' A' ' 247' ' ' PRO . . . 145.43 154.13 6.07 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 246' ' ' GLY . 51.8 Cg_exo -58.46 154.92 38.69 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.658 1.572 . . . . 0.0 111.208 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.442 ' CD1' ' O ' ' A' ' 248' ' ' PHE . 1.2 t80 -54.99 -45.45 75.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 178.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.56 -25.81 67.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.244 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.72 -49.03 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 255' ' ' LEU . 62.8 t -66.48 -39.55 84.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.177 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -54.57 -33.16 59.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.205 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -65.57 -34.96 79.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.226 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -108.95 4.88 23.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.193 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.571 ' N ' ' HD2' ' A' ' 256' ' ' PRO . 63.0 tp -64.36 -52.1 56.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.225 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 255' ' ' LEU . 42.7 Cg_endo -67.21 -24.8 43.7 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.697 1.598 . . . . 0.0 111.211 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.13 -49.69 71.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.192 171.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.19 -38.12 89.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 48.0 mt -62.4 -44.89 95.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.15 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.33 -33.05 74.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.199 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -71.79 -23.62 61.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.23 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 25.3 m -103.66 -0.26 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.226 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 107.03 -2.15 35.44 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 169.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 64.2 mtt -89.76 90.75 8.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 0.0 111.224 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -72.77 111.45 7.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 95.7 t -68.02 131.34 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 65.5 p -109.46 -30.98 7.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.246 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -168.65 161.21 11.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.197 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 39.9 t -147.05 125.21 12.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.239 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 92.8 m -93.81 115.05 27.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.255 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 92.0 mtm180 -80.58 -22.42 40.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.228 -173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 89.9 p -79.35 -15.28 58.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.192 -177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -119.77 -19.92 7.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.246 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 74.88 42.91 29.31 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -129.74 118.07 21.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 0.0 111.203 -171.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 59.7 ttm -111.58 131.89 54.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.239 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -103.13 133.77 47.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.17 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 19.5 m -132.71 147.37 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.195 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.0 m -98.47 115.22 28.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.255 166.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -93.57 115.07 27.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.191 -171.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -110.52 105.37 57.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.189 166.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -54.9 142.13 76.09 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.694 1.596 . . . . 0.0 111.216 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 287' ' ' ASP . 96.0 mt -80.28 153.47 28.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.195 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.7 p -75.22 167.92 20.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.23 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -55.38 -43.66 75.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.255 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 91.3 p -70.82 -31.24 67.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.193 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 283' ' ' LEU . 99.5 m-20 -66.58 -36.83 83.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -69.63 -29.89 67.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.219 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -71.48 -37.96 71.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.195 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.37 -41.86 79.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 55.8 tp -67.52 -39.93 85.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.208 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 87.99 40.96 6.44 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -140.56 159.91 41.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 111.214 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 89.1 p -77.19 165.59 24.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.202 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -103.63 108.54 59.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.197 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.79 169.44 21.18 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.723 1.615 . . . . 0.0 111.18 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -90.19 3.33 82.27 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 96.1 mt -53.71 176.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.772 0.32 . . . . 0.0 111.204 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -143.58 176.24 9.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.192 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 85.1 p -74.29 161.81 29.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.194 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 143.5 -177.66 22.16 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -91.24 104.94 17.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.799 0.333 . . . . 0.0 111.247 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -99.23 151.31 21.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.185 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -117.69 137.25 52.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.194 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 37.5 tp -121.93 106.93 11.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.23 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -93.36 121.53 34.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.168 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.49 127.31 70.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.192 -172.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -111.44 158.41 14.35 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -101.89 118.71 37.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.34 . . . . 0.0 111.229 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 89.6 mt -110.85 77.45 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.191 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.7 -108.54 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -100.9 28.71 5.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.165 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -134.24 151.82 51.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.25 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 57.8 m -109.62 128.59 55.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.151 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 32.7 t -106.4 111.42 23.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.19 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 69.7 mt -98.18 123.35 42.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.191 -172.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . 0.451 ' HB2' ' HE2' ' A' ' 241' ' ' MET . 65.4 tt0 -109.35 100.37 9.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.187 172.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -86.06 132.31 34.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.217 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 66.7 mt -124.6 124.27 67.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.224 -171.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -59.72 155.81 38.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.185 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -61.0 -18.63 58.8 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.663 1.575 . . . . 0.0 111.182 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -78.56 -11.94 59.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.189 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.73 14.53 43.15 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -119.06 152.77 35.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.804 0.335 . . . . 0.0 111.232 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 62.6 p -77.87 160.14 28.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.194 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 9.9 mp -70.35 142.39 52.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.229 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 69.9 p -81.45 164.58 21.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.199 -173.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -55.17 -36.97 66.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 76.9 p -62.57 -25.99 68.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.195 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -100.32 -29.24 12.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.196 -175.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -73.11 -24.25 60.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -80.33 -15.17 57.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.197 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -89.46 -29.47 18.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.188 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 88.3 mt -74.22 -10.34 59.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.162 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 6.0 m -66.74 -24.66 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.202 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -97.83 -32.01 11.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.234 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.23 -49.59 83.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.191 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -84.52 -33.62 23.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.187 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 66.9 tt0 -55.36 -45.82 76.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.214 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -64.72 -38.23 90.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.234 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.42 90.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.238 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -74.41 -30.21 61.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.179 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 90.1 p -85.57 -20.85 28.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.157 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 48.1 tptt . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.182 178.779 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.848 0.356 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.403 HG12 HG23 ' A' ' 244' ' ' VAL . 23.8 m -132.32 160.65 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.17 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -156.51 157.25 35.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.215 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 30.1 t -90.69 141.17 29.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.227 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -161.75 155.08 21.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.233 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.76 144.87 25.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.181 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 46.4 p30 -85.08 -164.66 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.218 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -65.01 -25.86 68.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.253 -172.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 53.8 p -95.45 -1.04 51.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.52 18.39 60.37 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 54.2 tp -90.72 115.85 65.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.164 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.67 130.37 38.35 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.711 1.607 . . . . 0.0 111.162 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -144.74 176.26 9.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.206 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 50.8 tp -102.88 127.09 50.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 99.8 t -110.47 125.52 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 314' ' ' SER . 47.8 t -99.22 137.56 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 176.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -80.64 80.0 7.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.201 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 170.04 159.47 15.99 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -53.06 136.17 60.61 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.673 1.582 . . . . 0.0 111.198 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -59.72 -27.82 66.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.249 -172.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -67.05 -40.71 87.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.179 173.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 68.1 t -68.85 -43.79 82.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.211 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 79.5 t -69.07 -40.54 80.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.233 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -55.1 -35.22 64.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.203 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -75.16 -33.16 61.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -97.33 -11.34 24.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.21 -172.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.526 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 57.0 tp -70.72 -43.6 15.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.175 -172.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 88.7 Cg_exo -51.26 -39.94 61.69 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.726 1.618 . . . . 0.0 111.21 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.13 -44.53 96.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.175 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.15 -39.55 93.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.21 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 256' ' ' PRO . 76.6 mt -60.78 -42.38 97.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.207 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -67.32 -22.97 65.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.184 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -93.28 -6.04 48.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.196 -174.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 29.4 m -111.17 -3.1 10.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.237 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 101.92 8.05 46.0 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 66.4 mtt -96.35 88.34 4.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 111.18 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.5 120.76 11.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.216 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.406 ' HA ' HG12 ' A' ' 278' ' ' VAL . 88.2 t -73.38 122.83 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.22 -175.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 60.3 p -110.45 -28.06 8.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.194 -175.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -161.39 155.82 22.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.209 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 40.8 t -162.09 115.92 1.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.199 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 86.8 m -125.43 112.16 15.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.213 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -75.26 -23.1 57.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.199 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 84.2 p -74.78 -16.29 60.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.216 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -118.3 -14.11 9.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.191 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 72.72 29.94 64.66 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -116.13 111.52 20.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 0.0 111.242 -169.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.4 ' SD ' HD21 ' A' ' 255' ' ' LEU . 95.1 mtp -115.84 152.81 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.2 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -142.88 135.02 27.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.192 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 266' ' ' VAL . 34.2 m -135.14 158.79 41.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.268 -175.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.4 m -110.07 118.62 36.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.186 165.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -95.8 127.44 41.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 -173.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -121.35 122.96 27.86 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.218 167.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -54.84 136.86 73.7 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.714 1.609 . . . . 0.0 111.192 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 77.1 mt -91.19 157.53 17.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.226 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.8 p -75.21 165.24 25.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.185 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -54.77 -43.88 73.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.19 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 91.8 p -69.03 -31.06 69.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.215 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.63 -40.45 95.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.22 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -70.59 -30.2 66.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.158 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -69.36 -39.64 77.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.198 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.62 -39.81 80.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.208 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.6 -45.0 84.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.183 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 97.84 34.7 5.37 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -142.64 155.8 44.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.231 -175.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 94.0 p -80.57 159.63 25.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.197 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -71.34 119.87 76.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.224 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.38 -15.02 25.24 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.687 1.591 . . . . 0.0 111.247 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.79 29.35 55.0 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 98.1 mt -93.91 143.29 26.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 0.0 111.208 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -90.09 163.81 14.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.206 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 82.9 p -69.64 160.67 31.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.225 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 145.57 178.63 21.24 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 174.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.57 132.74 34.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 0.0 111.173 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -122.37 149.55 43.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.202 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.86 154.91 23.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.174 174.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.557 HD13 ' C ' ' A' ' 305' ' ' LEU . 3.2 tm? -139.61 111.24 7.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.211 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 317' ' ' GLN . 62.5 tp60 -92.44 120.71 33.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.175 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 92.8 t -87.57 126.78 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.169 175.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -87.31 161.77 32.95 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 175.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -97.59 87.45 4.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 111.172 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 97.7 mt -113.65 142.83 45.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 175.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -70.34 -49.98 43.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.206 -172.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -111.08 4.65 19.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.213 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -138.5 171.71 13.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.17 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' SER . . . . . 0.414 ' HB3' ' HB ' ' A' ' 244' ' ' VAL . 46.3 t -128.24 114.82 17.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 171.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 11.3 t -81.32 113.63 19.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.183 175.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 73.0 mt -105.65 98.62 8.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.187 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 306' ' ' GLN . 62.7 tt0 -88.93 99.01 12.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.2 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -84.01 132.38 34.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 86.4 mt -125.05 129.54 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.189 -173.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.431 ' HB2' ' HD2' ' A' ' 321' ' ' PRO . 31.4 p30 -75.6 173.46 7.05 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.164 -173.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 320' ' ' ASP . 52.9 Cg_exo -59.94 -26.25 81.82 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.641 1.561 . . . . 0.0 111.264 -175.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -81.56 -8.5 59.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.191 -175.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.24 24.1 27.64 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -119.79 139.31 52.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.761 0.315 . . . . 0.0 111.222 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 74.3 m -65.08 137.39 57.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.223 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 88.4 mt -61.86 147.44 46.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.185 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 60.1 p -82.19 168.48 17.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.177 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -52.88 -41.95 64.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.173 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 89.4 p -64.96 -26.18 68.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.182 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -91.55 -23.13 20.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.215 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -85.07 -29.95 24.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.214 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -65.5 -36.87 85.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.176 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -64.79 -34.77 79.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.167 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.24 -13.96 60.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.235 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.16 -58.39 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.21 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.43 -35.01 79.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.204 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.84 -51.65 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.237 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -78.12 -30.68 49.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.216 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -52.76 -45.4 67.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.166 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -70.01 -39.19 75.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.178 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.19 -35.04 79.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.218 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -77.4 -24.78 50.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 65.5 p -76.99 -18.2 58.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.165 175.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 173.094 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.772 0.32 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 10.0 p -147.05 146.8 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.207 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -146.51 169.07 19.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.209 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 29.0 t -100.95 142.07 32.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.196 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -155.64 161.05 40.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -86.02 144.95 27.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.179 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 43.5 p30 -92.87 -171.59 2.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.162 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -69.86 -18.33 63.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.176 -173.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 70.8 p -95.62 -7.1 38.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.186 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.93 7.48 64.3 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 99.4 mt -93.63 148.83 36.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.787 0.327 . . . . 0.0 111.164 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.06 141.6 48.56 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.733 1.622 . . . . 0.0 111.182 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -143.82 163.38 33.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.234 175.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 36.6 tp -103.82 114.22 28.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.163 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.86 123.28 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.182 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 96.6 t -100.11 135.64 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.235 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -76.12 74.49 2.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.212 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.402 ' HA2' ' HD3' ' A' ' 247' ' ' PRO . . . 168.83 157.64 11.77 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 173.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . 0.402 ' HD3' ' HA2' ' A' ' 246' ' ' GLY . 51.8 Cg_exo -60.63 157.68 36.0 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.699 1.6 . . . . 0.0 111.209 -178.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.418 ' HA ' HG23 ' A' ' 251' ' ' VAL . 50.5 p90 -65.23 -20.26 66.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.205 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -69.87 -28.49 65.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.217 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 75.2 t -85.1 -39.21 13.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.173 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 248' ' ' PHE . 14.7 m -67.26 -17.77 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -67.13 -13.71 62.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.182 173.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -105.35 -27.95 11.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.195 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.29 -42.58 36.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.546 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 82.3 mt -72.18 -41.47 8.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.182 -165.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 87.8 Cg_exo -48.26 -42.73 33.24 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.654 1.569 . . . . 0.0 111.199 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -88.59 -42.24 12.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -41.44 97.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.185 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.43 -48.79 78.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.19 -36.87 76.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.181 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -87.56 3.06 49.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.216 -172.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 34.2 m -119.03 14.26 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.202 172.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 104.64 -1.76 42.32 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 168.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' MET . . . . . 0.401 ' HG2' ' HB2' ' A' ' 280' ' ' TYR . 73.1 mtm -108.96 85.28 2.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.766 0.317 . . . . 0.0 111.179 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -68.27 122.07 17.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.218 -175.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.472 ' HA ' HG12 ' A' ' 278' ' ' VAL . 91.3 t -70.53 124.51 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.22 -176.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 72.4 p -109.58 -25.78 10.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -162.47 162.35 27.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 32.1 t -162.61 136.44 6.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.165 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 89.4 m -123.25 117.98 26.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.217 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -74.31 -35.56 63.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 94.5 p -65.51 -21.31 66.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.205 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -107.97 -21.62 12.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.193 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 72.14 38.28 59.38 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -129.35 128.52 43.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.207 -169.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 90.7 mtp -117.51 147.98 42.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.201 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -120.98 130.14 53.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 266' ' ' VAL . 33.8 m -131.12 153.43 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 -174.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 85.9 m -106.35 122.93 47.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.223 167.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . 0.401 ' HB2' ' HG2' ' A' ' 264' ' ' MET . 54.2 t80 -101.68 129.62 47.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.223 -171.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.4 124.94 27.05 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.186 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.76 130.25 39.43 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.698 1.599 . . . . 0.0 111.197 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 78.5 mt -96.92 155.26 16.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.214 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 56.1 p -73.53 163.83 27.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.198 -176.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.08 -36.69 70.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 89.1 p -71.45 -30.89 66.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.241 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.56 -41.9 92.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.199 175.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -73.36 -29.19 62.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.213 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -66.78 -40.04 88.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.195 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.82 -38.16 85.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.194 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 59.7 tp -65.31 -39.59 92.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.179 173.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 91.24 35.28 7.11 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -142.58 163.53 32.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 111.147 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 94.2 p -86.55 167.35 14.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.178 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -65.03 120.97 71.43 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.222 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.88 -18.96 47.0 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.679 1.586 . . . . 0.0 111.184 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 80.92 34.61 26.78 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 80.5 mt -105.64 137.21 43.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.827 0.346 . . . . 0.0 111.187 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -93.76 160.47 14.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.237 173.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.9 p -60.67 156.63 16.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.208 -173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 136.13 -176.3 20.35 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -86.93 136.55 32.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 111.173 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -123.01 153.98 39.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -119.17 148.67 42.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.226 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 44.3 tp -134.6 113.53 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.203 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -98.55 130.33 45.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.204 174.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.96 127.58 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.169 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -107.69 154.21 16.63 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -91.3 105.48 17.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 -175.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.705 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 90.6 mt -95.41 3.01 54.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.234 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . 0.705 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 52.5 t0 101.42 -117.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.203 -174.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -71.37 -9.1 57.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.229 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -119.77 173.76 6.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 175.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 75.4 m -126.92 147.47 50.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 29.8 t -104.64 118.91 37.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 47.0 mt -96.1 113.15 24.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -105.51 110.41 22.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -95.26 133.42 39.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.217 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 87.1 mt -122.84 128.98 75.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.196 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.456 ' HB2' ' HD2' ' A' ' 321' ' ' PRO . 33.5 p30 -80.21 174.94 5.34 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -175.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 320' ' ' ASP . 53.4 Cg_exo -59.97 -24.46 76.46 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.678 1.585 . . . . 0.0 111.198 -175.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.29 -5.29 59.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.184 -174.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.67 18.78 56.01 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -117.49 150.46 38.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 0.0 111.214 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 73.9 p -76.73 160.75 29.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.181 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 85.9 mt -76.93 150.13 35.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.192 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 40.5 p -75.19 166.96 22.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -54.85 -40.41 69.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.227 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 99.4 p -68.89 -33.66 74.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.174 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -75.63 -35.52 60.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.209 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -76.18 -31.18 58.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.198 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.71 -38.42 83.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.235 174.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -65.42 -34.75 79.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.202 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.03 -20.35 65.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.215 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 76.7 t -56.87 -54.03 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.165 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.12 -35.83 82.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.191 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.7 -49.95 82.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.169 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -81.6 -28.55 33.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.221 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -57.78 -43.02 85.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.236 173.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -69.21 -43.49 73.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.184 175.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.92 -28.09 69.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.181 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -84.21 -37.62 21.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.242 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 84.8 p -70.61 -21.4 62.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.223 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.194 175.783 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.749 0.309 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 82.9 t -124.99 130.79 73.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.168 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -121.28 156.17 33.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.192 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.6 t -91.72 140.68 29.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.99 179.77 8.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.24 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -128.89 148.0 50.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.163 172.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 42.5 p30 -85.06 -170.02 2.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.209 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.01 -24.17 67.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.213 -171.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 61.6 p -97.34 -1.51 44.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.182 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.91 18.18 60.11 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.7 mt -91.46 157.28 42.48 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 0.0 111.192 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -55.07 134.86 66.12 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.667 1.578 . . . . 0.0 111.261 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 67.9 ttp -148.81 149.04 30.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.222 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 83.2 mt -113.8 144.61 42.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.199 169.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 95.3 t -113.19 119.73 61.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.225 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.4 t -105.33 137.38 35.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.227 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.9 ttt180 -64.77 107.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.459 ' HA2' ' HD3' ' A' ' 247' ' ' PRO . . . 130.76 143.56 5.33 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.459 ' HD3' ' HA2' ' A' ' 246' ' ' GLY . 45.0 Cg_exo -58.55 167.73 4.77 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.732 1.621 . . . . 0.0 111.191 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -48.99 -46.99 44.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -62.99 -26.19 68.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.159 -173.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 81.3 t -85.29 -52.56 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.224 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 255' ' ' LEU . 74.0 t -73.58 -53.81 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.181 -173.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -56.27 -39.87 73.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 -172.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -73.86 -29.75 62.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -107.55 6.01 27.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.177 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.543 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 60.8 tp -65.48 -42.38 56.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.23 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 85.9 Cg_exo -51.75 -35.4 58.25 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.693 1.595 . . . . 0.0 111.188 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.94 79.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.11 -34.91 77.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.213 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.434 HD23 ' SD ' ' A' ' 264' ' ' MET . 81.0 mt -63.48 -41.76 98.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.186 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.56 -25.39 67.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.192 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -80.69 -20.07 43.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.21 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 31.6 m -105.16 9.82 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.204 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.64 20.22 58.63 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' MET . . . . . 0.514 ' SD ' HG22 ' A' ' 278' ' ' VAL . 59.7 ttm -119.09 103.24 9.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.775 0.321 . . . . 0.0 111.213 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -93.65 129.08 40.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.166 -170.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.456 ' HA ' HG12 ' A' ' 278' ' ' VAL . 95.0 t -73.2 127.7 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.213 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 65.3 p -108.84 -27.88 9.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.219 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -162.71 166.31 24.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.237 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 82.8 p -161.41 153.78 20.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.208 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 85.1 m -133.92 112.0 10.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.185 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -72.86 -22.11 60.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 84.9 p -77.99 -12.41 59.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.178 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -116.87 -20.04 9.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.224 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.31 25.94 67.18 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -172.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -110.04 149.99 29.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.776 0.322 . . . . 0.0 111.187 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 56.7 ttm -140.07 136.76 33.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.196 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -110.59 125.6 53.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.197 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.514 HG22 ' SD ' ' A' ' 264' ' ' MET . 34.8 m -134.46 155.4 38.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.19 -169.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.0 m -117.92 125.06 49.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 172.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -113.15 137.61 51.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.209 -171.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -136.69 129.89 17.6 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.181 170.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.98 139.08 79.48 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.687 1.591 . . . . 0.0 111.269 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 64.3 mt -99.79 166.49 11.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.173 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 56.7 p -74.96 164.89 26.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.259 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -58.25 -39.3 78.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.21 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 93.9 p -70.29 -30.53 67.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.208 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.92 -43.58 92.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.215 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -71.63 -28.71 63.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.201 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -66.73 -40.53 88.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.194 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.98 -39.15 87.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.212 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.92 -39.0 90.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.188 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 90.3 39.93 5.89 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 -175.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -141.92 166.36 24.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.775 0.321 . . . . 0.0 111.208 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 82.8 p -99.43 -178.45 3.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.163 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.404 ' HA ' ' HD2' ' A' ' 296' ' ' PRO . 66.0 t0 -64.74 120.66 68.01 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.183 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 295' ' ' ASP . 37.9 Cg_endo -67.04 -22.94 47.05 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.728 1.619 . . . . 0.0 111.21 -177.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.86 19.09 60.15 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 10.8 mp -101.29 140.28 35.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.228 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -99.33 159.56 14.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.184 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.3 t -60.16 139.99 57.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.181 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 153.15 -179.33 29.64 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -86.08 136.36 33.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.748 0.308 . . . . 0.0 111.244 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -121.15 149.05 43.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 319' ' ' ILE . 87.7 tttt -110.72 122.13 47.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.212 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 62.8 mt -103.15 135.85 44.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.241 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -119.65 125.14 48.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.208 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 315' ' ' SER . 57.6 t -122.32 120.31 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -109.34 155.05 16.27 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -88.92 118.76 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 111.194 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.532 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 87.9 mt -95.45 11.41 32.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.225 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 37.1 t0 87.63 -64.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.157 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -101.81 -10.1 20.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.181 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 89.8 mmt-85 -137.69 176.57 8.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.217 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 50.3 m -119.99 136.59 54.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 307' ' ' VAL . 27.8 t -96.71 109.74 22.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 174.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 48.9 tp -111.72 124.0 51.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.182 -176.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -127.02 148.46 50.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.221 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -112.27 125.92 54.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -173.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' A' ' 304' ' ' LYS . 92.5 mt -108.23 124.41 64.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.225 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.452 ' HB2' ' HD2' ' A' ' 321' ' ' PRO . 35.1 p30 -75.13 173.83 6.32 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.241 -174.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 320' ' ' ASP . 51.8 Cg_exo -59.93 -25.18 78.79 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.73 1.62 . . . . 0.0 111.177 -176.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -80.18 -9.75 59.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.167 -173.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.58 17.17 42.97 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -120.42 162.01 20.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.797 0.332 . . . . 0.0 111.189 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 78.4 p -79.32 153.94 29.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.195 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 68.2 mt -76.47 158.43 31.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.197 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 41.0 p -76.76 167.05 22.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.199 -173.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -61.8 -35.04 77.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.21 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 98.9 p -71.51 -35.78 70.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.21 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -68.82 -41.95 77.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -67.61 -37.49 82.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.214 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -60.69 -37.41 81.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.195 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -66.7 -38.89 87.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.248 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 84.5 mt -68.19 -22.64 64.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.227 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.78 -56.75 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.169 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -67.98 -35.36 78.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.201 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.52 -46.53 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.179 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -79.66 -28.91 40.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.257 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -54.26 -42.07 69.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.221 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -76.17 -34.33 59.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.211 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.05 -40.82 95.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -74.02 -27.61 61.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.215 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 90.5 p -82.78 -27.83 30.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.215 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -62.68 124.84 84.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.237 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -53.91 130.28 38.45 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.701 1.6 . . . . 0.0 111.196 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 1.0 -14.531 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 . . . . . 0 CA--C 1.523 -0.071 0 CA-C-O 120.845 0.355 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 83.2 t -127.0 125.21 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.186 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -112.51 156.89 21.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.228 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 35.0 t -95.62 136.24 36.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.191 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.28 167.71 29.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.215 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -99.48 145.73 27.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 41.8 p30 -85.85 -169.9 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.35 -25.5 67.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.175 -172.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 68.6 p -97.58 -1.22 44.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.219 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.0 18.53 60.95 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 98.4 mt -94.0 158.09 36.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.753 0.311 . . . . 0.0 111.216 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.06 139.3 80.02 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.696 1.598 . . . . 0.0 111.212 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.421 ' SD ' ' OG ' ' A' ' 315' ' ' SER . 64.5 ttp -156.08 149.88 25.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.172 -175.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 88.6 mt -111.89 143.91 42.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.203 172.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 94.2 t -118.08 120.94 66.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 176.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.01 140.03 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.181 -175.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -74.88 92.51 2.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.179 -174.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 153.59 156.07 7.46 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 173.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.4 157.87 38.79 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.728 1.618 . . . . 0.0 111.207 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -48.18 -47.05 35.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -63.34 -24.07 67.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.202 -174.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 90.2 t -88.44 -51.1 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.207 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 255' ' ' LEU . 72.6 t -74.42 -52.0 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.24 -174.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 87.9 t90 -55.12 -39.92 69.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.239 -174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -75.19 -31.69 61.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.193 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -99.02 -0.71 41.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.201 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.522 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 55.9 tp -69.64 -43.61 22.28 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 -176.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 74.2 Cg_exo -53.2 -35.81 75.02 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.714 1.609 . . . . 0.0 111.147 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.56 -47.47 78.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.216 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.12 73.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.204 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 256' ' ' PRO . 56.0 mt -67.64 -49.85 60.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.181 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.78 -31.75 69.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.171 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -60.76 -31.46 70.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.21 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.3 24.95 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.191 -171.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.65 23.34 50.65 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 170.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' MET . . . . . 0.427 ' HB3' HG22 ' A' ' 278' ' ' VAL . 67.1 mtt -118.87 104.96 11.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.772 0.32 . . . . 0.0 111.227 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -96.7 112.23 24.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 95.7 t -69.62 127.84 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.234 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 79.6 p -103.84 -26.08 12.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.191 -174.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -165.12 162.26 20.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.157 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 86.0 p -159.48 154.34 24.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.191 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 91.6 m -132.08 109.91 10.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.184 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -72.54 -23.32 60.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.219 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 86.3 p -77.69 -12.7 60.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.199 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -119.56 -18.81 8.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.223 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.45 28.92 60.72 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -109.5 150.22 28.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.345 . . . . 0.0 111.196 -173.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 58.9 ttm -142.33 137.31 30.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.219 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -117.54 126.32 52.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.19 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 264' ' ' MET . 10.5 p -138.77 135.65 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.179 -167.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 98.0 m -95.85 125.01 40.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.246 176.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -114.16 137.78 51.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.163 -172.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 282' ' ' PRO . 89.1 tttt -132.62 127.58 20.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.203 169.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 281' ' ' LYS . 77.7 Cg_exo -55.03 137.6 76.71 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.765 1.643 . . . . 0.0 111.212 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 70.4 mt -99.23 163.85 12.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.21 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 58.7 p -71.55 163.26 28.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.174 -176.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.57 -38.69 75.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.194 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 90.9 p -69.64 -30.35 68.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.193 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.63 -43.96 92.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.254 175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -74.28 -26.45 60.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.184 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -67.56 -40.6 84.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.199 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -70.3 -35.1 73.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.21 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.87 -29.14 66.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 77.37 35.28 37.86 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -137.01 154.65 50.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.769 0.318 . . . . 0.0 111.182 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 36.1 t -70.45 142.16 52.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.209 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -64.72 117.21 36.09 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.214 175.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 156.83 62.34 Favored 'Trans proline' 0 C--N 1.327 -0.559 0 C-N-CA 121.696 1.597 . . . . 0.0 111.191 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -89.56 34.33 4.06 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 11.1 mp -100.32 139.92 35.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.762 0.315 . . . . 0.0 111.191 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -103.74 162.73 12.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.209 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.7 t -59.53 134.6 57.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 158.4 -178.97 34.41 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -86.82 133.42 33.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.804 0.335 . . . . 0.0 111.205 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -121.28 153.03 38.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.197 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -112.22 160.63 17.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.171 173.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 53.2 tp -144.98 128.82 17.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.173 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -109.75 122.77 48.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.199 170.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 47.7 t -116.48 126.9 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.199 -172.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -114.37 167.46 12.32 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -107.08 104.4 14.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 111.185 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.1 59.95 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 64.91 -104.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.189 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -93.93 16.02 15.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.234 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -131.6 166.14 22.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.174 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 58.2 m -118.37 138.79 52.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.203 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.421 ' OG ' ' SD ' ' A' ' 241' ' ' MET . 31.2 t -107.01 112.75 25.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.246 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 64.0 mt -101.76 113.59 26.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.193 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -105.72 102.4 11.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.165 170.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -86.97 135.11 33.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.219 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 79.5 mt -124.03 128.63 74.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.18 -172.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.429 ' HB2' ' HD2' ' A' ' 321' ' ' PRO . 30.8 p30 -72.7 173.32 5.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.189 -175.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 320' ' ' ASP . 50.4 Cg_exo -60.45 -24.67 78.55 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.668 1.579 . . . . 0.0 111.24 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -81.69 -8.42 59.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 -175.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 88.75 24.6 32.32 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -121.09 143.82 48.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.809 0.338 . . . . 0.0 111.245 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 87.6 m -62.82 135.0 57.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.23 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 95.5 mt -59.91 155.25 16.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.217 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 69.4 p -83.23 165.97 18.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.247 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.61 -34.96 76.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.229 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 83.1 p -64.89 -25.65 67.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.189 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -90.01 -41.17 11.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -70.0 -36.52 75.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -57.95 -36.58 72.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.241 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -71.57 -35.74 70.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.191 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.07 -19.5 63.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 54.5 t -53.55 -53.78 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.173 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -66.49 -35.4 80.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.214 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 63.0 t -58.26 -50.18 79.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.168 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -86.17 -24.69 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.209 -176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -53.88 -49.55 68.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.181 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -76.53 -46.28 27.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.198 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.12 -36.46 81.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.208 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -72.54 -41.75 65.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.162 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 87.1 p -78.21 -15.33 58.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.194 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -109.26 153.58 42.6 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.193 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.46 143.53 77.2 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.717 1.611 . . . . 0.0 111.156 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 1.0 -14.496 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.822 0.344 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 97.1 t -130.92 135.17 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -129.99 161.72 30.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 -176.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 31.9 t -101.93 145.98 28.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.201 172.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -154.28 166.96 31.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.203 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.73 139.82 30.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.209 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -81.78 173.04 12.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.25 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -65.31 -23.32 66.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 60.0 p -82.85 -15.43 51.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.197 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.43 -4.52 64.39 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 98.0 mt -81.84 154.15 70.34 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.173 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.14 130.0 38.33 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.655 1.57 . . . . 0.0 111.259 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 63.1 ttp -130.01 139.64 51.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 43.1 tp -104.56 128.45 52.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.23 174.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 31.7 m -123.91 149.95 28.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.222 -173.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.41 145.62 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -74.86 84.33 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.2 -172.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' A' ' 247' ' ' PRO . . . 158.59 156.57 8.07 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 171.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 246' ' ' GLY . 35.4 Cg_exo -61.45 161.14 24.93 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.718 1.612 . . . . 0.0 111.234 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -48.8 -46.16 41.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.192 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -60.35 -30.68 69.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.167 -175.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 81.5 t -83.12 -52.47 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.225 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 255' ' ' LEU . 79.2 t -73.89 -50.17 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.24 -171.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 91.1 t90 -55.81 -37.39 68.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 -173.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -74.88 -30.93 61.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -96.89 -8.07 31.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.212 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.513 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 61.4 tp -67.45 -44.12 44.63 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 -173.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 90.9 Cg_exo -49.34 -40.4 43.85 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.658 1.572 . . . . 0.0 111.192 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.09 -43.25 95.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.252 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.0 -27.46 66.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.205 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.409 HD23 ' SD ' ' A' ' 264' ' ' MET . 93.2 mt -77.1 -39.61 48.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.203 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -63.03 -26.71 68.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.221 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -77.64 -14.86 59.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 35.9 m -113.78 15.8 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.219 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.16 14.45 71.8 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' MET . . . . . 0.482 ' SD ' HG22 ' A' ' 278' ' ' VAL . 57.4 ttm -110.19 100.04 9.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 111.227 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -89.45 127.1 35.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 -171.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.448 ' HA ' HG12 ' A' ' 278' ' ' VAL . 96.3 t -74.31 124.84 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.201 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 64.6 p -107.73 -26.63 10.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.2 -177.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -163.41 158.7 21.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.168 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 87.9 p -159.36 155.4 26.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.175 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 81.3 m -140.11 116.69 10.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.228 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -67.14 -38.73 86.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.24 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 96.6 p -73.54 -21.84 60.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.189 -170.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -113.83 -12.1 12.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.212 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 74.39 36.81 48.95 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -91.03 134.96 34.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 111.24 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 59.9 tpp -135.82 96.65 3.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 174.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -95.29 120.77 36.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.193 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.482 HG22 ' SD ' ' A' ' 264' ' ' MET . 35.2 m -132.32 155.56 41.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.241 -169.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 98.4 m -116.09 123.39 47.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.222 168.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -109.06 132.75 53.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.181 -170.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 282' ' ' PRO . 88.5 tttt -129.01 126.51 23.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.195 170.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 281' ' ' LYS . 75.4 Cg_exo -55.08 141.0 80.52 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.703 1.602 . . . . 0.0 111.171 -177.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 66.3 mt -98.32 164.0 12.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.224 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 59.5 p -75.56 164.79 25.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.193 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.17 -39.36 78.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 91.5 p -70.15 -29.87 66.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.198 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.52 -42.74 91.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.204 174.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -72.32 -29.77 64.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.188 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -65.6 -40.1 92.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.196 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.08 -45.34 85.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 62.8 tp -61.4 -41.01 96.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 97.68 34.57 5.45 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -140.09 172.35 12.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.319 . . . . 0.0 111.247 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 83.1 p -107.73 -175.29 2.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.179 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -60.81 120.39 52.99 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.87 -19.9 39.92 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.707 1.605 . . . . 0.0 111.218 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 85.34 11.76 74.64 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.3 mt -95.14 138.21 33.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 111.229 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -101.88 156.46 17.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.206 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 43.5 t -57.76 138.71 55.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.179 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 149.64 -178.94 26.82 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -81.95 143.06 31.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.775 0.321 . . . . 0.0 111.203 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -126.13 140.1 52.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.202 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -105.19 114.88 29.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.178 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 43.8 tp -110.73 120.62 43.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.23 -176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -98.12 131.17 44.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.232 171.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.15 117.64 54.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.202 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -105.79 154.86 16.97 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -92.17 114.65 27.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.763 0.316 . . . . 0.0 111.16 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.51 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 84.4 mt -93.7 9.92 35.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.232 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 34.5 t0 87.55 -64.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.208 175.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -99.62 -7.28 25.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.186 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -137.76 173.27 11.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 71.0 m -126.88 139.6 52.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 170.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 90.7 p -94.5 154.35 17.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 74.5 mt -129.32 115.63 17.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.184 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -115.08 104.53 11.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 174.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -92.4 133.13 36.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.193 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 85.9 mt -115.96 124.88 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.231 168.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.444 ' HB2' ' HD2' ' A' ' 321' ' ' PRO . 31.2 p30 -76.05 174.37 5.71 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.209 -172.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 320' ' ' ASP . 64.0 Cg_exo -59.47 -25.44 78.65 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.688 1.592 . . . . 0.0 111.212 -175.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -84.34 -6.82 59.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.199 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.43 15.06 59.16 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -108.89 146.35 33.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.805 0.336 . . . . 0.0 111.22 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 74.9 p -67.25 149.97 49.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.419 ' HG ' ' HB2' ' A' ' 330' ' ' GLN . 13.9 tp -69.58 135.58 50.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.23 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 52.8 p -84.43 164.27 18.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.213 -168.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -54.98 -45.44 74.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.223 -174.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 97.3 p -63.02 -24.94 68.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . 0.419 ' HB2' ' HG ' ' A' ' 326' ' ' LEU . 74.7 mt-30 -88.72 -37.94 15.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.225 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -65.15 -37.45 87.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.179 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -72.84 -32.12 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.224 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -64.96 -33.07 75.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 94.3 mt -78.52 -7.94 58.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.24 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.06 -58.66 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.187 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -72.32 -33.45 67.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.239 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 68.5 t -63.95 -51.0 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.196 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -68.79 -41.29 78.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.18 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -54.55 -43.15 71.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -63.79 -41.13 97.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.186 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.79 -31.15 72.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.198 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -76.9 -34.64 57.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.151 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 83.5 p -77.04 -17.79 58.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.274 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -95.3 151.66 38.84 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.215 174.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.1 151.14 61.11 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.729 1.619 . . . . 0.0 111.204 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 0.999 -14.542 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.848 0.356 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 66.7 t -129.3 130.64 67.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -129.9 160.17 34.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.21 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 34.5 t -101.73 142.24 33.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.215 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -153.04 173.4 15.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.252 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -96.64 141.09 30.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.252 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -79.89 171.4 15.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.229 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.98 -25.62 67.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.166 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 61.7 p -83.55 -15.17 50.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.196 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.77 -5.56 58.31 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 95.3 mt -77.23 157.12 81.24 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.79 0.328 . . . . 0.0 111.19 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.49 133.03 55.71 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.74 1.627 . . . . 0.0 111.211 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 62.2 ttp -133.67 144.56 49.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.254 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 74.5 mt -109.98 145.72 36.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.166 171.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 68.5 t -124.34 127.12 72.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 94.2 t -111.93 134.77 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.223 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -65.82 113.06 4.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.187 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 127.73 142.19 5.45 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -73.31 169.21 22.82 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.738 1.625 . . . . 0.0 111.228 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -48.53 -45.29 37.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.187 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -63.37 -27.09 69.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.236 -173.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 72.9 t -88.26 -56.88 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.177 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 255' ' ' LEU . 76.6 t -67.58 -54.66 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.199 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -55.61 -39.71 71.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.207 -169.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -68.0 -35.95 79.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -107.99 8.81 28.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.211 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.546 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 50.7 tp -68.4 -41.7 25.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.223 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 82.4 Cg_exo -51.17 -38.95 61.87 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.689 1.593 . . . . 0.0 111.18 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.08 -44.91 87.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.222 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.19 -36.0 82.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.185 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.95 -38.2 66.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.203 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -57.67 -36.31 71.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.215 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -64.91 -26.24 68.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.176 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 35.7 m -106.71 18.75 5.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.233 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 85.78 14.57 67.32 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' MET . . . . . 0.442 ' SD ' HG22 ' A' ' 278' ' ' VAL . 58.1 ttm -111.9 99.92 8.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.764 0.316 . . . . 0.0 111.229 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.8 127.1 42.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.206 -171.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.41 ' HA ' HG12 ' A' ' 278' ' ' VAL . 98.0 t -72.61 127.98 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.227 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 73.8 p -108.21 -25.88 10.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.197 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -163.08 158.72 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 89.7 p -159.93 160.73 33.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.218 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 62.0 m -140.84 119.98 12.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 62.9 ttp180 -66.97 -43.52 82.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.182 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 96.9 p -73.33 -20.59 60.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.201 -169.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -112.41 -13.46 13.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 72.84 38.24 56.52 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -89.21 139.12 30.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 0.0 111.157 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 55.7 tpp -139.01 89.96 2.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.237 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -89.37 121.47 31.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.224 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.442 HG22 ' SD ' ' A' ' 264' ' ' MET . 34.6 m -129.99 153.63 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.239 -168.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.6 m -112.92 124.65 53.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.225 167.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -112.71 136.48 52.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.212 -171.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -134.69 128.73 19.07 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.22 171.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.17 140.48 81.0 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.643 1.562 . . . . 0.0 111.164 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 67.1 mt -99.67 163.9 12.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.239 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.3 p -73.47 163.13 28.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.186 -176.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.86 -35.3 72.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.241 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 87.9 p -71.42 -31.64 67.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.69 -43.08 94.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.189 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -72.5 -30.12 64.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.228 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -66.26 -40.2 90.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.172 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.19 -38.67 82.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.224 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.34 -36.28 81.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.214 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 94.72 19.16 32.62 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -174.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -115.71 -156.55 0.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.812 0.339 . . . . 0.0 111.194 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 10.7 t -147.84 -168.45 3.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.218 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -68.43 120.15 73.16 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.223 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.46 -15.03 25.04 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.686 1.591 . . . . 0.0 111.22 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 85.76 8.06 80.4 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.52 141.39 29.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.189 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -99.82 158.7 15.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.2 t -58.0 137.14 57.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.197 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 155.63 -179.65 31.42 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -87.03 138.23 31.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.325 . . . . 0.0 111.188 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -122.63 145.2 48.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.194 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -109.98 112.4 24.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.166 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 39.1 tp -105.73 120.06 40.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.235 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -92.25 128.18 38.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.173 170.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 52.7 t -115.09 122.79 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -116.25 157.2 15.17 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.77 120.28 34.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 0.0 111.165 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.524 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 88.2 mt -96.77 14.57 24.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.213 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 32.0 t0 87.61 -65.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -102.71 -10.42 19.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.213 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -139.16 176.7 8.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.218 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 58.7 m -119.83 138.05 53.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.231 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 23.7 t -100.06 128.59 46.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.182 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 68.4 mt -110.54 126.88 54.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.171 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -125.3 105.01 8.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -90.12 127.96 36.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.204 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 45.5 mm -108.89 127.66 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.253 170.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.427 ' C ' ' OD1' ' A' ' 320' ' ' ASP . 26.3 p30 -75.72 174.17 5.94 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.226 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 320' ' ' ASP . 71.9 Cg_exo -60.02 -26.07 81.43 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.716 1.611 . . . . 0.0 111.182 -173.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -83.29 -8.12 59.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.167 -174.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.73 15.13 58.63 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -105.94 146.9 29.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.799 0.333 . . . . 0.0 111.197 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 89.8 m -60.9 130.11 44.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.216 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 19.7 tp -63.24 134.71 56.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.166 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 56.7 p -81.29 164.75 22.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -166.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.75 -32.04 73.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.206 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 83.8 p -65.67 -18.11 65.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -107.85 -28.28 9.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.199 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -73.89 -42.28 60.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.227 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -62.04 -32.25 72.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.188 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -72.51 -35.02 68.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.238 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 38.5 mt -65.43 -32.39 73.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.195 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 58.0 t -52.6 -45.62 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -62.24 -45.47 93.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.196 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 5.3 m -78.82 -26.08 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -72.97 -43.96 61.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.214 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -55.36 -44.75 76.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -65.38 -41.03 94.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.08 -36.69 85.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.192 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -79.55 -38.83 33.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.239 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 90.0 p -73.06 -25.83 61.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.259 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -110.67 149.98 41.09 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.223 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.81 150.54 55.97 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.698 1.598 . . . . 0.0 111.189 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 0.999 -14.533 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 48.3 p30 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.82 0.343 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 91.2 t -125.05 137.45 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -149.97 163.01 39.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.199 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 26.3 t -96.33 139.08 32.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.177 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -162.7 157.74 22.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.39 147.15 23.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.227 176.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -85.14 -166.81 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.221 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.97 -25.41 67.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 -172.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 63.0 p -97.41 1.01 48.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 -176.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 86.98 21.28 50.71 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.406 HD12 ' HD2' ' A' ' 240' ' ' PRO . 59.1 tp -99.62 114.44 65.61 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.35 . . . . 0.0 111.205 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.406 ' HD2' HD12 ' A' ' 239' ' ' LEU . 53.6 Cg_exo -54.24 135.74 65.92 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.725 1.617 . . . . 0.0 111.221 177.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.3 163.93 39.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.193 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.7 tp -76.9 127.66 33.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.181 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.1 t -108.36 121.91 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.218 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.5 t -124.34 125.16 69.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.23 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -76.43 91.7 3.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 -172.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 172.46 161.2 22.53 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 172.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.17 156.15 52.11 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.646 1.564 . . . . 0.0 111.191 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -48.91 -45.89 42.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -63.95 -22.27 66.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.249 -175.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 91.8 t -91.22 -50.38 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.163 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 74.3 t -73.01 -46.95 50.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.184 -173.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -60.63 -40.14 90.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.232 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -71.61 -35.38 70.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.169 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -80.16 -25.57 39.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.185 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.564 ' HB3' ' HD3' ' A' ' 256' ' ' PRO . 49.7 tp -53.83 -48.67 92.84 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 -169.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 255' ' ' LEU . 90.0 Cg_exo -47.8 -44.47 26.75 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.671 1.581 . . . . 0.0 111.192 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.42 -40.84 93.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.195 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.42 -35.4 80.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.245 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 81.5 mt -67.39 -37.63 83.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.211 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.56 -26.45 68.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.211 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -92.64 1.59 57.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.201 -173.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 35.5 m -125.34 9.81 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.237 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.97 27.58 33.76 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 172.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 98.3 mtp -117.2 105.96 12.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.757 0.313 . . . . 0.0 111.239 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -87.75 118.11 27.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.218 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 90.9 t -70.28 126.64 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.211 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 67.1 p -106.23 -28.11 10.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.231 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -162.16 160.85 27.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.214 174.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 83.5 p -154.53 152.79 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.207 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 60.6 m -144.53 122.67 12.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -92.69 -19.98 21.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.242 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 88.8 p -75.75 -15.06 60.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.205 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -117.95 -20.64 8.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.245 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.02 48.86 10.48 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -145.96 175.24 10.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.335 . . . . 0.0 111.182 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 50.3 ttm -159.83 148.52 17.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.213 -175.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -116.81 121.22 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.192 174.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 45.4 t -138.53 131.29 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.202 -168.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 97.8 m -92.87 120.13 32.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.2 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -97.85 127.34 43.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.195 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -123.03 120.2 27.56 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.2 172.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.06 134.09 61.77 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.692 1.595 . . . . 0.0 111.188 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 68.5 mt -99.27 163.78 12.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.19 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 60.9 p -81.75 167.48 19.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.217 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -59.16 -32.68 70.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 85.2 p -69.81 -22.54 63.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.179 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -82.13 -39.57 23.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.203 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -74.24 -24.61 59.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.216 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -68.5 -40.2 80.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.203 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.72 -38.7 76.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.209 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 48.0 tp -67.95 -36.25 79.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.204 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 84.75 42.71 7.13 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -139.14 160.13 40.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 111.216 -174.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 87.8 p -94.28 162.62 13.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.212 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -41.26 120.96 1.98 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.247 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.22 -24.93 57.98 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.721 1.614 . . . . 0.0 111.172 -176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 81.86 15.63 74.75 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.37 143.36 26.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 0.0 111.205 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -100.35 145.23 28.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.211 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 46.3 t -54.34 139.08 37.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.204 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 143.65 -171.53 25.28 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -84.56 138.52 32.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 111.221 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -119.25 137.41 53.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.225 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.445 ' HB3' ' HB ' ' A' ' 319' ' ' ILE . 88.1 tttt -94.33 126.34 39.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.19 171.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.408 ' HB3' HD11 ' A' ' 316' ' ' LEU . 63.5 mt -108.13 134.75 50.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.243 -176.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -123.05 124.14 42.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.19 173.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.413 HG23 HD13 ' A' ' 316' ' ' LEU . 70.5 t -115.4 125.09 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.189 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -118.11 156.5 15.62 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 176.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -102.63 108.52 19.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.752 0.311 . . . . 0.0 111.216 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 83.5 mt -87.97 67.66 9.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.198 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 64.93 -102.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.24 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -89.23 -8.19 54.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -118.34 175.05 5.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.194 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 74.5 m -132.24 159.35 39.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.203 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 87.8 p -133.04 149.53 52.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.215 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.413 HD13 HG23 ' A' ' 307' ' ' VAL . 37.1 tp -133.07 118.06 18.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.165 -175.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -100.22 140.21 34.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.233 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . 0.445 ' HB2' ' HB2' ' A' ' 326' ' ' LEU . 46.1 m-85 -108.52 131.25 55.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.233 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 304' ' ' LYS . 85.9 mt -116.48 119.32 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.235 168.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.466 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 30.2 p30 -78.14 175.85 4.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.172 -171.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.466 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 67.9 Cg_exo -59.45 -25.65 79.31 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.748 1.632 . . . . 0.0 111.175 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.88 -6.72 59.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 88.67 14.47 61.31 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -98.96 142.72 30.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.73 0.3 . . . . 0.0 111.242 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 81.4 p -78.67 162.61 26.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.178 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 318' ' ' PHE . 25.3 tp -62.55 131.7 49.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.267 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 66.4 p -87.74 164.92 15.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.18 177.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -61.55 -47.75 84.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 73.8 m -55.9 -42.71 76.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.224 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -64.99 -49.22 71.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -63.48 -34.57 78.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.171 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.84 -40.37 97.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -68.48 -34.12 75.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.216 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.74 -13.73 61.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.206 -175.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 74.1 t -55.83 -58.46 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.226 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -66.28 -34.96 79.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.68 -49.86 82.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.227 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -87.25 -24.52 24.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.213 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -55.22 -49.99 70.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.191 171.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -67.07 -36.55 82.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.213 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -70.17 -42.34 72.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.23 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -75.69 -27.78 58.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.156 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 72.8 m -81.24 -22.37 38.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.218 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -58.46 125.86 77.23 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.224 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.25 128.9 26.89 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.686 1.591 . . . . 0.0 111.226 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 0.999 -14.533 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.795 0.331 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 96.9 t -120.84 138.87 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.193 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -130.29 163.04 27.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.226 176.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 40.7 t -92.85 140.37 29.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.182 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -146.69 175.83 10.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.202 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -119.58 144.32 47.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.238 174.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 42.2 p30 -88.63 -172.04 3.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.177 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -69.0 -19.21 64.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.188 -172.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 59.8 p -95.84 -7.37 37.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.183 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 92.89 6.49 63.5 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 240' ' ' PRO . 99.4 mt -87.43 145.45 37.53 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.783 0.325 . . . . 0.0 111.219 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 239' ' ' LEU . 54.6 Cg_exo -58.99 140.27 94.6 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.724 1.616 . . . . 0.0 111.192 -176.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -148.21 172.05 14.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.2 173.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 92.0 mt -108.89 150.49 27.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.195 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.9 149.43 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.221 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.78 138.71 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.203 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -71.9 74.08 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.169 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 174.94 164.44 29.7 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -76.25 159.83 36.49 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.718 1.612 . . . . 0.0 111.181 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -52.0 -44.28 64.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -63.42 -23.35 67.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.192 -171.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.16 -52.51 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.203 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.15 -52.94 55.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.204 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -57.71 -42.49 83.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.155 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -67.08 -34.7 78.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.185 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -100.0 4.55 44.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.211 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.528 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 46.6 tp -68.73 -43.39 28.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.217 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 85.9 Cg_exo -51.84 -36.91 64.85 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.73 1.62 . . . . 0.0 111.226 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.19 -45.54 91.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -66.27 -36.93 84.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 256' ' ' PRO . 49.0 mt -63.31 -43.82 96.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.158 -177.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.67 -20.19 66.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -93.52 -5.71 48.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.222 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 31.5 m -115.24 2.18 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.199 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 98.44 21.29 17.5 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' MET . . . . . 0.409 ' HG2' ' HB2' ' A' ' 280' ' ' TYR . 67.1 mtt -116.98 104.38 11.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 111.193 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -89.01 120.52 30.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.76 124.91 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.203 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 71.8 p -104.69 -25.37 12.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.216 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -164.99 160.62 19.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.226 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 84.7 p -162.89 157.67 21.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.179 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 68.3 m -143.23 121.06 11.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.217 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -73.26 -45.9 53.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.222 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 87.0 p -66.72 -21.07 66.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.202 -172.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.69 -21.81 12.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.213 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.61 42.59 26.3 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -128.14 160.6 31.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.801 0.334 . . . . 0.0 111.217 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 59.7 ttm -158.27 149.77 21.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.23 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -125.93 128.7 47.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.187 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.59 146.61 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.166 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 97.4 m -102.6 119.29 38.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.221 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . 0.409 ' HB2' ' HG2' ' A' ' 264' ' ' MET . 42.6 t80 -107.52 137.17 46.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.191 -172.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 282' ' ' PRO . 87.6 tttt -136.96 129.08 17.01 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.225 169.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 281' ' ' LYS . 76.0 Cg_exo -55.01 140.4 79.93 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.702 1.602 . . . . 0.0 111.215 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 56.5 mt -100.63 165.32 11.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.155 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.1 p -73.01 163.62 27.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.24 -37.37 74.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.156 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 89.5 p -71.25 -30.95 66.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.53 -42.41 92.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.222 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -71.55 -29.88 65.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.198 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -66.09 -39.95 90.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.206 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.92 -41.16 87.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.199 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.46 -41.88 98.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.213 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 97.48 35.6 5.15 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -143.64 160.27 40.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 111.141 -174.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 88.1 p -85.1 171.47 12.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.237 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -64.92 120.04 63.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.218 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -69.14 -21.03 36.95 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.76 1.64 . . . . 0.0 111.197 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.09 30.22 55.63 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 47.4 tp -106.4 133.44 51.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 111.188 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -86.4 164.75 16.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.236 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.0 p -68.72 164.71 21.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.191 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 145.36 172.12 15.52 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -91.75 109.32 20.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.747 0.308 . . . . 0.0 111.186 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -103.82 146.74 28.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -169.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -90.81 129.81 36.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.201 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.419 HD22 HD22 ' A' ' 255' ' ' LEU . 41.5 tp -123.19 119.93 31.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.219 -176.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -112.19 145.54 39.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 43.5 t -135.12 134.81 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.198 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -134.21 172.66 21.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -115.59 112.78 22.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 0.0 111.182 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.558 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 93.3 mt -83.37 0.52 45.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.177 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 34.0 t0 88.41 -64.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.178 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -76.4 -15.23 59.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.213 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -164.74 173.83 11.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.156 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 38.5 t -100.67 151.64 21.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.218 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 97.6 p -131.87 153.77 49.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.192 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 4.3 pp -150.59 156.47 41.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.218 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -149.21 136.5 20.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.179 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -102.13 138.49 39.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.202 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 85.4 mt -124.33 130.43 73.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.188 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -54.72 157.19 5.6 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.268 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.43 -25.67 49.72 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.681 1.587 . . . . 0.0 111.237 175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.84 0.8 57.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.222 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.83 32.01 10.51 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -124.42 121.6 35.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.802 0.334 . . . . 0.0 111.178 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 6.1 t -49.12 150.99 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 9.7 mp -62.53 151.5 37.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.158 165.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 69.6 p -85.14 161.83 19.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -57.25 -38.8 74.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.219 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 85.5 p -65.15 -26.03 68.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.197 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -88.72 -41.48 12.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.233 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -66.83 -41.22 87.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.242 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -57.52 -34.31 68.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.222 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -73.52 -36.79 65.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.202 173.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 67.9 mt -68.32 -20.11 64.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.182 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 55.9 t -54.13 -55.46 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.194 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -68.74 -34.97 76.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.84 -49.0 86.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.188 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -75.41 -37.95 60.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.211 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -53.57 -44.32 69.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.22 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -65.13 -41.27 94.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.197 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.52 -32.24 73.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.243 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -76.43 -29.33 56.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.209 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 72.2 p -76.99 -16.13 59.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.186 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -74.26 158.5 85.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.198 171.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -54.96 140.14 79.42 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.728 1.619 . . . . 0.0 111.166 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 1.0 -14.497 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.2 129.51 53.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.204 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -150.54 155.26 39.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 87.6 p -87.21 158.8 19.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.215 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -166.56 155.75 11.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.165 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -93.24 135.25 34.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.212 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 47.9 p30 -86.57 -165.81 1.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.215 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -65.15 -24.58 67.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.202 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 65.9 p -98.13 -2.3 40.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.201 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 86.46 11.28 72.08 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 32.4 tp -78.31 123.88 85.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 0.0 111.218 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.85 120.5 8.24 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.686 1.59 . . . . 0.0 111.223 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.451 ' HE2' ' HB2' ' A' ' 317' ' ' GLN . 67.9 mmm -129.79 160.04 34.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.223 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 33.6 tp -107.79 124.03 49.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.212 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.8 t -106.39 125.3 62.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 89.3 t -107.97 133.77 51.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.186 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -68.71 102.08 1.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' A' ' 247' ' ' PRO . . . 145.43 154.13 6.07 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 246' ' ' GLY . 51.8 Cg_exo -58.46 154.92 38.69 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.658 1.572 . . . . 0.0 111.208 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.442 ' CD1' ' O ' ' A' ' 248' ' ' PHE . 1.2 t80 -54.99 -45.45 75.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 178.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.56 -25.81 67.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.244 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.72 -49.03 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 255' ' ' LEU . 62.8 t -66.48 -39.55 84.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.177 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -54.57 -33.16 59.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.205 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -65.57 -34.96 79.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.226 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -108.95 4.88 23.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.193 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.571 ' N ' ' HD2' ' A' ' 256' ' ' PRO . 63.0 tp -64.36 -52.1 56.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.225 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 255' ' ' LEU . 42.7 Cg_endo -67.21 -24.8 43.7 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.697 1.598 . . . . 0.0 111.211 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.13 -49.69 71.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.192 171.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.19 -38.12 89.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 48.0 mt -62.4 -44.89 95.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.15 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.33 -33.05 74.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.199 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -71.79 -23.62 61.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.23 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 25.3 m -103.66 -0.26 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.226 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 107.03 -2.15 35.44 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 169.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 64.2 mtt -89.76 90.75 8.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 0.0 111.224 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -72.77 111.45 7.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 95.7 t -68.02 131.34 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 65.5 p -109.46 -30.98 7.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.246 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -168.65 161.21 11.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.197 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 39.9 t -147.05 125.21 12.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.239 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 92.8 m -93.81 115.05 27.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.255 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 92.0 mtm180 -80.58 -22.42 40.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.228 -173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 89.9 p -79.35 -15.28 58.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.192 -177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -119.77 -19.92 7.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.246 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 74.88 42.91 29.31 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -129.74 118.07 21.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 0.0 111.203 -171.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 59.7 ttm -111.58 131.89 54.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.239 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -103.13 133.77 47.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.17 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 19.5 m -132.71 147.37 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.195 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.0 m -98.47 115.22 28.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.255 166.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -93.57 115.07 27.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.191 -171.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -110.52 105.37 57.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.189 166.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -54.9 142.13 76.09 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.694 1.596 . . . . 0.0 111.216 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 287' ' ' ASP . 96.0 mt -80.28 153.47 28.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.195 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.7 p -75.22 167.92 20.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.23 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -55.38 -43.66 75.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.255 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 91.3 p -70.82 -31.24 67.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.193 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 283' ' ' LEU . 99.5 m-20 -66.58 -36.83 83.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -69.63 -29.89 67.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.219 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -71.48 -37.96 71.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.195 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.37 -41.86 79.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 55.8 tp -67.52 -39.93 85.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.208 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 87.99 40.96 6.44 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -140.56 159.91 41.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 111.214 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 89.1 p -77.19 165.59 24.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.202 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -103.63 108.54 59.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.197 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.79 169.44 21.18 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.723 1.615 . . . . 0.0 111.18 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -90.19 3.33 82.27 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 96.1 mt -53.71 176.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.772 0.32 . . . . 0.0 111.204 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -143.58 176.24 9.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.192 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 85.1 p -74.29 161.81 29.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.194 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 143.5 -177.66 22.16 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -91.24 104.94 17.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.799 0.333 . . . . 0.0 111.247 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -99.23 151.31 21.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.185 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -117.69 137.25 52.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.194 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 37.5 tp -121.93 106.93 11.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.23 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -93.36 121.53 34.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.168 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.49 127.31 70.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.192 -172.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -111.44 158.41 14.35 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -101.89 118.71 37.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.34 . . . . 0.0 111.229 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 89.6 mt -110.85 77.45 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.191 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.7 -108.54 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -100.9 28.71 5.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.165 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -134.24 151.82 51.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.25 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 57.8 m -109.62 128.59 55.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.151 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 32.7 t -106.4 111.42 23.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.19 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 69.7 mt -98.18 123.35 42.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.191 -172.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . 0.451 ' HB2' ' HE2' ' A' ' 241' ' ' MET . 65.4 tt0 -109.35 100.37 9.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.187 172.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -86.06 132.31 34.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.217 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 66.7 mt -124.6 124.27 67.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.224 -171.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -59.72 155.81 38.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.185 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -61.0 -18.63 58.8 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.663 1.575 . . . . 0.0 111.182 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -78.56 -11.94 59.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.189 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.73 14.53 43.15 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -119.06 152.77 35.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.804 0.335 . . . . 0.0 111.232 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 62.6 p -77.87 160.14 28.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.194 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 9.9 mp -70.35 142.39 52.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.229 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 69.9 p -81.45 164.58 21.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.199 -173.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -55.17 -36.97 66.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 76.9 p -62.57 -25.99 68.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.195 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -100.32 -29.24 12.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.196 -175.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -73.11 -24.25 60.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -80.33 -15.17 57.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.197 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -89.46 -29.47 18.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.188 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 88.3 mt -74.22 -10.34 59.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.162 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 6.0 m -66.74 -24.66 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.202 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -97.83 -32.01 11.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.234 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.23 -49.59 83.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.191 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -84.52 -33.62 23.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.187 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 66.9 tt0 -55.36 -45.82 76.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.214 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -64.72 -38.23 90.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.234 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.42 90.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.238 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -74.41 -30.21 61.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.179 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 90.1 p -85.57 -20.85 28.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.157 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -64.05 125.74 88.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.182 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -53.91 129.8 36.03 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.668 1.578 . . . . 0.0 111.191 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 0.999 -14.532 0 N-CA-C 111.236 -0.745 . . . . 0.0 111.236 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.848 0.356 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.403 HG12 HG23 ' A' ' 244' ' ' VAL . 23.8 m -132.32 160.65 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.17 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -156.51 157.25 35.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.215 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 30.1 t -90.69 141.17 29.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.227 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -161.75 155.08 21.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.233 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.76 144.87 25.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.181 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 46.4 p30 -85.08 -164.66 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.218 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -65.01 -25.86 68.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.253 -172.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 53.8 p -95.45 -1.04 51.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.52 18.39 60.37 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 54.2 tp -90.72 115.85 65.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.164 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.67 130.37 38.35 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.711 1.607 . . . . 0.0 111.162 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -144.74 176.26 9.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.206 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 50.8 tp -102.88 127.09 50.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 99.8 t -110.47 125.52 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 314' ' ' SER . 47.8 t -99.22 137.56 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 176.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -80.64 80.0 7.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.201 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 170.04 159.47 15.99 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -53.06 136.17 60.61 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.673 1.582 . . . . 0.0 111.198 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -59.72 -27.82 66.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.249 -172.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -67.05 -40.71 87.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.179 173.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 68.1 t -68.85 -43.79 82.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.211 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 79.5 t -69.07 -40.54 80.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.233 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -55.1 -35.22 64.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.203 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -75.16 -33.16 61.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -97.33 -11.34 24.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.21 -172.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.526 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 57.0 tp -70.72 -43.6 15.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.175 -172.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 88.7 Cg_exo -51.26 -39.94 61.69 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.726 1.618 . . . . 0.0 111.21 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.13 -44.53 96.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.175 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.15 -39.55 93.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.21 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 256' ' ' PRO . 76.6 mt -60.78 -42.38 97.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.207 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -67.32 -22.97 65.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.184 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -93.28 -6.04 48.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.196 -174.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 29.4 m -111.17 -3.1 10.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.237 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 101.92 8.05 46.0 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 66.4 mtt -96.35 88.34 4.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 111.18 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.5 120.76 11.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.216 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.406 ' HA ' HG12 ' A' ' 278' ' ' VAL . 88.2 t -73.38 122.83 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.22 -175.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 60.3 p -110.45 -28.06 8.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.194 -175.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -161.39 155.82 22.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.209 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 40.8 t -162.09 115.92 1.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.199 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 86.8 m -125.43 112.16 15.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.213 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -75.26 -23.1 57.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.199 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 84.2 p -74.78 -16.29 60.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.216 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -118.3 -14.11 9.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.191 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 72.72 29.94 64.66 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -116.13 111.52 20.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 0.0 111.242 -169.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.4 ' SD ' HD21 ' A' ' 255' ' ' LEU . 95.1 mtp -115.84 152.81 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.2 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -142.88 135.02 27.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.192 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 266' ' ' VAL . 34.2 m -135.14 158.79 41.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.268 -175.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.4 m -110.07 118.62 36.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.186 165.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -95.8 127.44 41.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 -173.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -121.35 122.96 27.86 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.218 167.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -54.84 136.86 73.7 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.714 1.609 . . . . 0.0 111.192 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 77.1 mt -91.19 157.53 17.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.226 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.8 p -75.21 165.24 25.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.185 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -54.77 -43.88 73.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.19 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 91.8 p -69.03 -31.06 69.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.215 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.63 -40.45 95.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.22 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -70.59 -30.2 66.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.158 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -69.36 -39.64 77.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.198 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.62 -39.81 80.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.208 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.6 -45.0 84.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.183 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 97.84 34.7 5.37 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -142.64 155.8 44.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.231 -175.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 94.0 p -80.57 159.63 25.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.197 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -71.34 119.87 76.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.224 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.38 -15.02 25.24 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.687 1.591 . . . . 0.0 111.247 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.79 29.35 55.0 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 98.1 mt -93.91 143.29 26.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 0.0 111.208 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -90.09 163.81 14.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.206 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 82.9 p -69.64 160.67 31.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.225 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 145.57 178.63 21.24 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 174.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.57 132.74 34.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 0.0 111.173 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -122.37 149.55 43.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.202 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.86 154.91 23.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.174 174.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.557 HD13 ' C ' ' A' ' 305' ' ' LEU . 3.2 tm? -139.61 111.24 7.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.211 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 317' ' ' GLN . 62.5 tp60 -92.44 120.71 33.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.175 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 92.8 t -87.57 126.78 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.169 175.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -87.31 161.77 32.95 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 175.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -97.59 87.45 4.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 111.172 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 97.7 mt -113.65 142.83 45.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 175.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -70.34 -49.98 43.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.206 -172.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -111.08 4.65 19.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.213 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -138.5 171.71 13.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.17 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' SER . . . . . 0.414 ' HB3' ' HB ' ' A' ' 244' ' ' VAL . 46.3 t -128.24 114.82 17.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 171.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 11.3 t -81.32 113.63 19.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.183 175.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 73.0 mt -105.65 98.62 8.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.187 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 306' ' ' GLN . 62.7 tt0 -88.93 99.01 12.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.2 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -84.01 132.38 34.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 86.4 mt -125.05 129.54 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.189 -173.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.431 ' HB2' ' HD2' ' A' ' 321' ' ' PRO . 31.4 p30 -75.6 173.46 7.05 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.164 -173.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 320' ' ' ASP . 52.9 Cg_exo -59.94 -26.25 81.82 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.641 1.561 . . . . 0.0 111.264 -175.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -81.56 -8.5 59.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.191 -175.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.24 24.1 27.64 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -119.79 139.31 52.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.761 0.315 . . . . 0.0 111.222 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 74.3 m -65.08 137.39 57.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.223 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 88.4 mt -61.86 147.44 46.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.185 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 60.1 p -82.19 168.48 17.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.177 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -52.88 -41.95 64.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.173 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 89.4 p -64.96 -26.18 68.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.182 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -91.55 -23.13 20.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.215 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -85.07 -29.95 24.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.214 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -65.5 -36.87 85.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.176 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -64.79 -34.77 79.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.167 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.24 -13.96 60.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.235 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.16 -58.39 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.21 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.43 -35.01 79.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.204 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.84 -51.65 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.237 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -78.12 -30.68 49.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.216 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -52.76 -45.4 67.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.166 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -70.01 -39.19 75.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.178 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.19 -35.04 79.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.218 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -77.4 -24.78 50.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 65.5 p -76.99 -18.2 58.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.165 175.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -74.76 151.73 86.86 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.03 135.56 69.25 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.643 1.562 . . . . 0.0 111.217 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 1.0 -14.486 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.772 0.32 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 10.0 p -147.05 146.8 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.207 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -146.51 169.07 19.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.209 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 29.0 t -100.95 142.07 32.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.196 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -155.64 161.05 40.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -86.02 144.95 27.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.179 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 43.5 p30 -92.87 -171.59 2.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.162 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -69.86 -18.33 63.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.176 -173.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 70.8 p -95.62 -7.1 38.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.186 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.93 7.48 64.3 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 99.4 mt -93.63 148.83 36.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.787 0.327 . . . . 0.0 111.164 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.06 141.6 48.56 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.733 1.622 . . . . 0.0 111.182 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -143.82 163.38 33.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.234 175.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 36.6 tp -103.82 114.22 28.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.163 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.86 123.28 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.182 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 96.6 t -100.11 135.64 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.235 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -76.12 74.49 2.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.212 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.402 ' HA2' ' HD3' ' A' ' 247' ' ' PRO . . . 168.83 157.64 11.77 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 173.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.402 ' HD3' ' HA2' ' A' ' 246' ' ' GLY . 51.8 Cg_exo -60.63 157.68 36.0 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.699 1.6 . . . . 0.0 111.209 -178.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.418 ' HA ' HG23 ' A' ' 251' ' ' VAL . 50.5 p90 -65.23 -20.26 66.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.205 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -69.87 -28.49 65.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.217 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 75.2 t -85.1 -39.21 13.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.173 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 248' ' ' PHE . 14.7 m -67.26 -17.77 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -67.13 -13.71 62.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.182 173.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -105.35 -27.95 11.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.195 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.29 -42.58 36.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.546 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 82.3 mt -72.18 -41.47 8.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.182 -165.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 87.8 Cg_exo -48.26 -42.73 33.24 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.654 1.569 . . . . 0.0 111.199 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -88.59 -42.24 12.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -41.44 97.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.185 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.43 -48.79 78.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.19 -36.87 76.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.181 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -87.56 3.06 49.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.216 -172.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 34.2 m -119.03 14.26 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.202 172.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 104.64 -1.76 42.32 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 168.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' MET . . . . . 0.401 ' HG2' ' HB2' ' A' ' 280' ' ' TYR . 73.1 mtm -108.96 85.28 2.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.766 0.317 . . . . 0.0 111.179 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -68.27 122.07 17.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.218 -175.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.472 ' HA ' HG12 ' A' ' 278' ' ' VAL . 91.3 t -70.53 124.51 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.22 -176.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 72.4 p -109.58 -25.78 10.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -162.47 162.35 27.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 32.1 t -162.61 136.44 6.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.165 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 89.4 m -123.25 117.98 26.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.217 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -74.31 -35.56 63.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 94.5 p -65.51 -21.31 66.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.205 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -107.97 -21.62 12.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.193 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 72.14 38.28 59.38 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -129.35 128.52 43.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.207 -169.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 90.7 mtp -117.51 147.98 42.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.201 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -120.98 130.14 53.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 266' ' ' VAL . 33.8 m -131.12 153.43 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 -174.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 85.9 m -106.35 122.93 47.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.223 167.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . 0.401 ' HB2' ' HG2' ' A' ' 264' ' ' MET . 54.2 t80 -101.68 129.62 47.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.223 -171.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.4 124.94 27.05 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.186 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.76 130.25 39.43 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.698 1.599 . . . . 0.0 111.197 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 78.5 mt -96.92 155.26 16.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.214 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 56.1 p -73.53 163.83 27.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.198 -176.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.08 -36.69 70.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 89.1 p -71.45 -30.89 66.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.241 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.56 -41.9 92.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.199 175.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -73.36 -29.19 62.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.213 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -66.78 -40.04 88.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.195 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.82 -38.16 85.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.194 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 59.7 tp -65.31 -39.59 92.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.179 173.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 91.24 35.28 7.11 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -142.58 163.53 32.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 111.147 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 94.2 p -86.55 167.35 14.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.178 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -65.03 120.97 71.43 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.222 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.88 -18.96 47.0 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.679 1.586 . . . . 0.0 111.184 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 80.92 34.61 26.78 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 80.5 mt -105.64 137.21 43.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.827 0.346 . . . . 0.0 111.187 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -93.76 160.47 14.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.237 173.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.9 p -60.67 156.63 16.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.208 -173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 136.13 -176.3 20.35 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -86.93 136.55 32.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 111.173 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -123.01 153.98 39.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -119.17 148.67 42.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.226 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 44.3 tp -134.6 113.53 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.203 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -98.55 130.33 45.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.204 174.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.96 127.58 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.169 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -107.69 154.21 16.63 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -91.3 105.48 17.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 -175.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.705 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 90.6 mt -95.41 3.01 54.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.234 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . 0.705 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 52.5 t0 101.42 -117.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.203 -174.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -71.37 -9.1 57.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.229 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -119.77 173.76 6.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 175.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 75.4 m -126.92 147.47 50.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 29.8 t -104.64 118.91 37.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 47.0 mt -96.1 113.15 24.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -105.51 110.41 22.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -95.26 133.42 39.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.217 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 87.1 mt -122.84 128.98 75.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.196 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.456 ' HB2' ' HD2' ' A' ' 321' ' ' PRO . 33.5 p30 -80.21 174.94 5.34 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -175.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 320' ' ' ASP . 53.4 Cg_exo -59.97 -24.46 76.46 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.678 1.585 . . . . 0.0 111.198 -175.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.29 -5.29 59.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.184 -174.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.67 18.78 56.01 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -117.49 150.46 38.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 0.0 111.214 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 73.9 p -76.73 160.75 29.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.181 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 85.9 mt -76.93 150.13 35.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.192 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 40.5 p -75.19 166.96 22.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -54.85 -40.41 69.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.227 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 99.4 p -68.89 -33.66 74.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.174 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -75.63 -35.52 60.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.209 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -76.18 -31.18 58.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.198 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.71 -38.42 83.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.235 174.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -65.42 -34.75 79.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.202 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.03 -20.35 65.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.215 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 76.7 t -56.87 -54.03 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.165 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.12 -35.83 82.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.191 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.7 -49.95 82.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.169 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -81.6 -28.55 33.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.221 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -57.78 -43.02 85.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.236 173.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -69.21 -43.49 73.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.184 175.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.92 -28.09 69.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.181 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -84.21 -37.62 21.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.242 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 84.8 p -70.61 -21.4 62.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.223 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -94.5 159.28 34.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.194 175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.98 141.97 85.7 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.685 1.59 . . . . 0.0 111.241 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 1.0 -14.53 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.749 0.309 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 82.9 t -124.99 130.79 73.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.168 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -121.28 156.17 33.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.192 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.6 t -91.72 140.68 29.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.99 179.77 8.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.24 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -128.89 148.0 50.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.163 172.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 42.5 p30 -85.06 -170.02 2.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.209 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.01 -24.17 67.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.213 -171.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 61.6 p -97.34 -1.51 44.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.182 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.91 18.18 60.11 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.7 mt -91.46 157.28 42.48 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 0.0 111.192 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.555 ' HG3' ' HG3' ' A' ' 328' ' ' GLN . 76.6 Cg_exo -55.07 134.86 66.12 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.667 1.578 . . . . 0.0 111.261 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 67.9 ttp -148.81 149.04 30.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.222 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 83.2 mt -113.8 144.61 42.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.199 169.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 95.3 t -113.19 119.73 61.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.225 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.4 t -105.33 137.38 35.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.227 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.9 ttt180 -64.77 107.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.443 ' HA2' ' HD3' ' A' ' 247' ' ' PRO . . . 130.76 143.56 5.33 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' PRO . . . . . 0.443 ' HD3' ' HA2' ' A' ' 246' ' ' GLY . 45.0 Cg_exo -58.55 167.73 4.77 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.732 1.621 . . . . 0.0 111.191 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -48.99 -46.99 44.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -62.99 -26.19 68.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.159 -173.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 81.3 t -85.29 -52.56 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.224 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 255' ' ' LEU . 74.0 t -73.58 -53.81 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.181 -173.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -56.27 -39.87 73.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 -172.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -73.86 -29.75 62.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -107.55 6.01 27.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.177 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.543 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 60.8 tp -65.48 -42.38 56.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.23 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 85.9 Cg_exo -51.75 -35.4 58.25 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.693 1.595 . . . . 0.0 111.188 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.94 79.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.11 -34.91 77.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.213 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.433 HD22 ' SD ' ' A' ' 264' ' ' MET . 81.0 mt -63.48 -41.76 98.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.186 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.56 -25.39 67.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.192 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -80.69 -20.07 43.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.21 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 31.6 m -105.16 9.82 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.204 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.64 20.22 58.63 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' MET . . . . . 0.514 ' SD ' HG21 ' A' ' 278' ' ' VAL . 59.7 ttm -119.09 103.24 9.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.775 0.321 . . . . 0.0 111.213 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -93.65 129.08 40.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.166 -170.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.468 ' HA ' HG12 ' A' ' 278' ' ' VAL . 95.0 t -73.2 127.7 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.213 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 65.3 p -108.84 -27.88 9.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.219 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -162.71 166.31 24.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.237 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 82.8 p -161.41 153.78 20.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.208 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 85.1 m -133.92 112.0 10.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.185 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -72.86 -22.11 60.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 84.9 p -77.99 -12.41 59.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.178 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -116.87 -20.04 9.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.224 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.31 25.94 67.18 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -172.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -110.04 149.99 29.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.776 0.322 . . . . 0.0 111.187 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.42 ' HB3' ' HB2' ' A' ' 305' ' ' LEU . 56.7 ttm -140.07 136.76 33.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.196 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -110.59 125.6 53.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.197 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.514 HG21 ' SD ' ' A' ' 264' ' ' MET . 34.8 m -134.46 155.4 38.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.19 -169.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.0 m -117.92 125.06 49.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 172.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -113.15 137.61 51.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.209 -171.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -136.69 129.89 17.6 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.181 170.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.98 139.08 79.48 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.687 1.591 . . . . 0.0 111.269 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 64.3 mt -99.79 166.49 11.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.173 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 56.7 p -74.96 164.89 26.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.259 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -58.25 -39.3 78.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.21 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 93.9 p -70.29 -30.53 67.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.208 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.92 -43.58 92.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.215 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -71.63 -28.71 63.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.201 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -66.73 -40.53 88.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.194 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.98 -39.15 87.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.212 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.92 -39.0 90.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.188 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 90.3 39.93 5.89 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 -175.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -141.92 166.36 24.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.775 0.321 . . . . 0.0 111.208 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 82.8 p -99.43 -178.45 3.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.163 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -64.74 120.66 68.01 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.183 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.04 -22.94 47.05 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.728 1.619 . . . . 0.0 111.21 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.86 19.09 60.15 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 10.8 mp -101.29 140.28 35.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.228 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -99.33 159.56 14.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.184 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.3 t -60.16 139.99 57.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.181 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 153.15 -179.33 29.64 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -86.08 136.36 33.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.748 0.308 . . . . 0.0 111.244 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -121.15 149.05 43.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.426 ' HB3' ' HB ' ' A' ' 319' ' ' ILE . 87.7 tttt -110.72 122.13 47.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.212 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 276' ' ' MET . 62.8 mt -103.15 135.85 44.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.241 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -119.65 125.14 48.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.208 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 315' ' ' SER . 57.6 t -122.32 120.31 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -109.34 155.05 16.27 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -88.92 118.76 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 111.194 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.532 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 87.9 mt -95.45 11.41 32.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.225 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 37.1 t0 87.63 -64.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.157 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -101.81 -10.1 20.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.181 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 89.8 mmt-85 -137.69 176.57 8.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.217 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 50.3 m -119.99 136.59 54.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 307' ' ' VAL . 27.8 t -96.71 109.74 22.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 174.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 48.9 tp -111.72 124.0 51.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.182 -176.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -127.02 148.46 50.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.221 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -112.27 125.92 54.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -173.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 304' ' ' LYS . 92.5 mt -108.23 124.41 64.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.225 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.526 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 35.1 p30 -75.13 173.83 6.32 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.241 -174.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.526 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 51.8 Cg_exo -59.93 -25.18 78.79 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.73 1.62 . . . . 0.0 111.177 -176.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -80.18 -9.75 59.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.167 -173.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.58 17.17 42.97 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -120.42 162.01 20.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.797 0.332 . . . . 0.0 111.189 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 78.4 p -79.32 153.94 29.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.195 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 68.2 mt -76.47 158.43 31.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.197 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 41.0 p -76.76 167.05 22.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.199 -173.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.555 ' HG3' ' HG3' ' A' ' 240' ' ' PRO . 88.8 mt-30 -61.8 -35.04 77.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.21 174.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 98.9 p -71.51 -35.78 70.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.21 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -68.82 -41.95 77.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -67.61 -37.49 82.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.214 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -60.69 -37.41 81.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.195 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -66.7 -38.89 87.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.248 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 84.5 mt -68.19 -22.64 64.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.227 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.78 -56.75 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.169 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -67.98 -35.36 78.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.201 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.52 -46.53 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.179 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -79.66 -28.91 40.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.257 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -54.26 -42.07 69.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.221 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -76.17 -34.33 59.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.211 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.05 -40.82 95.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -74.02 -27.61 61.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.215 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 90.5 p -82.78 -27.83 30.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.215 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 49.5 tptt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.237 -179.771 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 . . . . . 0 CA--C 1.523 -0.071 0 CA-C-O 120.845 0.355 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 83.2 t -127.0 125.21 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.186 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -112.51 156.89 21.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.228 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 35.0 t -95.62 136.24 36.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.191 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.28 167.71 29.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.215 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -99.48 145.73 27.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 41.8 p30 -85.85 -169.9 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.35 -25.5 67.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.175 -172.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 68.6 p -97.58 -1.22 44.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.219 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.0 18.53 60.95 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 98.4 mt -94.0 158.09 36.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.753 0.311 . . . . 0.0 111.216 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.595 ' HG3' ' HG3' ' A' ' 328' ' ' GLN . 54.0 Cg_exo -55.06 139.3 80.02 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.696 1.598 . . . . 0.0 111.212 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.407 ' SD ' ' OG ' ' A' ' 315' ' ' SER . 64.5 ttp -156.08 149.88 25.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.172 -175.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 88.6 mt -111.89 143.91 42.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.203 172.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 94.2 t -118.08 120.94 66.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 176.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.01 140.03 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.181 -175.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -74.88 92.51 2.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.179 -174.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 153.59 156.07 7.46 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 173.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.4 157.87 38.79 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.728 1.618 . . . . 0.0 111.207 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.431 ' HB2' ' HB2' ' A' ' 309' ' ' ASP . 62.0 t80 -48.18 -47.05 35.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 176.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -63.34 -24.07 67.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.202 -174.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 90.2 t -88.44 -51.1 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.207 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 255' ' ' LEU . 72.6 t -74.42 -52.0 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.24 -174.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 87.9 t90 -55.12 -39.92 69.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.239 -174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -75.19 -31.69 61.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.193 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -99.02 -0.71 41.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.201 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.53 ' HB3' ' HD3' ' A' ' 256' ' ' PRO . 55.9 tp -69.64 -43.61 22.28 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 -176.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 255' ' ' LEU . 74.2 Cg_exo -53.2 -35.81 75.02 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.714 1.609 . . . . 0.0 111.147 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.56 -47.47 78.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.216 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.12 73.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.204 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 56.0 mt -67.64 -49.85 60.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.181 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.78 -31.75 69.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.171 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -60.76 -31.46 70.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.21 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.3 24.95 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.191 -171.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.65 23.34 50.65 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 170.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' MET . . . . . 0.422 ' HB3' HG21 ' A' ' 278' ' ' VAL . 67.1 mtt -118.87 104.96 11.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.772 0.32 . . . . 0.0 111.227 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -96.7 112.23 24.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 95.7 t -69.62 127.84 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.234 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 79.6 p -103.84 -26.08 12.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.191 -174.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -165.12 162.26 20.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.157 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 86.0 p -159.48 154.34 24.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.191 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 91.6 m -132.08 109.91 10.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.184 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -72.54 -23.32 60.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.219 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 86.3 p -77.69 -12.7 60.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.199 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -119.56 -18.81 8.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.223 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.45 28.92 60.72 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -109.5 150.22 28.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.345 . . . . 0.0 111.196 -173.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 58.9 ttm -142.33 137.31 30.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.219 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -117.54 126.32 52.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.19 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' A' ' 264' ' ' MET . 10.5 p -138.77 135.65 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.179 -167.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 98.0 m -95.85 125.01 40.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.246 176.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -114.16 137.78 51.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.163 -172.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -132.62 127.58 20.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.203 169.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.03 137.6 76.71 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.765 1.643 . . . . 0.0 111.212 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 70.4 mt -99.23 163.85 12.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.21 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 58.7 p -71.55 163.26 28.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.174 -176.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.57 -38.69 75.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.194 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 90.9 p -69.64 -30.35 68.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.193 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.63 -43.96 92.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.254 175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -74.28 -26.45 60.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.184 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -67.56 -40.6 84.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.199 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -70.3 -35.1 73.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.21 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.87 -29.14 66.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 77.37 35.28 37.86 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -137.01 154.65 50.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.769 0.318 . . . . 0.0 111.182 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 36.1 t -70.45 142.16 52.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.209 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -64.72 117.21 36.09 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.214 175.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 156.83 62.34 Favored 'Trans proline' 0 C--N 1.327 -0.559 0 C-N-CA 121.696 1.597 . . . . 0.0 111.191 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -89.56 34.33 4.06 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 11.1 mp -100.32 139.92 35.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.762 0.315 . . . . 0.0 111.191 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -103.74 162.73 12.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.209 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.7 t -59.53 134.6 57.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 158.4 -178.97 34.41 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -86.82 133.42 33.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.804 0.335 . . . . 0.0 111.205 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -121.28 153.03 38.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.197 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -112.22 160.63 17.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.171 173.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 53.2 tp -144.98 128.82 17.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.173 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -109.75 122.77 48.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.199 170.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 47.7 t -116.48 126.9 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.199 -172.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -114.37 167.46 12.32 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . 25.1 t70 -107.08 104.4 14.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 111.185 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 313' ' ' ARG . 84.7 mt -86.1 59.95 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 175.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 310' ' ' LEU . 67.4 m-20 64.91 -104.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.189 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -93.93 16.02 15.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.234 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 310' ' ' LEU . 89.5 mmt-85 -131.6 166.14 22.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.174 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 58.2 m -118.37 138.79 52.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.203 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.407 ' OG ' ' SD ' ' A' ' 241' ' ' MET . 31.2 t -107.01 112.75 25.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.246 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 64.0 mt -101.76 113.59 26.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.193 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -105.72 102.4 11.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.165 170.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -86.97 135.11 33.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.219 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 79.5 mt -124.03 128.63 74.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.18 -172.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.517 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 30.8 p30 -72.7 173.32 5.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.189 -175.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.517 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 50.4 Cg_exo -60.45 -24.67 78.55 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.668 1.579 . . . . 0.0 111.24 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -81.69 -8.42 59.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 -175.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 88.75 24.6 32.32 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -121.09 143.82 48.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.809 0.338 . . . . 0.0 111.245 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 87.6 m -62.82 135.0 57.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.23 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 95.5 mt -59.91 155.25 16.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.217 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 69.4 p -83.23 165.97 18.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.247 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.595 ' HG3' ' HG3' ' A' ' 240' ' ' PRO . 89.2 mt-30 -61.61 -34.96 76.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.229 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 83.1 p -64.89 -25.65 67.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.189 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -90.01 -41.17 11.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -70.0 -36.52 75.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -57.95 -36.58 72.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.241 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -71.57 -35.74 70.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.191 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.07 -19.5 63.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 54.5 t -53.55 -53.78 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.173 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -66.49 -35.4 80.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.214 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 63.0 t -58.26 -50.18 79.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.168 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -86.17 -24.69 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.209 -176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -53.88 -49.55 68.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.181 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -76.53 -46.28 27.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.198 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.12 -36.46 81.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.208 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -72.54 -41.75 65.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.162 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 87.1 p -78.21 -15.33 58.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.194 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.193 -178.974 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.412 ' HA ' ' HG3' ' A' ' 339' ' ' GLN . 69.5 m-20 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.822 0.344 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 97.1 t -130.92 135.17 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -129.99 161.72 30.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 -176.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 31.9 t -101.93 145.98 28.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.201 172.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -154.28 166.96 31.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.203 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.73 139.82 30.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.209 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -81.78 173.04 12.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.25 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -65.31 -23.32 66.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 60.0 p -82.85 -15.43 51.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.197 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.43 -4.52 64.39 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 98.0 mt -81.84 154.15 70.34 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.173 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.14 130.0 38.33 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.655 1.57 . . . . 0.0 111.259 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 63.1 ttp -130.01 139.64 51.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 43.1 tp -104.56 128.45 52.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.23 174.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 31.7 m -123.91 149.95 28.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.222 -173.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.41 145.62 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -74.86 84.33 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.2 -172.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 158.59 156.57 8.07 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 171.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.45 161.14 24.93 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.718 1.612 . . . . 0.0 111.234 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -48.8 -46.16 41.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.192 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -60.35 -30.68 69.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.167 -175.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 81.5 t -83.12 -52.47 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.225 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 255' ' ' LEU . 79.2 t -73.89 -50.17 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.24 -171.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 91.1 t90 -55.81 -37.39 68.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 -173.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -74.88 -30.93 61.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -96.89 -8.07 31.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.212 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.513 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 61.4 tp -67.45 -44.12 44.63 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 -173.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 90.9 Cg_exo -49.34 -40.4 43.85 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.658 1.572 . . . . 0.0 111.192 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.09 -43.25 95.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.252 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.0 -27.46 66.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.205 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.408 HD22 ' SD ' ' A' ' 264' ' ' MET . 93.2 mt -77.1 -39.61 48.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.203 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -63.03 -26.71 68.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.221 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -77.64 -14.86 59.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 35.9 m -113.78 15.8 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.219 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.16 14.45 71.8 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' MET . . . . . 0.481 ' SD ' HG21 ' A' ' 278' ' ' VAL . 57.4 ttm -110.19 100.04 9.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 111.227 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -89.45 127.1 35.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 -171.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 278' ' ' VAL . 96.3 t -74.31 124.84 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.201 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 64.6 p -107.73 -26.63 10.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.2 -177.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -163.41 158.7 21.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.168 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 87.9 p -159.36 155.4 26.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.175 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 81.3 m -140.11 116.69 10.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.228 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -67.14 -38.73 86.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.24 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 96.6 p -73.54 -21.84 60.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.189 -170.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -113.83 -12.1 12.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.212 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 74.39 36.81 48.95 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -91.03 134.96 34.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 111.24 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 59.9 tpp -135.82 96.65 3.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 174.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -95.29 120.77 36.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.193 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.481 HG21 ' SD ' ' A' ' 264' ' ' MET . 35.2 m -132.32 155.56 41.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.241 -169.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 98.4 m -116.09 123.39 47.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.222 168.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -109.06 132.75 53.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.181 -170.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -129.01 126.51 23.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.195 170.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.08 141.0 80.52 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.703 1.602 . . . . 0.0 111.171 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 66.3 mt -98.32 164.0 12.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.224 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 59.5 p -75.56 164.79 25.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.193 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.17 -39.36 78.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 91.5 p -70.15 -29.87 66.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.198 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.52 -42.74 91.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.204 174.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -72.32 -29.77 64.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.188 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -65.6 -40.1 92.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.196 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.08 -45.34 85.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 62.8 tp -61.4 -41.01 96.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 97.68 34.57 5.45 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -140.09 172.35 12.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.319 . . . . 0.0 111.247 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 83.1 p -107.73 -175.29 2.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.179 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -60.81 120.39 52.99 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.87 -19.9 39.92 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.707 1.605 . . . . 0.0 111.218 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 85.34 11.76 74.64 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.3 mt -95.14 138.21 33.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 111.229 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -101.88 156.46 17.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.206 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 43.5 t -57.76 138.71 55.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.179 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 149.64 -178.94 26.82 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -81.95 143.06 31.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.775 0.321 . . . . 0.0 111.203 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -126.13 140.1 52.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.202 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -105.19 114.88 29.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.178 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 43.8 tp -110.73 120.62 43.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.23 -176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -98.12 131.17 44.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.232 171.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.15 117.64 54.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.202 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -105.79 154.86 16.97 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -92.17 114.65 27.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.763 0.316 . . . . 0.0 111.16 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.51 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 84.4 mt -93.7 9.92 35.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.232 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 34.5 t0 87.55 -64.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.208 175.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -99.62 -7.28 25.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.186 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -137.76 173.27 11.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 71.0 m -126.88 139.6 52.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 170.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 90.7 p -94.5 154.35 17.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 74.5 mt -129.32 115.63 17.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.184 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -115.08 104.53 11.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 174.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -92.4 133.13 36.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.193 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 85.9 mt -115.96 124.88 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.231 168.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.54 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 31.2 p30 -76.05 174.37 5.71 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.209 -172.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.54 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 64.0 Cg_exo -59.47 -25.44 78.65 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.688 1.592 . . . . 0.0 111.212 -175.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -84.34 -6.82 59.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.199 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.43 15.06 59.16 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -108.89 146.35 33.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.805 0.336 . . . . 0.0 111.22 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 74.9 p -67.25 149.97 49.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.461 ' HG ' ' HB2' ' A' ' 330' ' ' GLN . 13.9 tp -69.58 135.58 50.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.23 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 52.8 p -84.43 164.27 18.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.213 -168.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -54.98 -45.44 74.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.223 -174.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 97.3 p -63.02 -24.94 68.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' GLN . . . . . 0.461 ' HB2' ' HG ' ' A' ' 326' ' ' LEU . 74.7 mt-30 -88.72 -37.94 15.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.225 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -65.15 -37.45 87.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.179 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -72.84 -32.12 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.224 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -64.96 -33.07 75.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 94.3 mt -78.52 -7.94 58.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.24 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.06 -58.66 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.187 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -72.32 -33.45 67.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.239 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 68.5 t -63.95 -51.0 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.196 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -68.79 -41.29 78.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.18 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' GLN . . . . . 0.412 ' HG3' ' HA ' ' A' ' 229' ' ' ASP . 65.6 tt0 -54.55 -43.15 71.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -63.79 -41.13 97.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.186 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.79 -31.15 72.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.198 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -76.9 -34.64 57.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.151 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 83.5 p -77.04 -17.79 58.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.274 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.215 174.221 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.848 0.356 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.441 ' HB ' ' HG3' ' A' ' 339' ' ' GLN . 66.7 t -129.3 130.64 67.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -129.9 160.17 34.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.21 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 34.5 t -101.73 142.24 33.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.215 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -153.04 173.4 15.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.252 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -96.64 141.09 30.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.252 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -79.89 171.4 15.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.229 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.98 -25.62 67.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.166 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 61.7 p -83.55 -15.17 50.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.196 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.77 -5.56 58.31 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 95.3 mt -77.23 157.12 81.24 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.79 0.328 . . . . 0.0 111.19 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.476 ' HG3' ' HG3' ' A' ' 328' ' ' GLN . 51.2 Cg_exo -55.49 133.03 55.71 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.74 1.627 . . . . 0.0 111.211 177.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 62.2 ttp -133.67 144.56 49.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.254 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 74.5 mt -109.98 145.72 36.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.166 171.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 68.5 t -124.34 127.12 72.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 94.2 t -111.93 134.77 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.223 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -65.82 113.06 4.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.187 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 127.73 142.19 5.45 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -73.31 169.21 22.82 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.738 1.625 . . . . 0.0 111.228 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -48.53 -45.29 37.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.187 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -63.37 -27.09 69.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.236 -173.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 72.9 t -88.26 -56.88 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.177 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 255' ' ' LEU . 76.6 t -67.58 -54.66 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.199 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -55.61 -39.71 71.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.207 -169.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -68.0 -35.95 79.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -107.99 8.81 28.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.211 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.546 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 50.7 tp -68.4 -41.7 25.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.223 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 82.4 Cg_exo -51.17 -38.95 61.87 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.689 1.593 . . . . 0.0 111.18 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.08 -44.91 87.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.222 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.19 -36.0 82.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.185 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.95 -38.2 66.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.203 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -57.67 -36.31 71.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.215 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -64.91 -26.24 68.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.176 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 35.7 m -106.71 18.75 5.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.233 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 85.78 14.57 67.32 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' MET . . . . . 0.442 ' SD ' HG21 ' A' ' 278' ' ' VAL . 58.1 ttm -111.9 99.92 8.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.764 0.316 . . . . 0.0 111.229 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.8 127.1 42.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.206 -171.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.421 ' HA ' HG12 ' A' ' 278' ' ' VAL . 98.0 t -72.61 127.98 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.227 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 73.8 p -108.21 -25.88 10.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.197 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -163.08 158.72 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 89.7 p -159.93 160.73 33.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.218 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 62.0 m -140.84 119.98 12.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 62.9 ttp180 -66.97 -43.52 82.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.182 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 96.9 p -73.33 -20.59 60.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.201 -169.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -112.41 -13.46 13.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 72.84 38.24 56.52 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -89.21 139.12 30.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 0.0 111.157 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 55.7 tpp -139.01 89.96 2.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.237 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -89.37 121.47 31.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.224 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.442 HG21 ' SD ' ' A' ' 264' ' ' MET . 34.6 m -129.99 153.63 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.239 -168.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.6 m -112.92 124.65 53.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.225 167.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -112.71 136.48 52.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.212 -171.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -134.69 128.73 19.07 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.22 171.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.17 140.48 81.0 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.643 1.562 . . . . 0.0 111.164 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 67.1 mt -99.67 163.9 12.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.239 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.3 p -73.47 163.13 28.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.186 -176.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.86 -35.3 72.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.241 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 87.9 p -71.42 -31.64 67.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.69 -43.08 94.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.189 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -72.5 -30.12 64.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.228 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -66.26 -40.2 90.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.172 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.19 -38.67 82.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.224 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.34 -36.28 81.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.214 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 94.72 19.16 32.62 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -174.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -115.71 -156.55 0.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.812 0.339 . . . . 0.0 111.194 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 10.7 t -147.84 -168.45 3.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.218 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -68.43 120.15 73.16 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.223 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.46 -15.03 25.04 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.686 1.591 . . . . 0.0 111.22 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 85.76 8.06 80.4 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.52 141.39 29.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.189 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -99.82 158.7 15.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.2 t -58.0 137.14 57.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.197 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 155.63 -179.65 31.42 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -87.03 138.23 31.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.325 . . . . 0.0 111.188 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -122.63 145.2 48.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.194 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -109.98 112.4 24.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.166 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 39.1 tp -105.73 120.06 40.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.235 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -92.25 128.18 38.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.173 170.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 52.7 t -115.09 122.79 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -116.25 157.2 15.17 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.77 120.28 34.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 0.0 111.165 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.524 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 88.2 mt -96.77 14.57 24.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.213 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 32.0 t0 87.61 -65.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -102.71 -10.42 19.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.213 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -139.16 176.7 8.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.218 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 58.7 m -119.83 138.05 53.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.231 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 23.7 t -100.06 128.59 46.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.182 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 68.4 mt -110.54 126.88 54.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.171 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -125.3 105.01 8.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -90.12 127.96 36.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.204 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 45.5 mm -108.89 127.66 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.253 170.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.53 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 26.3 p30 -75.72 174.17 5.94 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.226 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.53 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 71.9 Cg_exo -60.02 -26.07 81.43 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.716 1.611 . . . . 0.0 111.182 -173.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -83.29 -8.12 59.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.167 -174.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.73 15.13 58.63 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -105.94 146.9 29.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.799 0.333 . . . . 0.0 111.197 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 89.8 m -60.9 130.11 44.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.216 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 19.7 tp -63.24 134.71 56.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.166 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 56.7 p -81.29 164.75 22.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -166.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.476 ' HG3' ' HG3' ' A' ' 240' ' ' PRO . 88.2 mt-30 -63.75 -32.04 73.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.206 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 83.8 p -65.67 -18.11 65.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -107.85 -28.28 9.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.199 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -73.89 -42.28 60.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.227 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -62.04 -32.25 72.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.188 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -72.51 -35.02 68.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.238 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 38.5 mt -65.43 -32.39 73.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.195 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 58.0 t -52.6 -45.62 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -62.24 -45.47 93.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.196 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 5.3 m -78.82 -26.08 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -72.97 -43.96 61.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.214 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' GLN . . . . . 0.441 ' HG3' ' HB ' ' A' ' 230' ' ' VAL . 80.3 mt-30 -55.36 -44.75 76.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -65.38 -41.03 94.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.08 -36.69 85.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.192 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -79.55 -38.83 33.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.239 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 90.0 p -73.06 -25.83 61.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.259 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.223 -177.809 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 48.3 p30 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.82 0.343 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 91.2 t -125.05 137.45 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -149.97 163.01 39.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.199 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 26.3 t -96.33 139.08 32.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.177 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -162.7 157.74 22.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.39 147.15 23.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.227 176.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -85.14 -166.81 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.221 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.97 -25.41 67.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 -172.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 63.0 p -97.41 1.01 48.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 -176.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 86.98 21.28 50.71 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 59.1 tp -99.62 114.44 65.61 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.35 . . . . 0.0 111.205 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.24 135.74 65.92 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.725 1.617 . . . . 0.0 111.221 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.3 163.93 39.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.193 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.7 tp -76.9 127.66 33.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.181 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.1 t -108.36 121.91 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.218 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.5 t -124.34 125.16 69.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.23 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -76.43 91.7 3.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 -172.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 172.46 161.2 22.53 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 172.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.17 156.15 52.11 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.646 1.564 . . . . 0.0 111.191 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.431 ' HB2' ' HB2' ' A' ' 309' ' ' ASP . 66.0 t80 -48.91 -45.89 42.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 176.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -63.95 -22.27 66.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.249 -175.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 91.8 t -91.22 -50.38 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.163 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 74.3 t -73.01 -46.95 50.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.184 -173.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -60.63 -40.14 90.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.232 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -71.61 -35.38 70.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.169 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -80.16 -25.57 39.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.185 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.624 ' HB3' ' HD3' ' A' ' 256' ' ' PRO . 49.7 tp -53.83 -48.67 92.84 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 -169.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 255' ' ' LEU . 90.0 Cg_exo -47.8 -44.47 26.75 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.671 1.581 . . . . 0.0 111.192 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.42 -40.84 93.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.195 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.42 -35.4 80.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.245 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 81.5 mt -67.39 -37.63 83.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.211 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.56 -26.45 68.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.211 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -92.64 1.59 57.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.201 -173.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 35.5 m -125.34 9.81 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.237 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.97 27.58 33.76 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 172.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 98.3 mtp -117.2 105.96 12.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.757 0.313 . . . . 0.0 111.239 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -87.75 118.11 27.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.218 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 90.9 t -70.28 126.64 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.211 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 67.1 p -106.23 -28.11 10.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.231 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -162.16 160.85 27.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.214 174.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 83.5 p -154.53 152.79 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.207 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 60.6 m -144.53 122.67 12.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -92.69 -19.98 21.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.242 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 88.8 p -75.75 -15.06 60.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.205 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -117.95 -20.64 8.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.245 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.02 48.86 10.48 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -145.96 175.24 10.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.335 . . . . 0.0 111.182 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.439 ' HB3' ' HB2' ' A' ' 305' ' ' LEU . 50.3 ttm -159.83 148.52 17.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.213 -175.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -116.81 121.22 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.192 174.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 45.4 t -138.53 131.29 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.202 -168.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 97.8 m -92.87 120.13 32.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.2 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -97.85 127.34 43.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.195 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -123.03 120.2 27.56 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.2 172.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.06 134.09 61.77 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.692 1.595 . . . . 0.0 111.188 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 68.5 mt -99.27 163.78 12.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.19 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 60.9 p -81.75 167.48 19.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.217 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -59.16 -32.68 70.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 85.2 p -69.81 -22.54 63.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.179 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -82.13 -39.57 23.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.203 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -74.24 -24.61 59.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.216 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -68.5 -40.2 80.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.203 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.72 -38.7 76.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.209 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 48.0 tp -67.95 -36.25 79.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.204 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 84.75 42.71 7.13 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -139.14 160.13 40.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 111.216 -174.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 87.8 p -94.28 162.62 13.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.212 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -41.26 120.96 1.98 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.247 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.22 -24.93 57.98 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.721 1.614 . . . . 0.0 111.172 -176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 81.86 15.63 74.75 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.37 143.36 26.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 0.0 111.205 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -100.35 145.23 28.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.211 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 46.3 t -54.34 139.08 37.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.204 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 143.65 -171.53 25.28 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -84.56 138.52 32.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 111.221 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -119.25 137.41 53.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.225 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.431 ' HB3' ' HB ' ' A' ' 319' ' ' ILE . 88.1 tttt -94.33 126.34 39.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.19 171.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.481 ' HB3' HD11 ' A' ' 316' ' ' LEU . 63.5 mt -108.13 134.75 50.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.243 -176.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -123.05 124.14 42.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.19 173.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.416 HG22 HD13 ' A' ' 316' ' ' LEU . 70.5 t -115.4 125.09 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.189 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -118.11 156.5 15.62 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 176.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . 18.2 t0 -102.63 108.52 19.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.752 0.311 . . . . 0.0 111.216 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 311' ' ' ASP . 83.5 mt -87.97 67.66 9.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.198 177.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 310' ' ' LEU . 65.4 m-20 64.93 -102.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.24 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -89.23 -8.19 54.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -118.34 175.05 5.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.194 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 74.5 m -132.24 159.35 39.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.203 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 87.8 p -133.04 149.53 52.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.215 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.481 HD11 ' HB3' ' A' ' 305' ' ' LEU . 37.1 tp -133.07 118.06 18.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.165 -175.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -100.22 140.21 34.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.233 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' A' ' 326' ' ' LEU . 46.1 m-85 -108.52 131.25 55.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.233 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 304' ' ' LYS . 85.9 mt -116.48 119.32 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.235 168.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.571 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 30.2 p30 -78.14 175.85 4.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.172 -171.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.571 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 67.9 Cg_exo -59.45 -25.65 79.31 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.748 1.632 . . . . 0.0 111.175 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.88 -6.72 59.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 88.67 14.47 61.31 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -98.96 142.72 30.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.73 0.3 . . . . 0.0 111.242 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 81.4 p -78.67 162.61 26.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.178 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 318' ' ' PHE . 25.3 tp -62.55 131.7 49.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.267 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 66.4 p -87.74 164.92 15.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.18 177.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -61.55 -47.75 84.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 73.8 m -55.9 -42.71 76.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.224 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -64.99 -49.22 71.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -63.48 -34.57 78.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.171 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.84 -40.37 97.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -68.48 -34.12 75.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.216 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.74 -13.73 61.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.206 -175.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 74.1 t -55.83 -58.46 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.226 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -66.28 -34.96 79.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.68 -49.86 82.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.227 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -87.25 -24.52 24.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.213 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -55.22 -49.99 70.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.191 171.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -67.07 -36.55 82.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.213 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -70.17 -42.34 72.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.23 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -75.69 -27.78 58.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.156 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 72.8 m -81.24 -22.37 38.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.218 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 47.1 tptt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.224 178.468 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.795 0.331 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 96.9 t -120.84 138.87 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.193 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -130.29 163.04 27.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.226 176.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 40.7 t -92.85 140.37 29.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.182 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -146.69 175.83 10.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.202 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -119.58 144.32 47.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.238 174.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 42.2 p30 -88.63 -172.04 3.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.177 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -69.0 -19.21 64.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.188 -172.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 59.8 p -95.84 -7.37 37.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.183 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 92.89 6.49 63.5 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 240' ' ' PRO . 99.4 mt -87.43 145.45 37.53 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.783 0.325 . . . . 0.0 111.219 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 239' ' ' LEU . 54.6 Cg_exo -58.99 140.27 94.6 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.724 1.616 . . . . 0.0 111.192 -176.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -148.21 172.05 14.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.2 173.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 92.0 mt -108.89 150.49 27.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.195 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.9 149.43 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.221 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.78 138.71 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.203 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -71.9 74.08 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.169 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 174.94 164.44 29.7 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -76.25 159.83 36.49 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.718 1.612 . . . . 0.0 111.181 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -52.0 -44.28 64.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -63.42 -23.35 67.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.192 -171.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.16 -52.51 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.203 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.15 -52.94 55.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.204 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -57.71 -42.49 83.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.155 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -67.08 -34.7 78.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.185 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -100.0 4.55 44.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.211 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.528 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 46.6 tp -68.73 -43.39 28.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.217 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 85.9 Cg_exo -51.84 -36.91 64.85 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.73 1.62 . . . . 0.0 111.226 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.19 -45.54 91.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -66.27 -36.93 84.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 49.0 mt -63.31 -43.82 96.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.158 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.67 -20.19 66.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -93.52 -5.71 48.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.222 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 31.5 m -115.24 2.18 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.199 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 98.44 21.29 17.5 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 67.1 mtt -116.98 104.38 11.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 111.193 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -89.01 120.52 30.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.76 124.91 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.203 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 71.8 p -104.69 -25.37 12.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.216 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -164.99 160.62 19.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.226 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 84.7 p -162.89 157.67 21.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.179 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 68.3 m -143.23 121.06 11.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.217 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -73.26 -45.9 53.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.222 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 87.0 p -66.72 -21.07 66.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.202 -172.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.69 -21.81 12.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.213 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.61 42.59 26.3 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -128.14 160.6 31.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.801 0.334 . . . . 0.0 111.217 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 59.7 ttm -158.27 149.77 21.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.23 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -125.93 128.7 47.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.187 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.59 146.61 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.166 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 97.4 m -102.6 119.29 38.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.221 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -107.52 137.17 46.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.191 -172.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -136.96 129.08 17.01 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.225 169.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.01 140.4 79.93 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.702 1.602 . . . . 0.0 111.215 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 56.5 mt -100.63 165.32 11.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.155 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.1 p -73.01 163.62 27.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.24 -37.37 74.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.156 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 89.5 p -71.25 -30.95 66.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.53 -42.41 92.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.222 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -71.55 -29.88 65.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.198 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -66.09 -39.95 90.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.206 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.92 -41.16 87.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.199 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.46 -41.88 98.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.213 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 97.48 35.6 5.15 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -143.64 160.27 40.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 111.141 -174.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 88.1 p -85.1 171.47 12.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.237 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -64.92 120.04 63.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.218 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -69.14 -21.03 36.95 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.76 1.64 . . . . 0.0 111.197 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.09 30.22 55.63 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 47.4 tp -106.4 133.44 51.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 111.188 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -86.4 164.75 16.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.236 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.0 p -68.72 164.71 21.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.191 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 145.36 172.12 15.52 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -91.75 109.32 20.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.747 0.308 . . . . 0.0 111.186 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -103.82 146.74 28.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -169.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -90.81 129.81 36.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.201 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.418 HD21 HD21 ' A' ' 255' ' ' LEU . 41.5 tp -123.19 119.93 31.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.219 -176.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -112.19 145.54 39.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 43.5 t -135.12 134.81 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.198 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -134.21 172.66 21.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -115.59 112.78 22.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 0.0 111.182 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.558 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 93.3 mt -83.37 0.52 45.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.177 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 34.0 t0 88.41 -64.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.178 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -76.4 -15.23 59.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.213 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -164.74 173.83 11.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.156 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 38.5 t -100.67 151.64 21.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.218 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 97.6 p -131.87 153.77 49.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.192 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.404 ' HB2' HD11 ' A' ' 305' ' ' LEU . 4.3 pp -150.59 156.47 41.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.218 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -149.21 136.5 20.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.179 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -102.13 138.49 39.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.202 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 85.4 mt -124.33 130.43 73.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.188 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -54.72 157.19 5.6 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.268 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.43 -25.67 49.72 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.681 1.587 . . . . 0.0 111.237 175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.84 0.8 57.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.222 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.83 32.01 10.51 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -124.42 121.6 35.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.802 0.334 . . . . 0.0 111.178 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 6.1 t -49.12 150.99 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 9.7 mp -62.53 151.5 37.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.158 165.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 69.6 p -85.14 161.83 19.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -57.25 -38.8 74.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.219 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 85.5 p -65.15 -26.03 68.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.197 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -88.72 -41.48 12.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.233 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -66.83 -41.22 87.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.242 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -57.52 -34.31 68.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.222 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -73.52 -36.79 65.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.202 173.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 67.9 mt -68.32 -20.11 64.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.182 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 55.9 t -54.13 -55.46 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.194 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -68.74 -34.97 76.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.84 -49.0 86.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.188 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -75.41 -37.95 60.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.211 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -53.57 -44.32 69.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.22 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -65.13 -41.27 94.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.197 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.52 -32.24 73.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.243 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -76.43 -29.33 56.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.209 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 72.2 p -76.99 -16.13 59.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.186 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.198 171.687 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.2 129.51 53.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.204 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -150.54 155.26 39.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 87.6 p -87.21 158.8 19.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.215 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -166.56 155.75 11.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.165 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -93.24 135.25 34.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.212 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 47.9 p30 -86.57 -165.81 1.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.215 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -65.15 -24.58 67.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.202 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 65.9 p -98.13 -2.3 40.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.201 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 86.46 11.28 72.08 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 32.4 tp -78.31 123.88 85.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 0.0 111.218 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.85 120.5 8.24 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.686 1.59 . . . . 0.0 111.223 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 67.9 mmm -129.79 160.04 34.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.223 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 33.6 tp -107.79 124.03 49.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.212 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.8 t -106.39 125.3 62.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 89.3 t -107.97 133.77 51.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.186 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -68.71 102.08 1.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 145.43 154.13 6.07 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.46 154.92 38.69 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.658 1.572 . . . . 0.0 111.208 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.442 ' O ' ' CD1' ' A' ' 248' ' ' PHE . 1.2 t80 -54.99 -45.45 75.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 178.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.56 -25.81 67.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.244 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.72 -49.03 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 255' ' ' LEU . 62.8 t -66.48 -39.55 84.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.177 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -54.57 -33.16 59.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.205 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -65.57 -34.96 79.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.226 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -108.95 4.88 23.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.193 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.568 ' N ' ' HD2' ' A' ' 256' ' ' PRO . 63.0 tp -64.36 -52.1 56.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.225 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 255' ' ' LEU . 42.7 Cg_endo -67.21 -24.8 43.7 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.697 1.598 . . . . 0.0 111.211 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.13 -49.69 71.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.192 171.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.19 -38.12 89.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 48.0 mt -62.4 -44.89 95.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.15 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.33 -33.05 74.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.199 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -71.79 -23.62 61.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.23 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 25.3 m -103.66 -0.26 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.226 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 107.03 -2.15 35.44 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 169.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 64.2 mtt -89.76 90.75 8.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 0.0 111.224 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -72.77 111.45 7.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 95.7 t -68.02 131.34 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 65.5 p -109.46 -30.98 7.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.246 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -168.65 161.21 11.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.197 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 39.9 t -147.05 125.21 12.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.239 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 92.8 m -93.81 115.05 27.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.255 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 92.0 mtm180 -80.58 -22.42 40.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.228 -173.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 89.9 p -79.35 -15.28 58.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.192 -177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -119.77 -19.92 7.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.246 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 74.88 42.91 29.31 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -129.74 118.07 21.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 0.0 111.203 -171.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 59.7 ttm -111.58 131.89 54.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.239 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -103.13 133.77 47.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.17 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 19.5 m -132.71 147.37 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.195 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.0 m -98.47 115.22 28.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.255 166.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -93.57 115.07 27.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.191 -171.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -110.52 105.37 57.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.189 166.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -54.9 142.13 76.09 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.694 1.596 . . . . 0.0 111.216 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.28 153.47 28.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.195 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.7 p -75.22 167.92 20.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.23 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -55.38 -43.66 75.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.255 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 91.3 p -70.82 -31.24 67.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.193 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.58 -36.83 83.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 176.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -69.63 -29.89 67.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.219 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -71.48 -37.96 71.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.195 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.37 -41.86 79.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 55.8 tp -67.52 -39.93 85.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.208 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 87.99 40.96 6.44 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.408 ' HB1' ' HA ' ' A' ' 337' ' ' VAL . . . -140.56 159.91 41.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 111.214 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 89.1 p -77.19 165.59 24.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.202 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -103.63 108.54 59.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.197 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.79 169.44 21.18 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.723 1.615 . . . . 0.0 111.18 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -90.19 3.33 82.27 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 96.1 mt -53.71 176.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.772 0.32 . . . . 0.0 111.204 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -143.58 176.24 9.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.192 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 85.1 p -74.29 161.81 29.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.194 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 143.5 -177.66 22.16 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -91.24 104.94 17.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.799 0.333 . . . . 0.0 111.247 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -99.23 151.31 21.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.185 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -117.69 137.25 52.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.194 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 316' ' ' LEU . 37.5 tp -121.93 106.93 11.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.23 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -93.36 121.53 34.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.168 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.49 127.31 70.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.192 -172.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -111.44 158.41 14.35 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -101.89 118.71 37.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.34 . . . . 0.0 111.229 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 89.6 mt -110.85 77.45 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.191 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.7 -108.54 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -100.9 28.71 5.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.165 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -134.24 151.82 51.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.25 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 57.8 m -109.62 128.59 55.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.151 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 32.7 t -106.4 111.42 23.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.19 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.419 ' HB3' HD11 ' A' ' 305' ' ' LEU . 69.7 mt -98.18 123.35 42.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.191 -172.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -109.35 100.37 9.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.187 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -86.06 132.31 34.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.217 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 66.7 mt -124.6 124.27 67.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.224 -171.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -59.72 155.81 38.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.185 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -61.0 -18.63 58.8 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.663 1.575 . . . . 0.0 111.182 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -78.56 -11.94 59.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.189 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.73 14.53 43.15 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -119.06 152.77 35.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.804 0.335 . . . . 0.0 111.232 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 62.6 p -77.87 160.14 28.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.194 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 9.9 mp -70.35 142.39 52.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.229 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 69.9 p -81.45 164.58 21.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.199 -173.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -55.17 -36.97 66.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 76.9 p -62.57 -25.99 68.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.195 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -100.32 -29.24 12.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.196 -175.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -73.11 -24.25 60.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -80.33 -15.17 57.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.197 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -89.46 -29.47 18.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.188 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 88.3 mt -74.22 -10.34 59.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.162 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 6.0 m -66.74 -24.66 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.202 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -97.83 -32.01 11.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.234 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.408 ' HA ' ' HB1' ' A' ' 293' ' ' ALA . 53.5 t -60.23 -49.59 83.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.191 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -84.52 -33.62 23.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.187 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 66.9 tt0 -55.36 -45.82 76.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.214 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -64.72 -38.23 90.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.234 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.42 90.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.238 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -74.41 -30.21 61.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.179 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 90.1 p -85.57 -20.85 28.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.157 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 48.1 tptt . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.182 178.779 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.848 0.356 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.403 HG12 HG22 ' A' ' 244' ' ' VAL . 23.8 m -132.32 160.65 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.17 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -156.51 157.25 35.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.215 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 30.1 t -90.69 141.17 29.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.227 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -161.75 155.08 21.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.233 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.76 144.87 25.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.181 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 46.4 p30 -85.08 -164.66 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.218 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -65.01 -25.86 68.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.253 -172.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 53.8 p -95.45 -1.04 51.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.52 18.39 60.37 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 54.2 tp -90.72 115.85 65.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.164 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.67 130.37 38.35 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.711 1.607 . . . . 0.0 111.162 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -144.74 176.26 9.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.206 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 50.8 tp -102.88 127.09 50.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 99.8 t -110.47 125.52 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 314' ' ' SER . 47.8 t -99.22 137.56 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 176.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -80.64 80.0 7.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.201 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 170.04 159.47 15.99 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -53.06 136.17 60.61 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.673 1.582 . . . . 0.0 111.198 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -59.72 -27.82 66.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.249 -172.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -67.05 -40.71 87.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.179 173.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 68.1 t -68.85 -43.79 82.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.211 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 79.5 t -69.07 -40.54 80.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.233 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -55.1 -35.22 64.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.203 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -75.16 -33.16 61.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -97.33 -11.34 24.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.21 -172.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.526 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 57.0 tp -70.72 -43.6 15.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.175 -172.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 88.7 Cg_exo -51.26 -39.94 61.69 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.726 1.618 . . . . 0.0 111.21 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.13 -44.53 96.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.175 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.15 -39.55 93.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.21 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.78 -42.38 97.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.207 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -67.32 -22.97 65.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.184 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -93.28 -6.04 48.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.196 -174.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 29.4 m -111.17 -3.1 10.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.237 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 101.92 8.05 46.0 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 66.4 mtt -96.35 88.34 4.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 111.18 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.5 120.76 11.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.216 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.412 ' HA ' HG12 ' A' ' 278' ' ' VAL . 88.2 t -73.38 122.83 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.22 -175.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 60.3 p -110.45 -28.06 8.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.194 -175.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -161.39 155.82 22.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.209 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 40.8 t -162.09 115.92 1.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.199 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 86.8 m -125.43 112.16 15.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.213 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -75.26 -23.1 57.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.199 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 84.2 p -74.78 -16.29 60.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.216 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -118.3 -14.11 9.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.191 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 72.72 29.94 64.66 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -116.13 111.52 20.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 0.0 111.242 -169.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.4 ' SD ' HD23 ' A' ' 255' ' ' LEU . 95.1 mtp -115.84 152.81 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.2 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -142.88 135.02 27.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.192 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 266' ' ' VAL . 34.2 m -135.14 158.79 41.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.268 -175.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.4 m -110.07 118.62 36.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.186 165.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -95.8 127.44 41.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 -173.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -121.35 122.96 27.86 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.218 167.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -54.84 136.86 73.7 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.714 1.609 . . . . 0.0 111.192 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 77.1 mt -91.19 157.53 17.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.226 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.8 p -75.21 165.24 25.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.185 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -54.77 -43.88 73.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.19 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 91.8 p -69.03 -31.06 69.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.215 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.63 -40.45 95.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.22 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -70.59 -30.2 66.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.158 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -69.36 -39.64 77.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.198 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.62 -39.81 80.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.208 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.6 -45.0 84.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.183 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 97.84 34.7 5.37 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -142.64 155.8 44.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.231 -175.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 94.0 p -80.57 159.63 25.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.197 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -71.34 119.87 76.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.224 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.38 -15.02 25.24 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.687 1.591 . . . . 0.0 111.247 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.79 29.35 55.0 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 98.1 mt -93.91 143.29 26.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 0.0 111.208 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -90.09 163.81 14.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.206 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 82.9 p -69.64 160.67 31.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.225 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 145.57 178.63 21.24 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 174.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.57 132.74 34.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 0.0 111.173 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -122.37 149.55 43.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.202 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.86 154.91 23.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.174 174.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.556 HD13 ' C ' ' A' ' 305' ' ' LEU . 3.2 tm? -139.61 111.24 7.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.211 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 317' ' ' GLN . 62.5 tp60 -92.44 120.71 33.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.175 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 92.8 t -87.57 126.78 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.169 175.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -87.31 161.77 32.95 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 175.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -97.59 87.45 4.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 111.172 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 313' ' ' ARG . 97.7 mt -113.65 142.83 45.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 175.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -70.34 -49.98 43.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.206 -172.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -111.08 4.65 19.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.213 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 310' ' ' LEU . 89.4 mmt-85 -138.5 171.71 13.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.17 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' SER . . . . . 0.417 ' HB3' ' HB ' ' A' ' 244' ' ' VAL . 46.3 t -128.24 114.82 17.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 171.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 11.3 t -81.32 113.63 19.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.183 175.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 73.0 mt -105.65 98.62 8.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.187 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 306' ' ' GLN . 62.7 tt0 -88.93 99.01 12.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.2 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -84.01 132.38 34.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 86.4 mt -125.05 129.54 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.189 -173.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.521 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 31.4 p30 -75.6 173.46 7.05 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.164 -173.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.521 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 52.9 Cg_exo -59.94 -26.25 81.82 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.641 1.561 . . . . 0.0 111.264 -175.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -81.56 -8.5 59.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.191 -175.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.24 24.1 27.64 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -119.79 139.31 52.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.761 0.315 . . . . 0.0 111.222 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 74.3 m -65.08 137.39 57.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.223 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 88.4 mt -61.86 147.44 46.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.185 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 60.1 p -82.19 168.48 17.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.177 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -52.88 -41.95 64.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.173 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 89.4 p -64.96 -26.18 68.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.182 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -91.55 -23.13 20.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.215 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -85.07 -29.95 24.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.214 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -65.5 -36.87 85.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.176 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -64.79 -34.77 79.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.167 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.24 -13.96 60.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.235 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.16 -58.39 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.21 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.43 -35.01 79.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.204 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.84 -51.65 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.237 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -78.12 -30.68 49.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.216 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -52.76 -45.4 67.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.166 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -70.01 -39.19 75.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.178 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.19 -35.04 79.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.218 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -77.4 -24.78 50.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 65.5 p -76.99 -18.2 58.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.165 175.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 173.094 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.772 0.32 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 10.0 p -147.05 146.8 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.207 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -146.51 169.07 19.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.209 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 29.0 t -100.95 142.07 32.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.196 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -155.64 161.05 40.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -86.02 144.95 27.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.179 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 43.5 p30 -92.87 -171.59 2.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.162 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -69.86 -18.33 63.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.176 -173.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 70.8 p -95.62 -7.1 38.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.186 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.93 7.48 64.3 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 99.4 mt -93.63 148.83 36.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.787 0.327 . . . . 0.0 111.164 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.06 141.6 48.56 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.733 1.622 . . . . 0.0 111.182 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -143.82 163.38 33.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.234 175.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 316' ' ' LEU . 36.6 tp -103.82 114.22 28.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.163 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.86 123.28 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.182 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 96.6 t -100.11 135.64 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.235 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -76.12 74.49 2.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.212 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 168.83 157.64 11.77 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 173.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.63 157.68 36.0 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.699 1.6 . . . . 0.0 111.209 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.408 ' HA ' HG22 ' A' ' 251' ' ' VAL . 50.5 p90 -65.23 -20.26 66.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.205 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -69.87 -28.49 65.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.217 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 75.2 t -85.1 -39.21 13.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.173 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' A' ' 248' ' ' PHE . 14.7 m -67.26 -17.77 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -67.13 -13.71 62.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.182 173.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -105.35 -27.95 11.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.195 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.29 -42.58 36.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.546 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 82.3 mt -72.18 -41.47 8.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.182 -165.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 87.8 Cg_exo -48.26 -42.73 33.24 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.654 1.569 . . . . 0.0 111.199 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -88.59 -42.24 12.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -41.44 97.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.185 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.43 -48.79 78.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.19 -36.87 76.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.181 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -87.56 3.06 49.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.216 -172.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 34.2 m -119.03 14.26 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.202 172.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 104.64 -1.76 42.32 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 168.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 73.1 mtm -108.96 85.28 2.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.766 0.317 . . . . 0.0 111.179 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -68.27 122.07 17.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.218 -175.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 278' ' ' VAL . 91.3 t -70.53 124.51 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.22 -176.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 72.4 p -109.58 -25.78 10.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -162.47 162.35 27.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 32.1 t -162.61 136.44 6.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.165 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 89.4 m -123.25 117.98 26.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.217 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -74.31 -35.56 63.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 94.5 p -65.51 -21.31 66.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.205 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -107.97 -21.62 12.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.193 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 72.14 38.28 59.38 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -129.35 128.52 43.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.207 -169.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 90.7 mtp -117.51 147.98 42.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.201 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -120.98 130.14 53.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 266' ' ' VAL . 33.8 m -131.12 153.43 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 -174.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 85.9 m -106.35 122.93 47.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.223 167.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -101.68 129.62 47.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.223 -171.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.4 124.94 27.05 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.186 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.76 130.25 39.43 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.698 1.599 . . . . 0.0 111.197 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 78.5 mt -96.92 155.26 16.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.214 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 56.1 p -73.53 163.83 27.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.198 -176.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.08 -36.69 70.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 89.1 p -71.45 -30.89 66.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.241 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.56 -41.9 92.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.199 175.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -73.36 -29.19 62.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.213 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -66.78 -40.04 88.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.195 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.82 -38.16 85.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.194 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 59.7 tp -65.31 -39.59 92.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.179 173.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 91.24 35.28 7.11 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -142.58 163.53 32.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 111.147 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 94.2 p -86.55 167.35 14.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.178 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -65.03 120.97 71.43 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.222 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.88 -18.96 47.0 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.679 1.586 . . . . 0.0 111.184 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 80.92 34.61 26.78 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 80.5 mt -105.64 137.21 43.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.827 0.346 . . . . 0.0 111.187 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -93.76 160.47 14.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.237 173.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.9 p -60.67 156.63 16.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.208 -173.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 136.13 -176.3 20.35 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -86.93 136.55 32.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 111.173 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -123.01 153.98 39.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -119.17 148.67 42.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.226 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 44.3 tp -134.6 113.53 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.203 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -98.55 130.33 45.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.204 174.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.96 127.58 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.169 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -107.69 154.21 16.63 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -91.3 105.48 17.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 -175.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.705 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 90.6 mt -95.41 3.01 54.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.234 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ASP . . . . . 0.705 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 52.5 t0 101.42 -117.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.203 -174.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -71.37 -9.1 57.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.229 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -119.77 173.76 6.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 175.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 75.4 m -126.92 147.47 50.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 29.8 t -104.64 118.91 37.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 242' ' ' LEU . 47.0 mt -96.1 113.15 24.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 176.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -105.51 110.41 22.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -95.26 133.42 39.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.217 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 87.1 mt -122.84 128.98 75.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.196 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.55 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 33.5 p30 -80.21 174.94 5.34 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -175.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' PRO . . . . . 0.55 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 53.4 Cg_exo -59.97 -24.46 76.46 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.678 1.585 . . . . 0.0 111.198 -175.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.29 -5.29 59.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.184 -174.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.67 18.78 56.01 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -117.49 150.46 38.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 0.0 111.214 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 73.9 p -76.73 160.75 29.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.181 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 85.9 mt -76.93 150.13 35.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.192 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 40.5 p -75.19 166.96 22.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -54.85 -40.41 69.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.227 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 99.4 p -68.89 -33.66 74.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.174 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -75.63 -35.52 60.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.209 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -76.18 -31.18 58.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.198 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.71 -38.42 83.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.235 174.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -65.42 -34.75 79.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.202 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.03 -20.35 65.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.215 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 76.7 t -56.87 -54.03 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.165 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.12 -35.83 82.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.191 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.7 -49.95 82.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.169 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -81.6 -28.55 33.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.221 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -57.78 -43.02 85.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.236 173.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -69.21 -43.49 73.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.184 175.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.92 -28.09 69.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.181 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -84.21 -37.62 21.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.242 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 84.8 p -70.61 -21.4 62.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.223 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.194 175.783 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.749 0.309 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 82.9 t -124.99 130.79 73.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.168 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -121.28 156.17 33.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.192 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.6 t -91.72 140.68 29.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.99 179.77 8.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.24 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -128.89 148.0 50.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.163 172.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 42.5 p30 -85.06 -170.02 2.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.209 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.01 -24.17 67.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.213 -171.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 61.6 p -97.34 -1.51 44.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.182 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.91 18.18 60.11 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.7 mt -91.46 157.28 42.48 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 0.0 111.192 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.555 ' HG3' ' HG3' ' A' ' 328' ' ' GLN . 76.6 Cg_exo -55.07 134.86 66.12 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.667 1.578 . . . . 0.0 111.261 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 67.9 ttp -148.81 149.04 30.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.222 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 83.2 mt -113.8 144.61 42.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.199 169.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 95.3 t -113.19 119.73 61.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.225 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.4 t -105.33 137.38 35.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.227 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.9 ttt180 -64.77 107.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.443 ' HA2' ' HD3' ' A' ' 247' ' ' PRO . . . 130.76 143.56 5.33 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.443 ' HD3' ' HA2' ' A' ' 246' ' ' GLY . 45.0 Cg_exo -58.55 167.73 4.77 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.732 1.621 . . . . 0.0 111.191 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -48.99 -46.99 44.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -62.99 -26.19 68.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.159 -173.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 81.3 t -85.29 -52.56 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.224 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 255' ' ' LEU . 74.0 t -73.58 -53.81 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.181 -173.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -56.27 -39.87 73.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 -172.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -73.86 -29.75 62.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -107.55 6.01 27.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.177 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.543 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 60.8 tp -65.48 -42.38 56.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.23 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 85.9 Cg_exo -51.75 -35.4 58.25 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.693 1.595 . . . . 0.0 111.188 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.94 79.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.11 -34.91 77.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.213 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.433 HD22 ' SD ' ' A' ' 264' ' ' MET . 81.0 mt -63.48 -41.76 98.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.186 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.56 -25.39 67.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.192 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -80.69 -20.07 43.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.21 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 31.6 m -105.16 9.82 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.204 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.64 20.22 58.63 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' MET . . . . . 0.514 ' SD ' HG21 ' A' ' 278' ' ' VAL . 59.7 ttm -119.09 103.24 9.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.775 0.321 . . . . 0.0 111.213 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -93.65 129.08 40.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.166 -170.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.468 ' HA ' HG12 ' A' ' 278' ' ' VAL . 95.0 t -73.2 127.7 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.213 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 65.3 p -108.84 -27.88 9.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.219 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -162.71 166.31 24.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.237 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 82.8 p -161.41 153.78 20.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.208 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 85.1 m -133.92 112.0 10.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.185 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -72.86 -22.11 60.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 84.9 p -77.99 -12.41 59.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.178 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -116.87 -20.04 9.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.224 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.31 25.94 67.18 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -172.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -110.04 149.99 29.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.776 0.322 . . . . 0.0 111.187 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.42 ' HB3' ' HB2' ' A' ' 305' ' ' LEU . 56.7 ttm -140.07 136.76 33.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.196 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -110.59 125.6 53.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.197 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.514 HG21 ' SD ' ' A' ' 264' ' ' MET . 34.8 m -134.46 155.4 38.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.19 -169.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.0 m -117.92 125.06 49.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 172.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -113.15 137.61 51.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.209 -171.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -136.69 129.89 17.6 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.181 170.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.98 139.08 79.48 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.687 1.591 . . . . 0.0 111.269 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 64.3 mt -99.79 166.49 11.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.173 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 56.7 p -74.96 164.89 26.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.259 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -58.25 -39.3 78.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.21 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 93.9 p -70.29 -30.53 67.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.208 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.92 -43.58 92.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.215 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -71.63 -28.71 63.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.201 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -66.73 -40.53 88.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.194 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.98 -39.15 87.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.212 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.92 -39.0 90.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.188 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 90.3 39.93 5.89 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 -175.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -141.92 166.36 24.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.775 0.321 . . . . 0.0 111.208 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 82.8 p -99.43 -178.45 3.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.163 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -64.74 120.66 68.01 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.183 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.04 -22.94 47.05 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.728 1.619 . . . . 0.0 111.21 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.86 19.09 60.15 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 10.8 mp -101.29 140.28 35.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.228 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -99.33 159.56 14.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.184 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.3 t -60.16 139.99 57.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.181 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 153.15 -179.33 29.64 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -86.08 136.36 33.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.748 0.308 . . . . 0.0 111.244 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -121.15 149.05 43.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.426 ' HB3' ' HB ' ' A' ' 319' ' ' ILE . 87.7 tttt -110.72 122.13 47.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.212 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 276' ' ' MET . 62.8 mt -103.15 135.85 44.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.241 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -119.65 125.14 48.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.208 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 315' ' ' SER . 57.6 t -122.32 120.31 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -109.34 155.05 16.27 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -88.92 118.76 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 111.194 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.532 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 87.9 mt -95.45 11.41 32.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.225 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 37.1 t0 87.63 -64.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.157 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -101.81 -10.1 20.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.181 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 89.8 mmt-85 -137.69 176.57 8.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.217 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 50.3 m -119.99 136.59 54.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 307' ' ' VAL . 27.8 t -96.71 109.74 22.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 174.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 48.9 tp -111.72 124.0 51.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.182 -176.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -127.02 148.46 50.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.221 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -112.27 125.92 54.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -173.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 304' ' ' LYS . 92.5 mt -108.23 124.41 64.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.225 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.526 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 35.1 p30 -75.13 173.83 6.32 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.241 -174.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.526 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 51.8 Cg_exo -59.93 -25.18 78.79 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.73 1.62 . . . . 0.0 111.177 -176.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -80.18 -9.75 59.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.167 -173.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.58 17.17 42.97 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -120.42 162.01 20.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.797 0.332 . . . . 0.0 111.189 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 78.4 p -79.32 153.94 29.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.195 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 68.2 mt -76.47 158.43 31.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.197 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 41.0 p -76.76 167.05 22.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.199 -173.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.555 ' HG3' ' HG3' ' A' ' 240' ' ' PRO . 88.8 mt-30 -61.8 -35.04 77.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.21 174.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 98.9 p -71.51 -35.78 70.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.21 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -68.82 -41.95 77.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -67.61 -37.49 82.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.214 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -60.69 -37.41 81.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.195 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -66.7 -38.89 87.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.248 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 84.5 mt -68.19 -22.64 64.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.227 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.78 -56.75 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.169 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -67.98 -35.36 78.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.201 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.52 -46.53 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.179 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -79.66 -28.91 40.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.257 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -54.26 -42.07 69.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.221 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -76.17 -34.33 59.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.211 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.05 -40.82 95.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -74.02 -27.61 61.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.215 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 90.5 p -82.78 -27.83 30.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.215 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -62.68 124.84 84.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.237 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -53.91 130.28 38.45 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.701 1.6 . . . . 0.0 111.196 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 1.0 -14.531 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 . . . . . 0 CA--C 1.523 -0.071 0 CA-C-O 120.845 0.355 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 83.2 t -127.0 125.21 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.186 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -112.51 156.89 21.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.228 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 35.0 t -95.62 136.24 36.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.191 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.28 167.71 29.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.215 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -99.48 145.73 27.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 41.8 p30 -85.85 -169.9 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.35 -25.5 67.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.175 -172.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 68.6 p -97.58 -1.22 44.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.219 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.0 18.53 60.95 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 98.4 mt -94.0 158.09 36.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.753 0.311 . . . . 0.0 111.216 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.595 ' HG3' ' HG3' ' A' ' 328' ' ' GLN . 54.0 Cg_exo -55.06 139.3 80.02 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.696 1.598 . . . . 0.0 111.212 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.407 ' SD ' ' OG ' ' A' ' 315' ' ' SER . 64.5 ttp -156.08 149.88 25.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.172 -175.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 88.6 mt -111.89 143.91 42.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.203 172.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 94.2 t -118.08 120.94 66.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 176.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.01 140.03 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.181 -175.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -74.88 92.51 2.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.179 -174.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 153.59 156.07 7.46 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 173.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.4 157.87 38.79 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.728 1.618 . . . . 0.0 111.207 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.431 ' HB2' ' HB2' ' A' ' 309' ' ' ASP . 62.0 t80 -48.18 -47.05 35.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 176.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -63.34 -24.07 67.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.202 -174.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 90.2 t -88.44 -51.1 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.207 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 255' ' ' LEU . 72.6 t -74.42 -52.0 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.24 -174.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 87.9 t90 -55.12 -39.92 69.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.239 -174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -75.19 -31.69 61.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.193 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -99.02 -0.71 41.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.201 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.53 ' HB3' ' HD3' ' A' ' 256' ' ' PRO . 55.9 tp -69.64 -43.61 22.28 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 -176.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 255' ' ' LEU . 74.2 Cg_exo -53.2 -35.81 75.02 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.714 1.609 . . . . 0.0 111.147 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.56 -47.47 78.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.216 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.12 73.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.204 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 56.0 mt -67.64 -49.85 60.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.181 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.78 -31.75 69.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.171 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -60.76 -31.46 70.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.21 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.3 24.95 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.191 -171.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.65 23.34 50.65 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 170.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' MET . . . . . 0.422 ' HB3' HG21 ' A' ' 278' ' ' VAL . 67.1 mtt -118.87 104.96 11.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.772 0.32 . . . . 0.0 111.227 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -96.7 112.23 24.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 95.7 t -69.62 127.84 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.234 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 79.6 p -103.84 -26.08 12.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.191 -174.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -165.12 162.26 20.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.157 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 86.0 p -159.48 154.34 24.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.191 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 91.6 m -132.08 109.91 10.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.184 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -72.54 -23.32 60.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.219 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 86.3 p -77.69 -12.7 60.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.199 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -119.56 -18.81 8.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.223 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.45 28.92 60.72 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -109.5 150.22 28.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.345 . . . . 0.0 111.196 -173.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 58.9 ttm -142.33 137.31 30.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.219 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -117.54 126.32 52.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.19 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' A' ' 264' ' ' MET . 10.5 p -138.77 135.65 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.179 -167.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 98.0 m -95.85 125.01 40.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.246 176.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -114.16 137.78 51.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.163 -172.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -132.62 127.58 20.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.203 169.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.03 137.6 76.71 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.765 1.643 . . . . 0.0 111.212 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 70.4 mt -99.23 163.85 12.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.21 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 58.7 p -71.55 163.26 28.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.174 -176.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.57 -38.69 75.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.194 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 90.9 p -69.64 -30.35 68.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.193 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.63 -43.96 92.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.254 175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -74.28 -26.45 60.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.184 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -67.56 -40.6 84.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.199 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -70.3 -35.1 73.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.21 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.87 -29.14 66.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 77.37 35.28 37.86 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -137.01 154.65 50.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.769 0.318 . . . . 0.0 111.182 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 36.1 t -70.45 142.16 52.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.209 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -64.72 117.21 36.09 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.214 175.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 156.83 62.34 Favored 'Trans proline' 0 C--N 1.327 -0.559 0 C-N-CA 121.696 1.597 . . . . 0.0 111.191 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -89.56 34.33 4.06 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 11.1 mp -100.32 139.92 35.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.762 0.315 . . . . 0.0 111.191 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -103.74 162.73 12.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.209 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.7 t -59.53 134.6 57.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 158.4 -178.97 34.41 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -86.82 133.42 33.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.804 0.335 . . . . 0.0 111.205 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -121.28 153.03 38.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.197 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -112.22 160.63 17.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.171 173.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 53.2 tp -144.98 128.82 17.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.173 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -109.75 122.77 48.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.199 170.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 47.7 t -116.48 126.9 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.199 -172.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -114.37 167.46 12.32 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . 25.1 t70 -107.08 104.4 14.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 111.185 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 313' ' ' ARG . 84.7 mt -86.1 59.95 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 175.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 310' ' ' LEU . 67.4 m-20 64.91 -104.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.189 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -93.93 16.02 15.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.234 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 310' ' ' LEU . 89.5 mmt-85 -131.6 166.14 22.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.174 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 58.2 m -118.37 138.79 52.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.203 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.407 ' OG ' ' SD ' ' A' ' 241' ' ' MET . 31.2 t -107.01 112.75 25.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.246 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 64.0 mt -101.76 113.59 26.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.193 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -105.72 102.4 11.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.165 170.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -86.97 135.11 33.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.219 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 79.5 mt -124.03 128.63 74.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.18 -172.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.517 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 30.8 p30 -72.7 173.32 5.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.189 -175.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.517 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 50.4 Cg_exo -60.45 -24.67 78.55 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.668 1.579 . . . . 0.0 111.24 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -81.69 -8.42 59.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 -175.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 88.75 24.6 32.32 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -121.09 143.82 48.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.809 0.338 . . . . 0.0 111.245 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 87.6 m -62.82 135.0 57.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.23 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 95.5 mt -59.91 155.25 16.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.217 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 69.4 p -83.23 165.97 18.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.247 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.595 ' HG3' ' HG3' ' A' ' 240' ' ' PRO . 89.2 mt-30 -61.61 -34.96 76.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.229 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 83.1 p -64.89 -25.65 67.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.189 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -90.01 -41.17 11.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -70.0 -36.52 75.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -57.95 -36.58 72.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.241 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -71.57 -35.74 70.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.191 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.07 -19.5 63.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 54.5 t -53.55 -53.78 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.173 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -66.49 -35.4 80.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.214 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 63.0 t -58.26 -50.18 79.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.168 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -86.17 -24.69 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.209 -176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -53.88 -49.55 68.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.181 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -76.53 -46.28 27.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.198 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.12 -36.46 81.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.208 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -72.54 -41.75 65.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.162 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 87.1 p -78.21 -15.33 58.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.194 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -109.26 153.58 42.6 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.193 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.46 143.53 77.2 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.717 1.611 . . . . 0.0 111.156 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 1.0 -14.496 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.412 ' HA ' ' HG3' ' A' ' 339' ' ' GLN . 69.5 m-20 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.822 0.344 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 97.1 t -130.92 135.17 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -129.99 161.72 30.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 -176.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 31.9 t -101.93 145.98 28.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.201 172.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -154.28 166.96 31.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.203 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.73 139.82 30.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.209 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -81.78 173.04 12.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.25 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -65.31 -23.32 66.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 60.0 p -82.85 -15.43 51.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.197 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.43 -4.52 64.39 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 98.0 mt -81.84 154.15 70.34 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.173 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.14 130.0 38.33 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.655 1.57 . . . . 0.0 111.259 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 63.1 ttp -130.01 139.64 51.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 43.1 tp -104.56 128.45 52.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.23 174.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 31.7 m -123.91 149.95 28.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.222 -173.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.41 145.62 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -74.86 84.33 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.2 -172.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 158.59 156.57 8.07 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 171.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.45 161.14 24.93 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.718 1.612 . . . . 0.0 111.234 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -48.8 -46.16 41.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.192 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -60.35 -30.68 69.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.167 -175.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 81.5 t -83.12 -52.47 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.225 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 255' ' ' LEU . 79.2 t -73.89 -50.17 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.24 -171.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 91.1 t90 -55.81 -37.39 68.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 -173.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -74.88 -30.93 61.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -96.89 -8.07 31.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.212 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.513 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 61.4 tp -67.45 -44.12 44.63 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 -173.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 90.9 Cg_exo -49.34 -40.4 43.85 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.658 1.572 . . . . 0.0 111.192 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.09 -43.25 95.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.252 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.0 -27.46 66.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.205 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.408 HD22 ' SD ' ' A' ' 264' ' ' MET . 93.2 mt -77.1 -39.61 48.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.203 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -63.03 -26.71 68.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.221 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -77.64 -14.86 59.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 35.9 m -113.78 15.8 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.219 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.16 14.45 71.8 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' MET . . . . . 0.481 ' SD ' HG21 ' A' ' 278' ' ' VAL . 57.4 ttm -110.19 100.04 9.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 111.227 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -89.45 127.1 35.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 -171.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 278' ' ' VAL . 96.3 t -74.31 124.84 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.201 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 64.6 p -107.73 -26.63 10.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.2 -177.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -163.41 158.7 21.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.168 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 87.9 p -159.36 155.4 26.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.175 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 81.3 m -140.11 116.69 10.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.228 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -67.14 -38.73 86.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.24 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 96.6 p -73.54 -21.84 60.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.189 -170.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -113.83 -12.1 12.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.212 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 74.39 36.81 48.95 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -91.03 134.96 34.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 111.24 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 59.9 tpp -135.82 96.65 3.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 174.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -95.29 120.77 36.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.193 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.481 HG21 ' SD ' ' A' ' 264' ' ' MET . 35.2 m -132.32 155.56 41.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.241 -169.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 98.4 m -116.09 123.39 47.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.222 168.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -109.06 132.75 53.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.181 -170.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -129.01 126.51 23.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.195 170.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.08 141.0 80.52 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.703 1.602 . . . . 0.0 111.171 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 66.3 mt -98.32 164.0 12.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.224 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 59.5 p -75.56 164.79 25.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.193 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.17 -39.36 78.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 91.5 p -70.15 -29.87 66.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.198 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.52 -42.74 91.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.204 174.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -72.32 -29.77 64.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.188 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -65.6 -40.1 92.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.196 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.08 -45.34 85.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 62.8 tp -61.4 -41.01 96.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 97.68 34.57 5.45 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -140.09 172.35 12.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.319 . . . . 0.0 111.247 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 83.1 p -107.73 -175.29 2.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.179 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -60.81 120.39 52.99 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.87 -19.9 39.92 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.707 1.605 . . . . 0.0 111.218 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 85.34 11.76 74.64 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.3 mt -95.14 138.21 33.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 111.229 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -101.88 156.46 17.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.206 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 43.5 t -57.76 138.71 55.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.179 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 149.64 -178.94 26.82 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -81.95 143.06 31.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.775 0.321 . . . . 0.0 111.203 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -126.13 140.1 52.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.202 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -105.19 114.88 29.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.178 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 43.8 tp -110.73 120.62 43.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.23 -176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -98.12 131.17 44.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.232 171.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.15 117.64 54.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.202 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -105.79 154.86 16.97 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -92.17 114.65 27.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.763 0.316 . . . . 0.0 111.16 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.51 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 84.4 mt -93.7 9.92 35.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.232 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 34.5 t0 87.55 -64.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.208 175.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -99.62 -7.28 25.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.186 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -137.76 173.27 11.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 71.0 m -126.88 139.6 52.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 170.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 90.7 p -94.5 154.35 17.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 74.5 mt -129.32 115.63 17.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.184 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -115.08 104.53 11.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 174.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -92.4 133.13 36.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.193 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 85.9 mt -115.96 124.88 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.231 168.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.54 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 31.2 p30 -76.05 174.37 5.71 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.209 -172.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.54 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 64.0 Cg_exo -59.47 -25.44 78.65 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.688 1.592 . . . . 0.0 111.212 -175.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -84.34 -6.82 59.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.199 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.43 15.06 59.16 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -108.89 146.35 33.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.805 0.336 . . . . 0.0 111.22 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 74.9 p -67.25 149.97 49.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.461 ' HG ' ' HB2' ' A' ' 330' ' ' GLN . 13.9 tp -69.58 135.58 50.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.23 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 52.8 p -84.43 164.27 18.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.213 -168.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -54.98 -45.44 74.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.223 -174.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 97.3 p -63.02 -24.94 68.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' GLN . . . . . 0.461 ' HB2' ' HG ' ' A' ' 326' ' ' LEU . 74.7 mt-30 -88.72 -37.94 15.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.225 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -65.15 -37.45 87.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.179 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -72.84 -32.12 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.224 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -64.96 -33.07 75.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 94.3 mt -78.52 -7.94 58.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.24 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.06 -58.66 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.187 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -72.32 -33.45 67.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.239 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 68.5 t -63.95 -51.0 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.196 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -68.79 -41.29 78.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.18 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' GLN . . . . . 0.412 ' HG3' ' HA ' ' A' ' 229' ' ' ASP . 65.6 tt0 -54.55 -43.15 71.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -63.79 -41.13 97.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.186 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.79 -31.15 72.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.198 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -76.9 -34.64 57.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.151 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 83.5 p -77.04 -17.79 58.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.274 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -95.3 151.66 38.84 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.215 174.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.1 151.14 61.11 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.729 1.619 . . . . 0.0 111.204 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 0.999 -14.542 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.848 0.356 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.441 ' HB ' ' HG3' ' A' ' 339' ' ' GLN . 66.7 t -129.3 130.64 67.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -129.9 160.17 34.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.21 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 34.5 t -101.73 142.24 33.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.215 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -153.04 173.4 15.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.252 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -96.64 141.09 30.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.252 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -79.89 171.4 15.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.229 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.98 -25.62 67.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.166 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 61.7 p -83.55 -15.17 50.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.196 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.77 -5.56 58.31 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 95.3 mt -77.23 157.12 81.24 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.79 0.328 . . . . 0.0 111.19 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.476 ' HG3' ' HG3' ' A' ' 328' ' ' GLN . 51.2 Cg_exo -55.49 133.03 55.71 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.74 1.627 . . . . 0.0 111.211 177.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 62.2 ttp -133.67 144.56 49.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.254 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 74.5 mt -109.98 145.72 36.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.166 171.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 68.5 t -124.34 127.12 72.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 94.2 t -111.93 134.77 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.223 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -65.82 113.06 4.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.187 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 127.73 142.19 5.45 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -73.31 169.21 22.82 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.738 1.625 . . . . 0.0 111.228 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -48.53 -45.29 37.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.187 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -63.37 -27.09 69.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.236 -173.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 72.9 t -88.26 -56.88 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.177 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 255' ' ' LEU . 76.6 t -67.58 -54.66 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.199 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -55.61 -39.71 71.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.207 -169.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -68.0 -35.95 79.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -107.99 8.81 28.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.211 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.546 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 50.7 tp -68.4 -41.7 25.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.223 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 82.4 Cg_exo -51.17 -38.95 61.87 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.689 1.593 . . . . 0.0 111.18 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.08 -44.91 87.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.222 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.19 -36.0 82.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.185 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.95 -38.2 66.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.203 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -57.67 -36.31 71.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.215 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -64.91 -26.24 68.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.176 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 35.7 m -106.71 18.75 5.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.233 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 85.78 14.57 67.32 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' MET . . . . . 0.442 ' SD ' HG21 ' A' ' 278' ' ' VAL . 58.1 ttm -111.9 99.92 8.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.764 0.316 . . . . 0.0 111.229 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.8 127.1 42.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.206 -171.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.421 ' HA ' HG12 ' A' ' 278' ' ' VAL . 98.0 t -72.61 127.98 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.227 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 73.8 p -108.21 -25.88 10.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.197 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -163.08 158.72 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 89.7 p -159.93 160.73 33.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.218 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 62.0 m -140.84 119.98 12.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 62.9 ttp180 -66.97 -43.52 82.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.182 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 96.9 p -73.33 -20.59 60.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.201 -169.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -112.41 -13.46 13.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 72.84 38.24 56.52 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -89.21 139.12 30.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 0.0 111.157 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 55.7 tpp -139.01 89.96 2.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.237 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -89.37 121.47 31.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.224 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.442 HG21 ' SD ' ' A' ' 264' ' ' MET . 34.6 m -129.99 153.63 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.239 -168.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.6 m -112.92 124.65 53.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.225 167.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -112.71 136.48 52.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.212 -171.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -134.69 128.73 19.07 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.22 171.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.17 140.48 81.0 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.643 1.562 . . . . 0.0 111.164 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 67.1 mt -99.67 163.9 12.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.239 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.3 p -73.47 163.13 28.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.186 -176.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.86 -35.3 72.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.241 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 87.9 p -71.42 -31.64 67.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.69 -43.08 94.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.189 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -72.5 -30.12 64.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.228 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -66.26 -40.2 90.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.172 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.19 -38.67 82.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.224 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.34 -36.28 81.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.214 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 94.72 19.16 32.62 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -174.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -115.71 -156.55 0.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.812 0.339 . . . . 0.0 111.194 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 10.7 t -147.84 -168.45 3.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.218 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -68.43 120.15 73.16 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.223 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.46 -15.03 25.04 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.686 1.591 . . . . 0.0 111.22 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 85.76 8.06 80.4 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.52 141.39 29.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.189 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -99.82 158.7 15.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.2 t -58.0 137.14 57.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.197 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 155.63 -179.65 31.42 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -87.03 138.23 31.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.325 . . . . 0.0 111.188 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -122.63 145.2 48.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.194 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -109.98 112.4 24.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.166 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 39.1 tp -105.73 120.06 40.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.235 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -92.25 128.18 38.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.173 170.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 52.7 t -115.09 122.79 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -116.25 157.2 15.17 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.77 120.28 34.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 0.0 111.165 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.524 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 88.2 mt -96.77 14.57 24.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.213 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 32.0 t0 87.61 -65.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -102.71 -10.42 19.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.213 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -139.16 176.7 8.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.218 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 58.7 m -119.83 138.05 53.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.231 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 23.7 t -100.06 128.59 46.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.182 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 68.4 mt -110.54 126.88 54.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.171 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -125.3 105.01 8.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -90.12 127.96 36.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.204 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 45.5 mm -108.89 127.66 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.253 170.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.53 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 26.3 p30 -75.72 174.17 5.94 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.226 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.53 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 71.9 Cg_exo -60.02 -26.07 81.43 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.716 1.611 . . . . 0.0 111.182 -173.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -83.29 -8.12 59.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.167 -174.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.73 15.13 58.63 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -105.94 146.9 29.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.799 0.333 . . . . 0.0 111.197 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 89.8 m -60.9 130.11 44.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.216 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 19.7 tp -63.24 134.71 56.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.166 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 56.7 p -81.29 164.75 22.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -166.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.476 ' HG3' ' HG3' ' A' ' 240' ' ' PRO . 88.2 mt-30 -63.75 -32.04 73.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.206 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 83.8 p -65.67 -18.11 65.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -107.85 -28.28 9.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.199 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -73.89 -42.28 60.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.227 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -62.04 -32.25 72.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.188 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -72.51 -35.02 68.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.238 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 38.5 mt -65.43 -32.39 73.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.195 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 58.0 t -52.6 -45.62 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -62.24 -45.47 93.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.196 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 5.3 m -78.82 -26.08 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -72.97 -43.96 61.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.214 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' GLN . . . . . 0.441 ' HG3' ' HB ' ' A' ' 230' ' ' VAL . 80.3 mt-30 -55.36 -44.75 76.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -65.38 -41.03 94.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.08 -36.69 85.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.192 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -79.55 -38.83 33.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.239 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 90.0 p -73.06 -25.83 61.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.259 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -110.67 149.98 41.09 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.223 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.81 150.54 55.97 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.698 1.598 . . . . 0.0 111.189 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 0.999 -14.533 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 48.3 p30 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.82 0.343 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 91.2 t -125.05 137.45 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -149.97 163.01 39.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.199 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 26.3 t -96.33 139.08 32.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.177 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -162.7 157.74 22.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.39 147.15 23.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.227 176.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -85.14 -166.81 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.221 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.97 -25.41 67.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 -172.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 63.0 p -97.41 1.01 48.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 -176.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 86.98 21.28 50.71 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 59.1 tp -99.62 114.44 65.61 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.35 . . . . 0.0 111.205 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.24 135.74 65.92 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.725 1.617 . . . . 0.0 111.221 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.3 163.93 39.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.193 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.7 tp -76.9 127.66 33.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.181 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.1 t -108.36 121.91 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.218 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.5 t -124.34 125.16 69.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.23 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -76.43 91.7 3.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 -172.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 172.46 161.2 22.53 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 172.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.17 156.15 52.11 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.646 1.564 . . . . 0.0 111.191 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.431 ' HB2' ' HB2' ' A' ' 309' ' ' ASP . 66.0 t80 -48.91 -45.89 42.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 176.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -63.95 -22.27 66.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.249 -175.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 91.8 t -91.22 -50.38 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.163 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 74.3 t -73.01 -46.95 50.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.184 -173.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -60.63 -40.14 90.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.232 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -71.61 -35.38 70.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.169 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -80.16 -25.57 39.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.185 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.624 ' HB3' ' HD3' ' A' ' 256' ' ' PRO . 49.7 tp -53.83 -48.67 92.84 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 -169.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 255' ' ' LEU . 90.0 Cg_exo -47.8 -44.47 26.75 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.671 1.581 . . . . 0.0 111.192 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.42 -40.84 93.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.195 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.42 -35.4 80.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.245 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 81.5 mt -67.39 -37.63 83.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.211 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.56 -26.45 68.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.211 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -92.64 1.59 57.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.201 -173.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 35.5 m -125.34 9.81 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.237 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.97 27.58 33.76 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 172.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 98.3 mtp -117.2 105.96 12.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.757 0.313 . . . . 0.0 111.239 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -87.75 118.11 27.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.218 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 90.9 t -70.28 126.64 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.211 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 67.1 p -106.23 -28.11 10.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.231 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -162.16 160.85 27.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.214 174.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 83.5 p -154.53 152.79 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.207 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 60.6 m -144.53 122.67 12.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -92.69 -19.98 21.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.242 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 88.8 p -75.75 -15.06 60.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.205 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -117.95 -20.64 8.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.245 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.02 48.86 10.48 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -145.96 175.24 10.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.335 . . . . 0.0 111.182 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.439 ' HB3' ' HB2' ' A' ' 305' ' ' LEU . 50.3 ttm -159.83 148.52 17.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.213 -175.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -116.81 121.22 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.192 174.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 45.4 t -138.53 131.29 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.202 -168.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 97.8 m -92.87 120.13 32.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.2 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -97.85 127.34 43.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.195 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -123.03 120.2 27.56 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.2 172.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.06 134.09 61.77 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.692 1.595 . . . . 0.0 111.188 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 68.5 mt -99.27 163.78 12.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.19 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 60.9 p -81.75 167.48 19.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.217 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -59.16 -32.68 70.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 85.2 p -69.81 -22.54 63.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.179 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -82.13 -39.57 23.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.203 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -74.24 -24.61 59.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.216 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -68.5 -40.2 80.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.203 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.72 -38.7 76.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.209 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 48.0 tp -67.95 -36.25 79.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.204 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 84.75 42.71 7.13 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -139.14 160.13 40.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 111.216 -174.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 87.8 p -94.28 162.62 13.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.212 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -41.26 120.96 1.98 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.247 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.22 -24.93 57.98 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.721 1.614 . . . . 0.0 111.172 -176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 81.86 15.63 74.75 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.37 143.36 26.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 0.0 111.205 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -100.35 145.23 28.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.211 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 46.3 t -54.34 139.08 37.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.204 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 143.65 -171.53 25.28 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -84.56 138.52 32.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 111.221 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -119.25 137.41 53.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.225 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.431 ' HB3' ' HB ' ' A' ' 319' ' ' ILE . 88.1 tttt -94.33 126.34 39.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.19 171.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.481 ' HB3' HD11 ' A' ' 316' ' ' LEU . 63.5 mt -108.13 134.75 50.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.243 -176.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -123.05 124.14 42.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.19 173.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.416 HG22 HD13 ' A' ' 316' ' ' LEU . 70.5 t -115.4 125.09 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.189 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -118.11 156.5 15.62 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 176.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . 18.2 t0 -102.63 108.52 19.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.752 0.311 . . . . 0.0 111.216 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 311' ' ' ASP . 83.5 mt -87.97 67.66 9.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.198 177.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 310' ' ' LEU . 65.4 m-20 64.93 -102.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.24 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -89.23 -8.19 54.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -118.34 175.05 5.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.194 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 74.5 m -132.24 159.35 39.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.203 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 87.8 p -133.04 149.53 52.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.215 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.481 HD11 ' HB3' ' A' ' 305' ' ' LEU . 37.1 tp -133.07 118.06 18.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.165 -175.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -100.22 140.21 34.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.233 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' A' ' 326' ' ' LEU . 46.1 m-85 -108.52 131.25 55.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.233 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 304' ' ' LYS . 85.9 mt -116.48 119.32 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.235 168.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.571 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 30.2 p30 -78.14 175.85 4.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.172 -171.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.571 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 67.9 Cg_exo -59.45 -25.65 79.31 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.748 1.632 . . . . 0.0 111.175 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.88 -6.72 59.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 88.67 14.47 61.31 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -98.96 142.72 30.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.73 0.3 . . . . 0.0 111.242 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 81.4 p -78.67 162.61 26.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.178 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 318' ' ' PHE . 25.3 tp -62.55 131.7 49.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.267 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 66.4 p -87.74 164.92 15.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.18 177.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -61.55 -47.75 84.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 73.8 m -55.9 -42.71 76.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.224 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -64.99 -49.22 71.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -63.48 -34.57 78.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.171 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.84 -40.37 97.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -68.48 -34.12 75.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.216 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.74 -13.73 61.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.206 -175.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 74.1 t -55.83 -58.46 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.226 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -66.28 -34.96 79.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.68 -49.86 82.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.227 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -87.25 -24.52 24.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.213 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -55.22 -49.99 70.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.191 171.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -67.07 -36.55 82.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.213 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -70.17 -42.34 72.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.23 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -75.69 -27.78 58.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.156 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 72.8 m -81.24 -22.37 38.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.218 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -58.46 125.86 77.23 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.224 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.25 128.9 26.89 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.686 1.591 . . . . 0.0 111.226 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 0.999 -14.533 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.795 0.331 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 96.9 t -120.84 138.87 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.193 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -130.29 163.04 27.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.226 176.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 40.7 t -92.85 140.37 29.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.182 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -146.69 175.83 10.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.202 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -119.58 144.32 47.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.238 174.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 42.2 p30 -88.63 -172.04 3.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.177 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -69.0 -19.21 64.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.188 -172.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 59.8 p -95.84 -7.37 37.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.183 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 92.89 6.49 63.5 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 240' ' ' PRO . 99.4 mt -87.43 145.45 37.53 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.783 0.325 . . . . 0.0 111.219 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 239' ' ' LEU . 54.6 Cg_exo -58.99 140.27 94.6 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.724 1.616 . . . . 0.0 111.192 -176.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -148.21 172.05 14.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.2 173.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 92.0 mt -108.89 150.49 27.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.195 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.9 149.43 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.221 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.78 138.71 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.203 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -71.9 74.08 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.169 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 174.94 164.44 29.7 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -76.25 159.83 36.49 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.718 1.612 . . . . 0.0 111.181 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -52.0 -44.28 64.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -63.42 -23.35 67.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.192 -171.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.16 -52.51 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.203 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.15 -52.94 55.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.204 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -57.71 -42.49 83.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.155 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -67.08 -34.7 78.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.185 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -100.0 4.55 44.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.211 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.528 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 46.6 tp -68.73 -43.39 28.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.217 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 85.9 Cg_exo -51.84 -36.91 64.85 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.73 1.62 . . . . 0.0 111.226 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.19 -45.54 91.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -66.27 -36.93 84.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 49.0 mt -63.31 -43.82 96.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.158 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.67 -20.19 66.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -93.52 -5.71 48.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.222 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 31.5 m -115.24 2.18 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.199 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 98.44 21.29 17.5 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 67.1 mtt -116.98 104.38 11.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 111.193 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -89.01 120.52 30.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.76 124.91 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.203 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 71.8 p -104.69 -25.37 12.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.216 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -164.99 160.62 19.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.226 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 84.7 p -162.89 157.67 21.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.179 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 68.3 m -143.23 121.06 11.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.217 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -73.26 -45.9 53.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.222 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 87.0 p -66.72 -21.07 66.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.202 -172.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.69 -21.81 12.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.213 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.61 42.59 26.3 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -128.14 160.6 31.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.801 0.334 . . . . 0.0 111.217 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 59.7 ttm -158.27 149.77 21.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.23 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -125.93 128.7 47.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.187 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.59 146.61 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.166 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 97.4 m -102.6 119.29 38.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.221 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -107.52 137.17 46.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.191 -172.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -136.96 129.08 17.01 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.225 169.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.01 140.4 79.93 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.702 1.602 . . . . 0.0 111.215 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 56.5 mt -100.63 165.32 11.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.155 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.1 p -73.01 163.62 27.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.24 -37.37 74.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.156 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 89.5 p -71.25 -30.95 66.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.53 -42.41 92.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.222 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -71.55 -29.88 65.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.198 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -66.09 -39.95 90.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.206 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.92 -41.16 87.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.199 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.46 -41.88 98.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.213 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 97.48 35.6 5.15 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -143.64 160.27 40.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 111.141 -174.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 88.1 p -85.1 171.47 12.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.237 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -64.92 120.04 63.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.218 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -69.14 -21.03 36.95 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.76 1.64 . . . . 0.0 111.197 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.09 30.22 55.63 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 47.4 tp -106.4 133.44 51.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 111.188 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -86.4 164.75 16.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.236 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.0 p -68.72 164.71 21.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.191 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 145.36 172.12 15.52 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -91.75 109.32 20.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.747 0.308 . . . . 0.0 111.186 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -103.82 146.74 28.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -169.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -90.81 129.81 36.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.201 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.418 HD21 HD21 ' A' ' 255' ' ' LEU . 41.5 tp -123.19 119.93 31.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.219 -176.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -112.19 145.54 39.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 43.5 t -135.12 134.81 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.198 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -134.21 172.66 21.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -115.59 112.78 22.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 0.0 111.182 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.558 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 93.3 mt -83.37 0.52 45.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.177 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 34.0 t0 88.41 -64.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.178 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -76.4 -15.23 59.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.213 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -164.74 173.83 11.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.156 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 38.5 t -100.67 151.64 21.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.218 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 97.6 p -131.87 153.77 49.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.192 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.404 ' HB2' HD11 ' A' ' 305' ' ' LEU . 4.3 pp -150.59 156.47 41.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.218 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -149.21 136.5 20.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.179 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -102.13 138.49 39.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.202 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 85.4 mt -124.33 130.43 73.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.188 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -54.72 157.19 5.6 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.268 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.43 -25.67 49.72 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.681 1.587 . . . . 0.0 111.237 175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.84 0.8 57.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.222 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.83 32.01 10.51 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -124.42 121.6 35.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.802 0.334 . . . . 0.0 111.178 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 6.1 t -49.12 150.99 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 9.7 mp -62.53 151.5 37.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.158 165.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 69.6 p -85.14 161.83 19.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -57.25 -38.8 74.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.219 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 85.5 p -65.15 -26.03 68.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.197 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -88.72 -41.48 12.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.233 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -66.83 -41.22 87.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.242 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -57.52 -34.31 68.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.222 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -73.52 -36.79 65.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.202 173.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 67.9 mt -68.32 -20.11 64.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.182 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 55.9 t -54.13 -55.46 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.194 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -68.74 -34.97 76.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.84 -49.0 86.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.188 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -75.41 -37.95 60.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.211 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -53.57 -44.32 69.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.22 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -65.13 -41.27 94.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.197 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.52 -32.24 73.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.243 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -76.43 -29.33 56.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.209 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 72.2 p -76.99 -16.13 59.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.186 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -74.26 158.5 85.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.198 171.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -54.96 140.14 79.42 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.728 1.619 . . . . 0.0 111.166 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 1.0 -14.497 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.2 129.51 53.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.204 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -150.54 155.26 39.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 87.6 p -87.21 158.8 19.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.215 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -166.56 155.75 11.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.165 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -93.24 135.25 34.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.212 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 47.9 p30 -86.57 -165.81 1.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.215 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -65.15 -24.58 67.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.202 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 65.9 p -98.13 -2.3 40.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.201 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 86.46 11.28 72.08 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 32.4 tp -78.31 123.88 85.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 0.0 111.218 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.85 120.5 8.24 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.686 1.59 . . . . 0.0 111.223 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 67.9 mmm -129.79 160.04 34.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.223 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 33.6 tp -107.79 124.03 49.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.212 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.8 t -106.39 125.3 62.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 89.3 t -107.97 133.77 51.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.186 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -68.71 102.08 1.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 145.43 154.13 6.07 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.46 154.92 38.69 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.658 1.572 . . . . 0.0 111.208 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.442 ' O ' ' CD1' ' A' ' 248' ' ' PHE . 1.2 t80 -54.99 -45.45 75.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 178.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.56 -25.81 67.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.244 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.72 -49.03 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 255' ' ' LEU . 62.8 t -66.48 -39.55 84.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.177 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -54.57 -33.16 59.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.205 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -65.57 -34.96 79.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.226 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -108.95 4.88 23.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.193 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.568 ' N ' ' HD2' ' A' ' 256' ' ' PRO . 63.0 tp -64.36 -52.1 56.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.225 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 255' ' ' LEU . 42.7 Cg_endo -67.21 -24.8 43.7 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.697 1.598 . . . . 0.0 111.211 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.13 -49.69 71.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.192 171.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.19 -38.12 89.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 48.0 mt -62.4 -44.89 95.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.15 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.33 -33.05 74.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.199 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -71.79 -23.62 61.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.23 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 25.3 m -103.66 -0.26 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.226 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 107.03 -2.15 35.44 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 169.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 64.2 mtt -89.76 90.75 8.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 0.0 111.224 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -72.77 111.45 7.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 95.7 t -68.02 131.34 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 65.5 p -109.46 -30.98 7.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.246 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -168.65 161.21 11.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.197 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 39.9 t -147.05 125.21 12.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.239 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 92.8 m -93.81 115.05 27.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.255 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 92.0 mtm180 -80.58 -22.42 40.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.228 -173.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 89.9 p -79.35 -15.28 58.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.192 -177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -119.77 -19.92 7.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.246 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 74.88 42.91 29.31 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -129.74 118.07 21.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 0.0 111.203 -171.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 59.7 ttm -111.58 131.89 54.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.239 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -103.13 133.77 47.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.17 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 19.5 m -132.71 147.37 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.195 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.0 m -98.47 115.22 28.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.255 166.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -93.57 115.07 27.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.191 -171.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -110.52 105.37 57.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.189 166.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -54.9 142.13 76.09 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.694 1.596 . . . . 0.0 111.216 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.28 153.47 28.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.195 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.7 p -75.22 167.92 20.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.23 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -55.38 -43.66 75.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.255 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 91.3 p -70.82 -31.24 67.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.193 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.58 -36.83 83.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 176.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -69.63 -29.89 67.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.219 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -71.48 -37.96 71.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.195 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.37 -41.86 79.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 55.8 tp -67.52 -39.93 85.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.208 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 87.99 40.96 6.44 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.408 ' HB1' ' HA ' ' A' ' 337' ' ' VAL . . . -140.56 159.91 41.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 111.214 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 89.1 p -77.19 165.59 24.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.202 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -103.63 108.54 59.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.197 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.79 169.44 21.18 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.723 1.615 . . . . 0.0 111.18 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -90.19 3.33 82.27 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 96.1 mt -53.71 176.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.772 0.32 . . . . 0.0 111.204 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -143.58 176.24 9.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.192 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 85.1 p -74.29 161.81 29.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.194 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 143.5 -177.66 22.16 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -91.24 104.94 17.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.799 0.333 . . . . 0.0 111.247 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -99.23 151.31 21.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.185 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -117.69 137.25 52.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.194 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 316' ' ' LEU . 37.5 tp -121.93 106.93 11.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.23 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -93.36 121.53 34.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.168 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.49 127.31 70.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.192 -172.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -111.44 158.41 14.35 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -101.89 118.71 37.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.34 . . . . 0.0 111.229 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 89.6 mt -110.85 77.45 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.191 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.7 -108.54 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -100.9 28.71 5.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.165 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -134.24 151.82 51.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.25 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 57.8 m -109.62 128.59 55.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.151 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 32.7 t -106.4 111.42 23.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.19 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.419 ' HB3' HD11 ' A' ' 305' ' ' LEU . 69.7 mt -98.18 123.35 42.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.191 -172.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -109.35 100.37 9.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.187 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -86.06 132.31 34.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.217 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 66.7 mt -124.6 124.27 67.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.224 -171.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -59.72 155.81 38.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.185 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -61.0 -18.63 58.8 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.663 1.575 . . . . 0.0 111.182 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -78.56 -11.94 59.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.189 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.73 14.53 43.15 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -119.06 152.77 35.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.804 0.335 . . . . 0.0 111.232 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 62.6 p -77.87 160.14 28.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.194 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 9.9 mp -70.35 142.39 52.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.229 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 69.9 p -81.45 164.58 21.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.199 -173.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -55.17 -36.97 66.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 76.9 p -62.57 -25.99 68.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.195 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -100.32 -29.24 12.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.196 -175.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -73.11 -24.25 60.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -80.33 -15.17 57.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.197 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -89.46 -29.47 18.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.188 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 88.3 mt -74.22 -10.34 59.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.162 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 6.0 m -66.74 -24.66 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.202 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -97.83 -32.01 11.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.234 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.408 ' HA ' ' HB1' ' A' ' 293' ' ' ALA . 53.5 t -60.23 -49.59 83.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.191 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -84.52 -33.62 23.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.187 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 66.9 tt0 -55.36 -45.82 76.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.214 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -64.72 -38.23 90.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.234 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.42 90.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.238 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -74.41 -30.21 61.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.179 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 90.1 p -85.57 -20.85 28.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.157 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -64.05 125.74 88.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.182 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -53.91 129.8 36.03 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.668 1.578 . . . . 0.0 111.191 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 0.999 -14.532 0 N-CA-C 111.236 -0.745 . . . . 0.0 111.236 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.848 0.356 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.403 HG12 HG22 ' A' ' 244' ' ' VAL . 23.8 m -132.32 160.65 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.17 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -156.51 157.25 35.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.215 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 30.1 t -90.69 141.17 29.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.227 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -161.75 155.08 21.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.233 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.76 144.87 25.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.181 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 46.4 p30 -85.08 -164.66 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.218 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -65.01 -25.86 68.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.253 -172.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 53.8 p -95.45 -1.04 51.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.52 18.39 60.37 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 54.2 tp -90.72 115.85 65.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.164 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.67 130.37 38.35 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.711 1.607 . . . . 0.0 111.162 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -144.74 176.26 9.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.206 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 50.8 tp -102.88 127.09 50.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 99.8 t -110.47 125.52 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 314' ' ' SER . 47.8 t -99.22 137.56 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 176.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -80.64 80.0 7.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.201 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 170.04 159.47 15.99 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -53.06 136.17 60.61 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.673 1.582 . . . . 0.0 111.198 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -59.72 -27.82 66.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.249 -172.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -67.05 -40.71 87.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.179 173.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 68.1 t -68.85 -43.79 82.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.211 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 79.5 t -69.07 -40.54 80.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.233 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -55.1 -35.22 64.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.203 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -75.16 -33.16 61.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -97.33 -11.34 24.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.21 -172.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.526 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 57.0 tp -70.72 -43.6 15.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.175 -172.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 88.7 Cg_exo -51.26 -39.94 61.69 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.726 1.618 . . . . 0.0 111.21 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.13 -44.53 96.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.175 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.15 -39.55 93.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.21 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.78 -42.38 97.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.207 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -67.32 -22.97 65.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.184 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -93.28 -6.04 48.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.196 -174.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 29.4 m -111.17 -3.1 10.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.237 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 101.92 8.05 46.0 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 66.4 mtt -96.35 88.34 4.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 111.18 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.5 120.76 11.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.216 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.412 ' HA ' HG12 ' A' ' 278' ' ' VAL . 88.2 t -73.38 122.83 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.22 -175.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 60.3 p -110.45 -28.06 8.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.194 -175.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -161.39 155.82 22.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.209 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 40.8 t -162.09 115.92 1.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.199 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 86.8 m -125.43 112.16 15.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.213 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -75.26 -23.1 57.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.199 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 84.2 p -74.78 -16.29 60.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.216 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -118.3 -14.11 9.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.191 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 72.72 29.94 64.66 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -116.13 111.52 20.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 0.0 111.242 -169.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.4 ' SD ' HD23 ' A' ' 255' ' ' LEU . 95.1 mtp -115.84 152.81 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.2 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -142.88 135.02 27.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.192 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 266' ' ' VAL . 34.2 m -135.14 158.79 41.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.268 -175.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.4 m -110.07 118.62 36.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.186 165.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -95.8 127.44 41.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 -173.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -121.35 122.96 27.86 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.218 167.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -54.84 136.86 73.7 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.714 1.609 . . . . 0.0 111.192 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 77.1 mt -91.19 157.53 17.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.226 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.8 p -75.21 165.24 25.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.185 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -54.77 -43.88 73.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.19 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 91.8 p -69.03 -31.06 69.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.215 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.63 -40.45 95.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.22 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -70.59 -30.2 66.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.158 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -69.36 -39.64 77.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.198 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.62 -39.81 80.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.208 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.6 -45.0 84.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.183 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 97.84 34.7 5.37 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -142.64 155.8 44.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.231 -175.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 94.0 p -80.57 159.63 25.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.197 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -71.34 119.87 76.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.224 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.38 -15.02 25.24 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.687 1.591 . . . . 0.0 111.247 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.79 29.35 55.0 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 98.1 mt -93.91 143.29 26.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 0.0 111.208 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -90.09 163.81 14.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.206 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 82.9 p -69.64 160.67 31.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.225 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 145.57 178.63 21.24 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 174.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.57 132.74 34.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 0.0 111.173 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -122.37 149.55 43.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.202 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.86 154.91 23.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.174 174.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.556 HD13 ' C ' ' A' ' 305' ' ' LEU . 3.2 tm? -139.61 111.24 7.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.211 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 317' ' ' GLN . 62.5 tp60 -92.44 120.71 33.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.175 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 92.8 t -87.57 126.78 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.169 175.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -87.31 161.77 32.95 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 175.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -97.59 87.45 4.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 111.172 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 313' ' ' ARG . 97.7 mt -113.65 142.83 45.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 175.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -70.34 -49.98 43.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.206 -172.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -111.08 4.65 19.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.213 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 310' ' ' LEU . 89.4 mmt-85 -138.5 171.71 13.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.17 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' SER . . . . . 0.417 ' HB3' ' HB ' ' A' ' 244' ' ' VAL . 46.3 t -128.24 114.82 17.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 171.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 11.3 t -81.32 113.63 19.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.183 175.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 73.0 mt -105.65 98.62 8.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.187 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 306' ' ' GLN . 62.7 tt0 -88.93 99.01 12.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.2 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -84.01 132.38 34.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 86.4 mt -125.05 129.54 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.189 -173.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.521 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 31.4 p30 -75.6 173.46 7.05 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.164 -173.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.521 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 52.9 Cg_exo -59.94 -26.25 81.82 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.641 1.561 . . . . 0.0 111.264 -175.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -81.56 -8.5 59.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.191 -175.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.24 24.1 27.64 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -119.79 139.31 52.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.761 0.315 . . . . 0.0 111.222 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 74.3 m -65.08 137.39 57.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.223 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 88.4 mt -61.86 147.44 46.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.185 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 60.1 p -82.19 168.48 17.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.177 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -52.88 -41.95 64.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.173 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 89.4 p -64.96 -26.18 68.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.182 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -91.55 -23.13 20.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.215 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -85.07 -29.95 24.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.214 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -65.5 -36.87 85.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.176 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -64.79 -34.77 79.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.167 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.24 -13.96 60.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.235 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.16 -58.39 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.21 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.43 -35.01 79.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.204 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.84 -51.65 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.237 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -78.12 -30.68 49.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.216 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -52.76 -45.4 67.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.166 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -70.01 -39.19 75.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.178 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.19 -35.04 79.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.218 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -77.4 -24.78 50.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 65.5 p -76.99 -18.2 58.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.165 175.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -74.76 151.73 86.86 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.03 135.56 69.25 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.643 1.562 . . . . 0.0 111.217 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 1.0 -14.486 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.772 0.32 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 10.0 p -147.05 146.8 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.207 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -146.51 169.07 19.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.209 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 29.0 t -100.95 142.07 32.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.196 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -155.64 161.05 40.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -86.02 144.95 27.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.179 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 43.5 p30 -92.87 -171.59 2.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.162 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -69.86 -18.33 63.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.176 -173.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 70.8 p -95.62 -7.1 38.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.186 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.93 7.48 64.3 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 99.4 mt -93.63 148.83 36.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.787 0.327 . . . . 0.0 111.164 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.06 141.6 48.56 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.733 1.622 . . . . 0.0 111.182 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -143.82 163.38 33.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.234 175.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 316' ' ' LEU . 36.6 tp -103.82 114.22 28.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.163 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.86 123.28 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.182 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 96.6 t -100.11 135.64 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.235 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -76.12 74.49 2.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.212 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 168.83 157.64 11.77 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 173.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.63 157.68 36.0 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.699 1.6 . . . . 0.0 111.209 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.408 ' HA ' HG22 ' A' ' 251' ' ' VAL . 50.5 p90 -65.23 -20.26 66.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.205 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -69.87 -28.49 65.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.217 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 75.2 t -85.1 -39.21 13.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.173 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' A' ' 248' ' ' PHE . 14.7 m -67.26 -17.77 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -67.13 -13.71 62.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.182 173.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -105.35 -27.95 11.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.195 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.29 -42.58 36.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.546 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 82.3 mt -72.18 -41.47 8.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.182 -165.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 87.8 Cg_exo -48.26 -42.73 33.24 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.654 1.569 . . . . 0.0 111.199 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -88.59 -42.24 12.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -41.44 97.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.185 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.43 -48.79 78.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.19 -36.87 76.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.181 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -87.56 3.06 49.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.216 -172.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 34.2 m -119.03 14.26 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.202 172.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 104.64 -1.76 42.32 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 168.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 73.1 mtm -108.96 85.28 2.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.766 0.317 . . . . 0.0 111.179 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -68.27 122.07 17.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.218 -175.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 278' ' ' VAL . 91.3 t -70.53 124.51 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.22 -176.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 72.4 p -109.58 -25.78 10.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -162.47 162.35 27.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 32.1 t -162.61 136.44 6.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.165 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 89.4 m -123.25 117.98 26.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.217 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -74.31 -35.56 63.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 94.5 p -65.51 -21.31 66.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.205 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -107.97 -21.62 12.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.193 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 72.14 38.28 59.38 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -129.35 128.52 43.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.207 -169.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 90.7 mtp -117.51 147.98 42.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.201 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -120.98 130.14 53.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 266' ' ' VAL . 33.8 m -131.12 153.43 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 -174.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 85.9 m -106.35 122.93 47.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.223 167.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -101.68 129.62 47.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.223 -171.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.4 124.94 27.05 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.186 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.76 130.25 39.43 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.698 1.599 . . . . 0.0 111.197 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 78.5 mt -96.92 155.26 16.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.214 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 56.1 p -73.53 163.83 27.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.198 -176.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.08 -36.69 70.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 89.1 p -71.45 -30.89 66.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.241 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.56 -41.9 92.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.199 175.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -73.36 -29.19 62.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.213 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -66.78 -40.04 88.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.195 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.82 -38.16 85.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.194 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 59.7 tp -65.31 -39.59 92.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.179 173.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 91.24 35.28 7.11 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -142.58 163.53 32.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 111.147 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 94.2 p -86.55 167.35 14.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.178 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -65.03 120.97 71.43 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.222 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.88 -18.96 47.0 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.679 1.586 . . . . 0.0 111.184 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 80.92 34.61 26.78 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 80.5 mt -105.64 137.21 43.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.827 0.346 . . . . 0.0 111.187 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -93.76 160.47 14.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.237 173.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.9 p -60.67 156.63 16.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.208 -173.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 136.13 -176.3 20.35 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -86.93 136.55 32.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 111.173 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -123.01 153.98 39.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -119.17 148.67 42.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.226 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 44.3 tp -134.6 113.53 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.203 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -98.55 130.33 45.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.204 174.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.96 127.58 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.169 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -107.69 154.21 16.63 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -91.3 105.48 17.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 -175.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.705 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 90.6 mt -95.41 3.01 54.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.234 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ASP . . . . . 0.705 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 52.5 t0 101.42 -117.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.203 -174.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -71.37 -9.1 57.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.229 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -119.77 173.76 6.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 175.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 75.4 m -126.92 147.47 50.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 29.8 t -104.64 118.91 37.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 242' ' ' LEU . 47.0 mt -96.1 113.15 24.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 176.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -105.51 110.41 22.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -95.26 133.42 39.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.217 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 87.1 mt -122.84 128.98 75.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.196 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.55 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 33.5 p30 -80.21 174.94 5.34 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -175.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.55 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 53.4 Cg_exo -59.97 -24.46 76.46 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.678 1.585 . . . . 0.0 111.198 -175.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.29 -5.29 59.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.184 -174.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.67 18.78 56.01 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -117.49 150.46 38.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 0.0 111.214 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 73.9 p -76.73 160.75 29.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.181 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 85.9 mt -76.93 150.13 35.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.192 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 40.5 p -75.19 166.96 22.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -54.85 -40.41 69.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.227 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 99.4 p -68.89 -33.66 74.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.174 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -75.63 -35.52 60.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.209 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -76.18 -31.18 58.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.198 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.71 -38.42 83.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.235 174.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -65.42 -34.75 79.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.202 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.03 -20.35 65.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.215 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 76.7 t -56.87 -54.03 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.165 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.12 -35.83 82.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.191 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.7 -49.95 82.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.169 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -81.6 -28.55 33.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.221 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -57.78 -43.02 85.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.236 173.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -69.21 -43.49 73.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.184 175.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.92 -28.09 69.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.181 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -84.21 -37.62 21.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.242 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 84.8 p -70.61 -21.4 62.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.223 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -94.5 159.28 34.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.194 175.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.98 141.97 85.7 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.685 1.59 . . . . 0.0 111.241 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 1.0 -14.53 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.749 0.309 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 82.9 t -124.99 130.79 73.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.168 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -121.28 156.17 33.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.192 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.6 t -91.72 140.68 29.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.99 179.77 8.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.24 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -128.89 148.0 50.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.163 172.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 42.5 p30 -85.06 -170.02 2.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.209 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.01 -24.17 67.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.213 -171.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 61.6 p -97.34 -1.51 44.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.182 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.91 18.18 60.11 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.7 mt -91.46 157.28 42.48 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 0.0 111.192 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.555 ' HG3' ' HG3' ' A' ' 328' ' ' GLN . 76.6 Cg_exo -55.07 134.86 66.12 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.667 1.578 . . . . 0.0 111.261 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 67.9 ttp -148.81 149.04 30.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.222 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 83.2 mt -113.8 144.61 42.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.199 169.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 95.3 t -113.19 119.73 61.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.225 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.4 t -105.33 137.38 35.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.227 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.9 ttt180 -64.77 107.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.443 ' HA2' ' HD3' ' A' ' 247' ' ' PRO . . . 130.76 143.56 5.33 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . 0.443 ' HD3' ' HA2' ' A' ' 246' ' ' GLY . 45.0 Cg_exo -58.55 167.73 4.77 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.732 1.621 . . . . 0.0 111.191 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -48.99 -46.99 44.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -62.99 -26.19 68.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.159 -173.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 81.3 t -85.29 -52.56 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.224 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 255' ' ' LEU . 74.0 t -73.58 -53.81 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.181 -173.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -56.27 -39.87 73.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 -172.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -73.86 -29.75 62.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -107.55 6.01 27.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.177 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.543 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 60.8 tp -65.48 -42.38 56.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.23 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 85.9 Cg_exo -51.75 -35.4 58.25 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.693 1.595 . . . . 0.0 111.188 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.94 79.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.11 -34.91 77.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.213 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.433 HD22 ' SD ' ' A' ' 264' ' ' MET . 81.0 mt -63.48 -41.76 98.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.186 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.56 -25.39 67.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.192 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -80.69 -20.07 43.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.21 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 31.6 m -105.16 9.82 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.204 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.64 20.22 58.63 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . 0.514 ' SD ' HG21 ' A' ' 278' ' ' VAL . 59.7 ttm -119.09 103.24 9.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.775 0.321 . . . . 0.0 111.213 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -93.65 129.08 40.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.166 -170.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.468 ' HA ' HG12 ' A' ' 278' ' ' VAL . 95.0 t -73.2 127.7 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.213 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 65.3 p -108.84 -27.88 9.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.219 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -162.71 166.31 24.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.237 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 82.8 p -161.41 153.78 20.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.208 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 85.1 m -133.92 112.0 10.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.185 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -72.86 -22.11 60.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 84.9 p -77.99 -12.41 59.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.178 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -116.87 -20.04 9.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.224 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.31 25.94 67.18 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -172.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -110.04 149.99 29.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.776 0.322 . . . . 0.0 111.187 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.42 ' HB3' ' HB2' ' A' ' 305' ' ' LEU . 56.7 ttm -140.07 136.76 33.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.196 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -110.59 125.6 53.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.197 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.514 HG21 ' SD ' ' A' ' 264' ' ' MET . 34.8 m -134.46 155.4 38.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.19 -169.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.0 m -117.92 125.06 49.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 172.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -113.15 137.61 51.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.209 -171.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -136.69 129.89 17.6 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.181 170.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.98 139.08 79.48 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.687 1.591 . . . . 0.0 111.269 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 64.3 mt -99.79 166.49 11.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.173 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 56.7 p -74.96 164.89 26.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.259 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -58.25 -39.3 78.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.21 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 93.9 p -70.29 -30.53 67.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.208 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.92 -43.58 92.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.215 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -71.63 -28.71 63.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.201 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -66.73 -40.53 88.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.194 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.98 -39.15 87.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.212 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.92 -39.0 90.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.188 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 90.3 39.93 5.89 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 -175.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -141.92 166.36 24.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.775 0.321 . . . . 0.0 111.208 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 82.8 p -99.43 -178.45 3.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.163 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -64.74 120.66 68.01 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.183 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.04 -22.94 47.05 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.728 1.619 . . . . 0.0 111.21 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.86 19.09 60.15 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 10.8 mp -101.29 140.28 35.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.228 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -99.33 159.56 14.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.184 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.3 t -60.16 139.99 57.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.181 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 153.15 -179.33 29.64 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -86.08 136.36 33.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.748 0.308 . . . . 0.0 111.244 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -121.15 149.05 43.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.426 ' HB3' ' HB ' ' A' ' 319' ' ' ILE . 87.7 tttt -110.72 122.13 47.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.212 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 276' ' ' MET . 62.8 mt -103.15 135.85 44.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.241 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -119.65 125.14 48.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.208 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 315' ' ' SER . 57.6 t -122.32 120.31 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -109.34 155.05 16.27 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -88.92 118.76 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 111.194 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.532 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 87.9 mt -95.45 11.41 32.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.225 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 37.1 t0 87.63 -64.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.157 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -101.81 -10.1 20.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.181 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 89.8 mmt-85 -137.69 176.57 8.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.217 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 50.3 m -119.99 136.59 54.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 307' ' ' VAL . 27.8 t -96.71 109.74 22.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 174.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 48.9 tp -111.72 124.0 51.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.182 -176.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -127.02 148.46 50.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.221 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -112.27 125.92 54.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -173.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 304' ' ' LYS . 92.5 mt -108.23 124.41 64.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.225 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.526 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 35.1 p30 -75.13 173.83 6.32 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.241 -174.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.526 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 51.8 Cg_exo -59.93 -25.18 78.79 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.73 1.62 . . . . 0.0 111.177 -176.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -80.18 -9.75 59.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.167 -173.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.58 17.17 42.97 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -120.42 162.01 20.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.797 0.332 . . . . 0.0 111.189 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 78.4 p -79.32 153.94 29.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.195 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 68.2 mt -76.47 158.43 31.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.197 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 41.0 p -76.76 167.05 22.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.199 -173.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.555 ' HG3' ' HG3' ' A' ' 240' ' ' PRO . 88.8 mt-30 -61.8 -35.04 77.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.21 174.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 98.9 p -71.51 -35.78 70.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.21 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -68.82 -41.95 77.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -67.61 -37.49 82.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.214 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -60.69 -37.41 81.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.195 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -66.7 -38.89 87.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.248 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 84.5 mt -68.19 -22.64 64.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.227 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.78 -56.75 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.169 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -67.98 -35.36 78.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.201 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.52 -46.53 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.179 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -79.66 -28.91 40.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.257 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -54.26 -42.07 69.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.221 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -76.17 -34.33 59.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.211 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.05 -40.82 95.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -74.02 -27.61 61.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.215 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 90.5 p -82.78 -27.83 30.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.215 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 49.5 tptt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.237 -179.771 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 . . . . . 0 CA--C 1.523 -0.071 0 CA-C-O 120.845 0.355 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 83.2 t -127.0 125.21 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.186 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -112.51 156.89 21.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.228 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 35.0 t -95.62 136.24 36.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.191 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.28 167.71 29.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.215 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -99.48 145.73 27.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 41.8 p30 -85.85 -169.9 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.35 -25.5 67.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.175 -172.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 68.6 p -97.58 -1.22 44.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.219 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.0 18.53 60.95 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 98.4 mt -94.0 158.09 36.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.753 0.311 . . . . 0.0 111.216 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.595 ' HG3' ' HG3' ' A' ' 328' ' ' GLN . 54.0 Cg_exo -55.06 139.3 80.02 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.696 1.598 . . . . 0.0 111.212 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.407 ' SD ' ' OG ' ' A' ' 315' ' ' SER . 64.5 ttp -156.08 149.88 25.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.172 -175.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 88.6 mt -111.89 143.91 42.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.203 172.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 94.2 t -118.08 120.94 66.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 176.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.01 140.03 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.181 -175.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -74.88 92.51 2.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.179 -174.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 153.59 156.07 7.46 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 173.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.4 157.87 38.79 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.728 1.618 . . . . 0.0 111.207 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.431 ' HB2' ' HB2' ' A' ' 309' ' ' ASP . 62.0 t80 -48.18 -47.05 35.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 176.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -63.34 -24.07 67.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.202 -174.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 90.2 t -88.44 -51.1 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.207 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 255' ' ' LEU . 72.6 t -74.42 -52.0 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.24 -174.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 87.9 t90 -55.12 -39.92 69.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.239 -174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -75.19 -31.69 61.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.193 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -99.02 -0.71 41.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.201 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.53 ' HB3' ' HD3' ' A' ' 256' ' ' PRO . 55.9 tp -69.64 -43.61 22.28 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 -176.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 255' ' ' LEU . 74.2 Cg_exo -53.2 -35.81 75.02 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.714 1.609 . . . . 0.0 111.147 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.56 -47.47 78.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.216 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.12 73.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.204 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 56.0 mt -67.64 -49.85 60.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.181 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.78 -31.75 69.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.171 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -60.76 -31.46 70.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.21 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.3 24.95 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.191 -171.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.65 23.34 50.65 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 170.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . 0.422 ' HB3' HG21 ' A' ' 278' ' ' VAL . 67.1 mtt -118.87 104.96 11.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.772 0.32 . . . . 0.0 111.227 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -96.7 112.23 24.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 95.7 t -69.62 127.84 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.234 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 79.6 p -103.84 -26.08 12.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.191 -174.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -165.12 162.26 20.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.157 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 86.0 p -159.48 154.34 24.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.191 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 91.6 m -132.08 109.91 10.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.184 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -72.54 -23.32 60.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.219 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 86.3 p -77.69 -12.7 60.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.199 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -119.56 -18.81 8.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.223 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.45 28.92 60.72 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -109.5 150.22 28.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.345 . . . . 0.0 111.196 -173.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 58.9 ttm -142.33 137.31 30.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.219 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -117.54 126.32 52.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.19 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' A' ' 264' ' ' MET . 10.5 p -138.77 135.65 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.179 -167.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 98.0 m -95.85 125.01 40.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.246 176.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -114.16 137.78 51.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.163 -172.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -132.62 127.58 20.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.203 169.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.03 137.6 76.71 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.765 1.643 . . . . 0.0 111.212 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 70.4 mt -99.23 163.85 12.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.21 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 58.7 p -71.55 163.26 28.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.174 -176.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.57 -38.69 75.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.194 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 90.9 p -69.64 -30.35 68.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.193 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.63 -43.96 92.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.254 175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -74.28 -26.45 60.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.184 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -67.56 -40.6 84.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.199 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -70.3 -35.1 73.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.21 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.87 -29.14 66.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 77.37 35.28 37.86 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -137.01 154.65 50.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.769 0.318 . . . . 0.0 111.182 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 36.1 t -70.45 142.16 52.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.209 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -64.72 117.21 36.09 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.214 175.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 156.83 62.34 Favored 'Trans proline' 0 C--N 1.327 -0.559 0 C-N-CA 121.696 1.597 . . . . 0.0 111.191 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -89.56 34.33 4.06 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 11.1 mp -100.32 139.92 35.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.762 0.315 . . . . 0.0 111.191 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -103.74 162.73 12.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.209 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.7 t -59.53 134.6 57.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 158.4 -178.97 34.41 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -86.82 133.42 33.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.804 0.335 . . . . 0.0 111.205 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -121.28 153.03 38.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.197 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -112.22 160.63 17.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.171 173.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 53.2 tp -144.98 128.82 17.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.173 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -109.75 122.77 48.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.199 170.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 47.7 t -116.48 126.9 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.199 -172.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -114.37 167.46 12.32 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . 25.1 t70 -107.08 104.4 14.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 111.185 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 313' ' ' ARG . 84.7 mt -86.1 59.95 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 175.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 310' ' ' LEU . 67.4 m-20 64.91 -104.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.189 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -93.93 16.02 15.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.234 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 310' ' ' LEU . 89.5 mmt-85 -131.6 166.14 22.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.174 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 58.2 m -118.37 138.79 52.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.203 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.407 ' OG ' ' SD ' ' A' ' 241' ' ' MET . 31.2 t -107.01 112.75 25.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.246 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 64.0 mt -101.76 113.59 26.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.193 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -105.72 102.4 11.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.165 170.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -86.97 135.11 33.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.219 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 79.5 mt -124.03 128.63 74.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.18 -172.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.517 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 30.8 p30 -72.7 173.32 5.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.189 -175.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.517 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 50.4 Cg_exo -60.45 -24.67 78.55 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.668 1.579 . . . . 0.0 111.24 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -81.69 -8.42 59.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 -175.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 88.75 24.6 32.32 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -121.09 143.82 48.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.809 0.338 . . . . 0.0 111.245 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 87.6 m -62.82 135.0 57.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.23 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 95.5 mt -59.91 155.25 16.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.217 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 69.4 p -83.23 165.97 18.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.247 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.595 ' HG3' ' HG3' ' A' ' 240' ' ' PRO . 89.2 mt-30 -61.61 -34.96 76.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.229 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 83.1 p -64.89 -25.65 67.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.189 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -90.01 -41.17 11.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -70.0 -36.52 75.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -57.95 -36.58 72.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.241 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -71.57 -35.74 70.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.191 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.07 -19.5 63.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 54.5 t -53.55 -53.78 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.173 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -66.49 -35.4 80.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.214 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 63.0 t -58.26 -50.18 79.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.168 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -86.17 -24.69 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.209 -176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -53.88 -49.55 68.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.181 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -76.53 -46.28 27.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.198 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.12 -36.46 81.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.208 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -72.54 -41.75 65.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.162 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 87.1 p -78.21 -15.33 58.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.194 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.193 -178.974 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.412 ' HA ' ' HG3' ' A' ' 339' ' ' GLN . 69.5 m-20 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.822 0.344 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 97.1 t -130.92 135.17 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -129.99 161.72 30.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 -176.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 31.9 t -101.93 145.98 28.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.201 172.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -154.28 166.96 31.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.203 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.73 139.82 30.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.209 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -81.78 173.04 12.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.25 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -65.31 -23.32 66.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 60.0 p -82.85 -15.43 51.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.197 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.43 -4.52 64.39 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 98.0 mt -81.84 154.15 70.34 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.173 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.14 130.0 38.33 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.655 1.57 . . . . 0.0 111.259 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 63.1 ttp -130.01 139.64 51.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 43.1 tp -104.56 128.45 52.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.23 174.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 31.7 m -123.91 149.95 28.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.222 -173.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.41 145.62 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -74.86 84.33 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.2 -172.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 158.59 156.57 8.07 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 171.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.45 161.14 24.93 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.718 1.612 . . . . 0.0 111.234 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -48.8 -46.16 41.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.192 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -60.35 -30.68 69.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.167 -175.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 81.5 t -83.12 -52.47 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.225 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 255' ' ' LEU . 79.2 t -73.89 -50.17 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.24 -171.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 91.1 t90 -55.81 -37.39 68.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 -173.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -74.88 -30.93 61.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -96.89 -8.07 31.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.212 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.513 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 61.4 tp -67.45 -44.12 44.63 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 -173.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 90.9 Cg_exo -49.34 -40.4 43.85 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.658 1.572 . . . . 0.0 111.192 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.09 -43.25 95.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.252 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.0 -27.46 66.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.205 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.408 HD22 ' SD ' ' A' ' 264' ' ' MET . 93.2 mt -77.1 -39.61 48.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.203 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -63.03 -26.71 68.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.221 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -77.64 -14.86 59.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 35.9 m -113.78 15.8 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.219 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.16 14.45 71.8 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . 0.481 ' SD ' HG21 ' A' ' 278' ' ' VAL . 57.4 ttm -110.19 100.04 9.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 111.227 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -89.45 127.1 35.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 -171.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 278' ' ' VAL . 96.3 t -74.31 124.84 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.201 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 64.6 p -107.73 -26.63 10.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.2 -177.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -163.41 158.7 21.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.168 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 87.9 p -159.36 155.4 26.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.175 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 81.3 m -140.11 116.69 10.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.228 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -67.14 -38.73 86.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.24 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 96.6 p -73.54 -21.84 60.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.189 -170.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -113.83 -12.1 12.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.212 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 74.39 36.81 48.95 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -91.03 134.96 34.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 111.24 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 59.9 tpp -135.82 96.65 3.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 174.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -95.29 120.77 36.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.193 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.481 HG21 ' SD ' ' A' ' 264' ' ' MET . 35.2 m -132.32 155.56 41.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.241 -169.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 98.4 m -116.09 123.39 47.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.222 168.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -109.06 132.75 53.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.181 -170.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -129.01 126.51 23.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.195 170.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.08 141.0 80.52 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.703 1.602 . . . . 0.0 111.171 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 66.3 mt -98.32 164.0 12.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.224 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 59.5 p -75.56 164.79 25.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.193 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.17 -39.36 78.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 91.5 p -70.15 -29.87 66.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.198 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.52 -42.74 91.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.204 174.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -72.32 -29.77 64.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.188 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -65.6 -40.1 92.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.196 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.08 -45.34 85.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 62.8 tp -61.4 -41.01 96.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 97.68 34.57 5.45 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -140.09 172.35 12.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.319 . . . . 0.0 111.247 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 83.1 p -107.73 -175.29 2.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.179 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -60.81 120.39 52.99 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.87 -19.9 39.92 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.707 1.605 . . . . 0.0 111.218 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 85.34 11.76 74.64 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.3 mt -95.14 138.21 33.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 111.229 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -101.88 156.46 17.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.206 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 43.5 t -57.76 138.71 55.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.179 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 149.64 -178.94 26.82 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -81.95 143.06 31.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.775 0.321 . . . . 0.0 111.203 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -126.13 140.1 52.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.202 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -105.19 114.88 29.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.178 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 43.8 tp -110.73 120.62 43.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.23 -176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -98.12 131.17 44.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.232 171.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.15 117.64 54.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.202 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -105.79 154.86 16.97 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -92.17 114.65 27.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.763 0.316 . . . . 0.0 111.16 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.51 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 84.4 mt -93.7 9.92 35.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.232 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 34.5 t0 87.55 -64.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.208 175.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -99.62 -7.28 25.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.186 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -137.76 173.27 11.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 71.0 m -126.88 139.6 52.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 170.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 90.7 p -94.5 154.35 17.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 74.5 mt -129.32 115.63 17.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.184 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -115.08 104.53 11.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 174.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -92.4 133.13 36.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.193 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 85.9 mt -115.96 124.88 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.231 168.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.54 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 31.2 p30 -76.05 174.37 5.71 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.209 -172.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.54 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 64.0 Cg_exo -59.47 -25.44 78.65 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.688 1.592 . . . . 0.0 111.212 -175.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -84.34 -6.82 59.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.199 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.43 15.06 59.16 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -108.89 146.35 33.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.805 0.336 . . . . 0.0 111.22 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 74.9 p -67.25 149.97 49.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.461 ' HG ' ' HB2' ' A' ' 330' ' ' GLN . 13.9 tp -69.58 135.58 50.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.23 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 52.8 p -84.43 164.27 18.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.213 -168.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -54.98 -45.44 74.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.223 -174.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 97.3 p -63.02 -24.94 68.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . 0.461 ' HB2' ' HG ' ' A' ' 326' ' ' LEU . 74.7 mt-30 -88.72 -37.94 15.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.225 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -65.15 -37.45 87.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.179 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -72.84 -32.12 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.224 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -64.96 -33.07 75.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 94.3 mt -78.52 -7.94 58.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.24 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.06 -58.66 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.187 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -72.32 -33.45 67.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.239 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 68.5 t -63.95 -51.0 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.196 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -68.79 -41.29 78.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.18 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . 0.412 ' HG3' ' HA ' ' A' ' 229' ' ' ASP . 65.6 tt0 -54.55 -43.15 71.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -63.79 -41.13 97.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.186 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.79 -31.15 72.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.198 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -76.9 -34.64 57.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.151 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 83.5 p -77.04 -17.79 58.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.274 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.215 174.221 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.848 0.356 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.441 ' HB ' ' HG3' ' A' ' 339' ' ' GLN . 66.7 t -129.3 130.64 67.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -129.9 160.17 34.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.21 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 34.5 t -101.73 142.24 33.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.215 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -153.04 173.4 15.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.252 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -96.64 141.09 30.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.252 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -79.89 171.4 15.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.229 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.98 -25.62 67.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.166 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 61.7 p -83.55 -15.17 50.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.196 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.77 -5.56 58.31 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 95.3 mt -77.23 157.12 81.24 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.79 0.328 . . . . 0.0 111.19 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.476 ' HG3' ' HG3' ' A' ' 328' ' ' GLN . 51.2 Cg_exo -55.49 133.03 55.71 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.74 1.627 . . . . 0.0 111.211 177.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 62.2 ttp -133.67 144.56 49.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.254 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 74.5 mt -109.98 145.72 36.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.166 171.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 68.5 t -124.34 127.12 72.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 94.2 t -111.93 134.77 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.223 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -65.82 113.06 4.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.187 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 127.73 142.19 5.45 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -73.31 169.21 22.82 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.738 1.625 . . . . 0.0 111.228 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -48.53 -45.29 37.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.187 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -63.37 -27.09 69.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.236 -173.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 72.9 t -88.26 -56.88 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.177 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 255' ' ' LEU . 76.6 t -67.58 -54.66 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.199 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -55.61 -39.71 71.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.207 -169.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -68.0 -35.95 79.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -107.99 8.81 28.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.211 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.546 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 50.7 tp -68.4 -41.7 25.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.223 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 82.4 Cg_exo -51.17 -38.95 61.87 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.689 1.593 . . . . 0.0 111.18 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.08 -44.91 87.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.222 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.19 -36.0 82.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.185 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.95 -38.2 66.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.203 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -57.67 -36.31 71.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.215 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -64.91 -26.24 68.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.176 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 35.7 m -106.71 18.75 5.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.233 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 85.78 14.57 67.32 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . 0.442 ' SD ' HG21 ' A' ' 278' ' ' VAL . 58.1 ttm -111.9 99.92 8.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.764 0.316 . . . . 0.0 111.229 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.8 127.1 42.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.206 -171.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.421 ' HA ' HG12 ' A' ' 278' ' ' VAL . 98.0 t -72.61 127.98 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.227 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 73.8 p -108.21 -25.88 10.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.197 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -163.08 158.72 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 89.7 p -159.93 160.73 33.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.218 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 62.0 m -140.84 119.98 12.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 62.9 ttp180 -66.97 -43.52 82.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.182 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 96.9 p -73.33 -20.59 60.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.201 -169.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -112.41 -13.46 13.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 72.84 38.24 56.52 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -89.21 139.12 30.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 0.0 111.157 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 55.7 tpp -139.01 89.96 2.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.237 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -89.37 121.47 31.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.224 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.442 HG21 ' SD ' ' A' ' 264' ' ' MET . 34.6 m -129.99 153.63 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.239 -168.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.6 m -112.92 124.65 53.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.225 167.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -112.71 136.48 52.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.212 -171.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -134.69 128.73 19.07 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.22 171.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.17 140.48 81.0 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.643 1.562 . . . . 0.0 111.164 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 67.1 mt -99.67 163.9 12.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.239 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.3 p -73.47 163.13 28.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.186 -176.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.86 -35.3 72.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.241 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 87.9 p -71.42 -31.64 67.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.69 -43.08 94.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.189 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -72.5 -30.12 64.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.228 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -66.26 -40.2 90.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.172 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.19 -38.67 82.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.224 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.34 -36.28 81.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.214 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 94.72 19.16 32.62 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -174.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -115.71 -156.55 0.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.812 0.339 . . . . 0.0 111.194 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 10.7 t -147.84 -168.45 3.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.218 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -68.43 120.15 73.16 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.223 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.46 -15.03 25.04 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.686 1.591 . . . . 0.0 111.22 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 85.76 8.06 80.4 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.52 141.39 29.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.189 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -99.82 158.7 15.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.2 t -58.0 137.14 57.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.197 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 155.63 -179.65 31.42 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -87.03 138.23 31.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.325 . . . . 0.0 111.188 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -122.63 145.2 48.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.194 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -109.98 112.4 24.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.166 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 39.1 tp -105.73 120.06 40.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.235 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -92.25 128.18 38.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.173 170.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 52.7 t -115.09 122.79 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -116.25 157.2 15.17 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.77 120.28 34.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 0.0 111.165 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.524 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 88.2 mt -96.77 14.57 24.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.213 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 32.0 t0 87.61 -65.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -102.71 -10.42 19.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.213 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -139.16 176.7 8.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.218 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 58.7 m -119.83 138.05 53.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.231 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 23.7 t -100.06 128.59 46.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.182 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 68.4 mt -110.54 126.88 54.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.171 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -125.3 105.01 8.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -90.12 127.96 36.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.204 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 45.5 mm -108.89 127.66 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.253 170.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.53 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 26.3 p30 -75.72 174.17 5.94 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.226 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.53 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 71.9 Cg_exo -60.02 -26.07 81.43 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.716 1.611 . . . . 0.0 111.182 -173.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -83.29 -8.12 59.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.167 -174.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.73 15.13 58.63 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -105.94 146.9 29.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.799 0.333 . . . . 0.0 111.197 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 89.8 m -60.9 130.11 44.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.216 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 19.7 tp -63.24 134.71 56.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.166 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 56.7 p -81.29 164.75 22.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -166.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.476 ' HG3' ' HG3' ' A' ' 240' ' ' PRO . 88.2 mt-30 -63.75 -32.04 73.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.206 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 83.8 p -65.67 -18.11 65.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -107.85 -28.28 9.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.199 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -73.89 -42.28 60.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.227 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -62.04 -32.25 72.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.188 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -72.51 -35.02 68.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.238 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 38.5 mt -65.43 -32.39 73.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.195 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 58.0 t -52.6 -45.62 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -62.24 -45.47 93.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.196 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 5.3 m -78.82 -26.08 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -72.97 -43.96 61.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.214 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . 0.441 ' HG3' ' HB ' ' A' ' 230' ' ' VAL . 80.3 mt-30 -55.36 -44.75 76.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -65.38 -41.03 94.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.08 -36.69 85.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.192 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -79.55 -38.83 33.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.239 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 90.0 p -73.06 -25.83 61.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.259 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.223 -177.809 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 48.3 p30 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.82 0.343 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 91.2 t -125.05 137.45 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -149.97 163.01 39.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.199 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 26.3 t -96.33 139.08 32.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.177 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -162.7 157.74 22.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.39 147.15 23.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.227 176.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -85.14 -166.81 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.221 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.97 -25.41 67.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 -172.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 63.0 p -97.41 1.01 48.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 -176.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 86.98 21.28 50.71 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 59.1 tp -99.62 114.44 65.61 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.35 . . . . 0.0 111.205 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.24 135.74 65.92 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.725 1.617 . . . . 0.0 111.221 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.3 163.93 39.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.193 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.7 tp -76.9 127.66 33.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.181 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.1 t -108.36 121.91 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.218 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.5 t -124.34 125.16 69.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.23 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -76.43 91.7 3.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 -172.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 172.46 161.2 22.53 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 172.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.17 156.15 52.11 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.646 1.564 . . . . 0.0 111.191 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.431 ' HB2' ' HB2' ' A' ' 309' ' ' ASP . 66.0 t80 -48.91 -45.89 42.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 176.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -63.95 -22.27 66.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.249 -175.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 91.8 t -91.22 -50.38 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.163 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 74.3 t -73.01 -46.95 50.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.184 -173.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -60.63 -40.14 90.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.232 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -71.61 -35.38 70.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.169 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -80.16 -25.57 39.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.185 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.624 ' HB3' ' HD3' ' A' ' 256' ' ' PRO . 49.7 tp -53.83 -48.67 92.84 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 -169.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 255' ' ' LEU . 90.0 Cg_exo -47.8 -44.47 26.75 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.671 1.581 . . . . 0.0 111.192 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.42 -40.84 93.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.195 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.42 -35.4 80.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.245 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 81.5 mt -67.39 -37.63 83.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.211 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.56 -26.45 68.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.211 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -92.64 1.59 57.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.201 -173.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 35.5 m -125.34 9.81 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.237 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.97 27.58 33.76 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 172.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 98.3 mtp -117.2 105.96 12.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.757 0.313 . . . . 0.0 111.239 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -87.75 118.11 27.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.218 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 90.9 t -70.28 126.64 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.211 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 67.1 p -106.23 -28.11 10.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.231 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -162.16 160.85 27.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.214 174.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 83.5 p -154.53 152.79 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.207 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 60.6 m -144.53 122.67 12.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -92.69 -19.98 21.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.242 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 88.8 p -75.75 -15.06 60.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.205 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -117.95 -20.64 8.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.245 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.02 48.86 10.48 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -145.96 175.24 10.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.335 . . . . 0.0 111.182 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.439 ' HB3' ' HB2' ' A' ' 305' ' ' LEU . 50.3 ttm -159.83 148.52 17.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.213 -175.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -116.81 121.22 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.192 174.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 45.4 t -138.53 131.29 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.202 -168.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 97.8 m -92.87 120.13 32.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.2 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -97.85 127.34 43.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.195 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -123.03 120.2 27.56 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.2 172.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.06 134.09 61.77 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.692 1.595 . . . . 0.0 111.188 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 68.5 mt -99.27 163.78 12.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.19 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 60.9 p -81.75 167.48 19.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.217 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -59.16 -32.68 70.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 85.2 p -69.81 -22.54 63.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.179 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -82.13 -39.57 23.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.203 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -74.24 -24.61 59.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.216 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -68.5 -40.2 80.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.203 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.72 -38.7 76.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.209 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 48.0 tp -67.95 -36.25 79.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.204 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 84.75 42.71 7.13 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -139.14 160.13 40.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 111.216 -174.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 87.8 p -94.28 162.62 13.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.212 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -41.26 120.96 1.98 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.247 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.22 -24.93 57.98 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.721 1.614 . . . . 0.0 111.172 -176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 81.86 15.63 74.75 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.37 143.36 26.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 0.0 111.205 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -100.35 145.23 28.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.211 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 46.3 t -54.34 139.08 37.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.204 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 143.65 -171.53 25.28 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -84.56 138.52 32.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 111.221 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -119.25 137.41 53.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.225 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.431 ' HB3' ' HB ' ' A' ' 319' ' ' ILE . 88.1 tttt -94.33 126.34 39.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.19 171.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.481 ' HB3' HD11 ' A' ' 316' ' ' LEU . 63.5 mt -108.13 134.75 50.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.243 -176.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -123.05 124.14 42.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.19 173.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.416 HG22 HD13 ' A' ' 316' ' ' LEU . 70.5 t -115.4 125.09 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.189 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -118.11 156.5 15.62 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 176.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . 18.2 t0 -102.63 108.52 19.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.752 0.311 . . . . 0.0 111.216 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 311' ' ' ASP . 83.5 mt -87.97 67.66 9.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.198 177.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 310' ' ' LEU . 65.4 m-20 64.93 -102.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.24 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -89.23 -8.19 54.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -118.34 175.05 5.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.194 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 74.5 m -132.24 159.35 39.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.203 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 87.8 p -133.04 149.53 52.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.215 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.481 HD11 ' HB3' ' A' ' 305' ' ' LEU . 37.1 tp -133.07 118.06 18.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.165 -175.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -100.22 140.21 34.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.233 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' A' ' 326' ' ' LEU . 46.1 m-85 -108.52 131.25 55.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.233 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 304' ' ' LYS . 85.9 mt -116.48 119.32 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.235 168.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.571 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 30.2 p30 -78.14 175.85 4.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.172 -171.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.571 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 67.9 Cg_exo -59.45 -25.65 79.31 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.748 1.632 . . . . 0.0 111.175 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.88 -6.72 59.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 88.67 14.47 61.31 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -98.96 142.72 30.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.73 0.3 . . . . 0.0 111.242 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 81.4 p -78.67 162.61 26.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.178 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 318' ' ' PHE . 25.3 tp -62.55 131.7 49.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.267 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 66.4 p -87.74 164.92 15.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.18 177.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -61.55 -47.75 84.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 73.8 m -55.9 -42.71 76.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.224 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -64.99 -49.22 71.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -63.48 -34.57 78.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.171 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.84 -40.37 97.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -68.48 -34.12 75.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.216 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.74 -13.73 61.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.206 -175.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 74.1 t -55.83 -58.46 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.226 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -66.28 -34.96 79.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.68 -49.86 82.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.227 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -87.25 -24.52 24.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.213 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -55.22 -49.99 70.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.191 171.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -67.07 -36.55 82.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.213 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -70.17 -42.34 72.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.23 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -75.69 -27.78 58.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.156 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 72.8 m -81.24 -22.37 38.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.218 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 47.1 tptt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.224 178.468 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.795 0.331 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 96.9 t -120.84 138.87 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.193 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -130.29 163.04 27.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.226 176.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 40.7 t -92.85 140.37 29.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.182 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -146.69 175.83 10.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.202 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -119.58 144.32 47.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.238 174.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 42.2 p30 -88.63 -172.04 3.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.177 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -69.0 -19.21 64.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.188 -172.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 59.8 p -95.84 -7.37 37.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.183 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 92.89 6.49 63.5 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 240' ' ' PRO . 99.4 mt -87.43 145.45 37.53 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.783 0.325 . . . . 0.0 111.219 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 239' ' ' LEU . 54.6 Cg_exo -58.99 140.27 94.6 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.724 1.616 . . . . 0.0 111.192 -176.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -148.21 172.05 14.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.2 173.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 92.0 mt -108.89 150.49 27.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.195 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.9 149.43 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.221 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.78 138.71 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.203 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -71.9 74.08 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.169 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 174.94 164.44 29.7 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -76.25 159.83 36.49 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.718 1.612 . . . . 0.0 111.181 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -52.0 -44.28 64.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -63.42 -23.35 67.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.192 -171.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.16 -52.51 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.203 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.15 -52.94 55.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.204 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -57.71 -42.49 83.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.155 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -67.08 -34.7 78.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.185 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -100.0 4.55 44.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.211 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.528 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 46.6 tp -68.73 -43.39 28.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.217 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 85.9 Cg_exo -51.84 -36.91 64.85 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.73 1.62 . . . . 0.0 111.226 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.19 -45.54 91.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -66.27 -36.93 84.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 49.0 mt -63.31 -43.82 96.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.158 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.67 -20.19 66.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -93.52 -5.71 48.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.222 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 31.5 m -115.24 2.18 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.199 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 98.44 21.29 17.5 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 67.1 mtt -116.98 104.38 11.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 111.193 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -89.01 120.52 30.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.76 124.91 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.203 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 71.8 p -104.69 -25.37 12.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.216 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -164.99 160.62 19.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.226 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 84.7 p -162.89 157.67 21.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.179 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 68.3 m -143.23 121.06 11.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.217 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -73.26 -45.9 53.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.222 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 87.0 p -66.72 -21.07 66.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.202 -172.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.69 -21.81 12.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.213 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.61 42.59 26.3 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -128.14 160.6 31.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.801 0.334 . . . . 0.0 111.217 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 59.7 ttm -158.27 149.77 21.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.23 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -125.93 128.7 47.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.187 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.59 146.61 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.166 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 97.4 m -102.6 119.29 38.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.221 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -107.52 137.17 46.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.191 -172.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -136.96 129.08 17.01 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.225 169.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.01 140.4 79.93 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.702 1.602 . . . . 0.0 111.215 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 56.5 mt -100.63 165.32 11.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.155 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.1 p -73.01 163.62 27.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.24 -37.37 74.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.156 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 89.5 p -71.25 -30.95 66.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.53 -42.41 92.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.222 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -71.55 -29.88 65.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.198 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -66.09 -39.95 90.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.206 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.92 -41.16 87.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.199 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.46 -41.88 98.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.213 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 97.48 35.6 5.15 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -143.64 160.27 40.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 111.141 -174.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 88.1 p -85.1 171.47 12.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.237 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -64.92 120.04 63.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.218 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -69.14 -21.03 36.95 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.76 1.64 . . . . 0.0 111.197 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.09 30.22 55.63 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 47.4 tp -106.4 133.44 51.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 111.188 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -86.4 164.75 16.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.236 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.0 p -68.72 164.71 21.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.191 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 145.36 172.12 15.52 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -91.75 109.32 20.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.747 0.308 . . . . 0.0 111.186 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -103.82 146.74 28.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -169.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -90.81 129.81 36.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.201 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.418 HD21 HD21 ' A' ' 255' ' ' LEU . 41.5 tp -123.19 119.93 31.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.219 -176.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -112.19 145.54 39.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 43.5 t -135.12 134.81 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.198 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -134.21 172.66 21.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -115.59 112.78 22.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 0.0 111.182 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.558 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 93.3 mt -83.37 0.52 45.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.177 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 34.0 t0 88.41 -64.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.178 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -76.4 -15.23 59.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.213 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -164.74 173.83 11.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.156 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 38.5 t -100.67 151.64 21.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.218 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 97.6 p -131.87 153.77 49.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.192 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.404 ' HB2' HD11 ' A' ' 305' ' ' LEU . 4.3 pp -150.59 156.47 41.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.218 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -149.21 136.5 20.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.179 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -102.13 138.49 39.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.202 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 85.4 mt -124.33 130.43 73.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.188 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -54.72 157.19 5.6 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.268 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.43 -25.67 49.72 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.681 1.587 . . . . 0.0 111.237 175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.84 0.8 57.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.222 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.83 32.01 10.51 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -124.42 121.6 35.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.802 0.334 . . . . 0.0 111.178 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 6.1 t -49.12 150.99 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 9.7 mp -62.53 151.5 37.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.158 165.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 69.6 p -85.14 161.83 19.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -57.25 -38.8 74.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.219 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 85.5 p -65.15 -26.03 68.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.197 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -88.72 -41.48 12.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.233 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -66.83 -41.22 87.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.242 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -57.52 -34.31 68.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.222 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -73.52 -36.79 65.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.202 173.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 67.9 mt -68.32 -20.11 64.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.182 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 55.9 t -54.13 -55.46 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.194 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -68.74 -34.97 76.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.84 -49.0 86.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.188 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -75.41 -37.95 60.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.211 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -53.57 -44.32 69.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.22 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -65.13 -41.27 94.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.197 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.52 -32.24 73.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.243 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -76.43 -29.33 56.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.209 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 72.2 p -76.99 -16.13 59.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.186 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.198 171.687 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.2 129.51 53.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.204 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -150.54 155.26 39.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 87.6 p -87.21 158.8 19.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.215 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -166.56 155.75 11.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.165 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -93.24 135.25 34.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.212 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 47.9 p30 -86.57 -165.81 1.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.215 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -65.15 -24.58 67.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.202 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 65.9 p -98.13 -2.3 40.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.201 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 86.46 11.28 72.08 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 32.4 tp -78.31 123.88 85.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 0.0 111.218 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.85 120.5 8.24 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.686 1.59 . . . . 0.0 111.223 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 67.9 mmm -129.79 160.04 34.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.223 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 33.6 tp -107.79 124.03 49.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.212 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.8 t -106.39 125.3 62.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 89.3 t -107.97 133.77 51.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.186 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -68.71 102.08 1.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 145.43 154.13 6.07 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.46 154.92 38.69 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.658 1.572 . . . . 0.0 111.208 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.442 ' CD1' ' O ' ' A' ' 248' ' ' PHE . 1.2 t80 -54.99 -45.45 75.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 178.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.56 -25.81 67.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.244 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.72 -49.03 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 255' ' ' LEU . 62.8 t -66.48 -39.55 84.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.177 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -54.57 -33.16 59.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.205 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -65.57 -34.96 79.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.226 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -108.95 4.88 23.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.193 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.568 ' N ' ' HD2' ' A' ' 256' ' ' PRO . 63.0 tp -64.36 -52.1 56.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.225 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 255' ' ' LEU . 42.7 Cg_endo -67.21 -24.8 43.7 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.697 1.598 . . . . 0.0 111.211 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.13 -49.69 71.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.192 171.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.19 -38.12 89.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 48.0 mt -62.4 -44.89 95.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.15 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.33 -33.05 74.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.199 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -71.79 -23.62 61.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.23 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 25.3 m -103.66 -0.26 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.226 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 107.03 -2.15 35.44 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 169.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 64.2 mtt -89.76 90.75 8.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 0.0 111.224 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -72.77 111.45 7.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 95.7 t -68.02 131.34 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 65.5 p -109.46 -30.98 7.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.246 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -168.65 161.21 11.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.197 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 39.9 t -147.05 125.21 12.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.239 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 92.8 m -93.81 115.05 27.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.255 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 92.0 mtm180 -80.58 -22.42 40.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.228 -173.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 89.9 p -79.35 -15.28 58.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.192 -177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -119.77 -19.92 7.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.246 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 74.88 42.91 29.31 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -129.74 118.07 21.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 0.0 111.203 -171.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 59.7 ttm -111.58 131.89 54.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.239 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -103.13 133.77 47.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.17 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 19.5 m -132.71 147.37 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.195 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.0 m -98.47 115.22 28.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.255 166.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -93.57 115.07 27.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.191 -171.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -110.52 105.37 57.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.189 166.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -54.9 142.13 76.09 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.694 1.596 . . . . 0.0 111.216 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.28 153.47 28.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.195 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.7 p -75.22 167.92 20.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.23 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -55.38 -43.66 75.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.255 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 91.3 p -70.82 -31.24 67.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.193 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.58 -36.83 83.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 176.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -69.63 -29.89 67.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.219 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -71.48 -37.96 71.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.195 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.37 -41.86 79.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 55.8 tp -67.52 -39.93 85.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.208 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 87.99 40.96 6.44 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.408 ' HB1' ' HA ' ' A' ' 337' ' ' VAL . . . -140.56 159.91 41.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 111.214 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 89.1 p -77.19 165.59 24.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.202 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -103.63 108.54 59.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.197 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.79 169.44 21.18 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.723 1.615 . . . . 0.0 111.18 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -90.19 3.33 82.27 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 96.1 mt -53.71 176.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.772 0.32 . . . . 0.0 111.204 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -143.58 176.24 9.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.192 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 85.1 p -74.29 161.81 29.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.194 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 143.5 -177.66 22.16 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -91.24 104.94 17.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.799 0.333 . . . . 0.0 111.247 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -99.23 151.31 21.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.185 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -117.69 137.25 52.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.194 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 316' ' ' LEU . 37.5 tp -121.93 106.93 11.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.23 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -93.36 121.53 34.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.168 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.49 127.31 70.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.192 -172.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -111.44 158.41 14.35 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -101.89 118.71 37.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.34 . . . . 0.0 111.229 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 89.6 mt -110.85 77.45 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.191 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.7 -108.54 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -100.9 28.71 5.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.165 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -134.24 151.82 51.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.25 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 57.8 m -109.62 128.59 55.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.151 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 32.7 t -106.4 111.42 23.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.19 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.419 ' HB3' HD11 ' A' ' 305' ' ' LEU . 69.7 mt -98.18 123.35 42.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.191 -172.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -109.35 100.37 9.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.187 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -86.06 132.31 34.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.217 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 66.7 mt -124.6 124.27 67.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.224 -171.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -59.72 155.81 38.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.185 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -61.0 -18.63 58.8 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.663 1.575 . . . . 0.0 111.182 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -78.56 -11.94 59.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.189 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.73 14.53 43.15 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -119.06 152.77 35.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.804 0.335 . . . . 0.0 111.232 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 62.6 p -77.87 160.14 28.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.194 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 9.9 mp -70.35 142.39 52.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.229 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 69.9 p -81.45 164.58 21.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.199 -173.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -55.17 -36.97 66.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 76.9 p -62.57 -25.99 68.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.195 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -100.32 -29.24 12.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.196 -175.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -73.11 -24.25 60.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -80.33 -15.17 57.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.197 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -89.46 -29.47 18.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.188 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 88.3 mt -74.22 -10.34 59.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.162 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 6.0 m -66.74 -24.66 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.202 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -97.83 -32.01 11.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.234 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.408 ' HA ' ' HB1' ' A' ' 293' ' ' ALA . 53.5 t -60.23 -49.59 83.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.191 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -84.52 -33.62 23.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.187 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 66.9 tt0 -55.36 -45.82 76.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.214 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -64.72 -38.23 90.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.234 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.42 90.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.238 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -74.41 -30.21 61.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.179 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 90.1 p -85.57 -20.85 28.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.157 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 48.1 tptt . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.182 178.779 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.848 0.356 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.403 HG12 HG22 ' A' ' 244' ' ' VAL . 23.8 m -132.32 160.65 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.17 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -156.51 157.25 35.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.215 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 30.1 t -90.69 141.17 29.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.227 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -161.75 155.08 21.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.233 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.76 144.87 25.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.181 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 46.4 p30 -85.08 -164.66 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.218 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -65.01 -25.86 68.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.253 -172.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 53.8 p -95.45 -1.04 51.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.52 18.39 60.37 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 54.2 tp -90.72 115.85 65.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.164 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.67 130.37 38.35 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.711 1.607 . . . . 0.0 111.162 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -144.74 176.26 9.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.206 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 50.8 tp -102.88 127.09 50.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 99.8 t -110.47 125.52 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 314' ' ' SER . 47.8 t -99.22 137.56 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 176.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -80.64 80.0 7.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.201 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 170.04 159.47 15.99 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -53.06 136.17 60.61 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.673 1.582 . . . . 0.0 111.198 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -59.72 -27.82 66.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.249 -172.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -67.05 -40.71 87.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.179 173.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 68.1 t -68.85 -43.79 82.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.211 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 79.5 t -69.07 -40.54 80.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.233 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -55.1 -35.22 64.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.203 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -75.16 -33.16 61.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -97.33 -11.34 24.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.21 -172.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.526 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 57.0 tp -70.72 -43.6 15.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.175 -172.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 88.7 Cg_exo -51.26 -39.94 61.69 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.726 1.618 . . . . 0.0 111.21 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.13 -44.53 96.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.175 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.15 -39.55 93.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.21 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.78 -42.38 97.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.207 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -67.32 -22.97 65.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.184 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -93.28 -6.04 48.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.196 -174.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 29.4 m -111.17 -3.1 10.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.237 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 101.92 8.05 46.0 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 66.4 mtt -96.35 88.34 4.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 111.18 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.5 120.76 11.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.216 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.412 ' HA ' HG12 ' A' ' 278' ' ' VAL . 88.2 t -73.38 122.83 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.22 -175.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 60.3 p -110.45 -28.06 8.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.194 -175.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -161.39 155.82 22.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.209 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 40.8 t -162.09 115.92 1.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.199 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 86.8 m -125.43 112.16 15.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.213 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -75.26 -23.1 57.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.199 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 84.2 p -74.78 -16.29 60.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.216 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -118.3 -14.11 9.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.191 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 72.72 29.94 64.66 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -116.13 111.52 20.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 0.0 111.242 -169.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.4 ' SD ' HD23 ' A' ' 255' ' ' LEU . 95.1 mtp -115.84 152.81 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.2 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -142.88 135.02 27.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.192 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 266' ' ' VAL . 34.2 m -135.14 158.79 41.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.268 -175.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.4 m -110.07 118.62 36.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.186 165.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -95.8 127.44 41.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 -173.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -121.35 122.96 27.86 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.218 167.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -54.84 136.86 73.7 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.714 1.609 . . . . 0.0 111.192 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 77.1 mt -91.19 157.53 17.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.226 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.8 p -75.21 165.24 25.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.185 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -54.77 -43.88 73.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.19 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 91.8 p -69.03 -31.06 69.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.215 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.63 -40.45 95.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.22 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -70.59 -30.2 66.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.158 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -69.36 -39.64 77.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.198 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.62 -39.81 80.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.208 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.6 -45.0 84.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.183 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 97.84 34.7 5.37 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -142.64 155.8 44.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.231 -175.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 94.0 p -80.57 159.63 25.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.197 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -71.34 119.87 76.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.224 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.38 -15.02 25.24 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.687 1.591 . . . . 0.0 111.247 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.79 29.35 55.0 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 98.1 mt -93.91 143.29 26.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 0.0 111.208 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -90.09 163.81 14.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.206 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 82.9 p -69.64 160.67 31.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.225 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 145.57 178.63 21.24 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 174.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.57 132.74 34.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 0.0 111.173 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -122.37 149.55 43.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.202 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.86 154.91 23.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.174 174.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.556 HD13 ' C ' ' A' ' 305' ' ' LEU . 3.2 tm? -139.61 111.24 7.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.211 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 317' ' ' GLN . 62.5 tp60 -92.44 120.71 33.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.175 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 92.8 t -87.57 126.78 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.169 175.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -87.31 161.77 32.95 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 175.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -97.59 87.45 4.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 111.172 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 313' ' ' ARG . 97.7 mt -113.65 142.83 45.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 175.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -70.34 -49.98 43.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.206 -172.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -111.08 4.65 19.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.213 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 310' ' ' LEU . 89.4 mmt-85 -138.5 171.71 13.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.17 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . 0.417 ' HB3' ' HB ' ' A' ' 244' ' ' VAL . 46.3 t -128.24 114.82 17.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 171.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 11.3 t -81.32 113.63 19.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.183 175.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 73.0 mt -105.65 98.62 8.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.187 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 306' ' ' GLN . 62.7 tt0 -88.93 99.01 12.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.2 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -84.01 132.38 34.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 86.4 mt -125.05 129.54 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.189 -173.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.521 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 31.4 p30 -75.6 173.46 7.05 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.164 -173.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.521 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 52.9 Cg_exo -59.94 -26.25 81.82 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.641 1.561 . . . . 0.0 111.264 -175.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -81.56 -8.5 59.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.191 -175.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.24 24.1 27.64 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -119.79 139.31 52.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.761 0.315 . . . . 0.0 111.222 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 74.3 m -65.08 137.39 57.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.223 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 88.4 mt -61.86 147.44 46.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.185 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 60.1 p -82.19 168.48 17.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.177 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -52.88 -41.95 64.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.173 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 89.4 p -64.96 -26.18 68.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.182 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -91.55 -23.13 20.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.215 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -85.07 -29.95 24.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.214 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -65.5 -36.87 85.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.176 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -64.79 -34.77 79.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.167 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.24 -13.96 60.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.235 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.16 -58.39 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.21 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.43 -35.01 79.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.204 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.84 -51.65 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.237 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -78.12 -30.68 49.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.216 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -52.76 -45.4 67.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.166 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -70.01 -39.19 75.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.178 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.19 -35.04 79.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.218 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -77.4 -24.78 50.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 65.5 p -76.99 -18.2 58.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.165 175.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 173.094 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.772 0.32 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 10.0 p -147.05 146.8 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.207 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -146.51 169.07 19.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.209 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 29.0 t -100.95 142.07 32.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.196 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -155.64 161.05 40.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -86.02 144.95 27.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.179 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 43.5 p30 -92.87 -171.59 2.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.162 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -69.86 -18.33 63.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.176 -173.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 70.8 p -95.62 -7.1 38.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.186 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.93 7.48 64.3 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 99.4 mt -93.63 148.83 36.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.787 0.327 . . . . 0.0 111.164 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.06 141.6 48.56 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.733 1.622 . . . . 0.0 111.182 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -143.82 163.38 33.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.234 175.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 316' ' ' LEU . 36.6 tp -103.82 114.22 28.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.163 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.86 123.28 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.182 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 96.6 t -100.11 135.64 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.235 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -76.12 74.49 2.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.212 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 168.83 157.64 11.77 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 173.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.63 157.68 36.0 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.699 1.6 . . . . 0.0 111.209 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.408 ' HA ' HG22 ' A' ' 251' ' ' VAL . 50.5 p90 -65.23 -20.26 66.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.205 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -69.87 -28.49 65.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.217 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 75.2 t -85.1 -39.21 13.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.173 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' A' ' 248' ' ' PHE . 14.7 m -67.26 -17.77 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -67.13 -13.71 62.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.182 173.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -105.35 -27.95 11.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.195 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.29 -42.58 36.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.546 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 82.3 mt -72.18 -41.47 8.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.182 -165.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 87.8 Cg_exo -48.26 -42.73 33.24 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.654 1.569 . . . . 0.0 111.199 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -88.59 -42.24 12.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -41.44 97.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.185 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.43 -48.79 78.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.19 -36.87 76.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.181 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -87.56 3.06 49.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.216 -172.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 34.2 m -119.03 14.26 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.202 172.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 104.64 -1.76 42.32 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 168.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 73.1 mtm -108.96 85.28 2.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.766 0.317 . . . . 0.0 111.179 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -68.27 122.07 17.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.218 -175.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 278' ' ' VAL . 91.3 t -70.53 124.51 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.22 -176.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 72.4 p -109.58 -25.78 10.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -162.47 162.35 27.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 32.1 t -162.61 136.44 6.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.165 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 89.4 m -123.25 117.98 26.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.217 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -74.31 -35.56 63.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 94.5 p -65.51 -21.31 66.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.205 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -107.97 -21.62 12.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.193 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 72.14 38.28 59.38 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -129.35 128.52 43.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.207 -169.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 90.7 mtp -117.51 147.98 42.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.201 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -120.98 130.14 53.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 266' ' ' VAL . 33.8 m -131.12 153.43 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 -174.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 85.9 m -106.35 122.93 47.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.223 167.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -101.68 129.62 47.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.223 -171.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.4 124.94 27.05 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.186 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.76 130.25 39.43 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.698 1.599 . . . . 0.0 111.197 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 78.5 mt -96.92 155.26 16.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.214 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 56.1 p -73.53 163.83 27.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.198 -176.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.08 -36.69 70.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 89.1 p -71.45 -30.89 66.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.241 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.56 -41.9 92.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.199 175.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -73.36 -29.19 62.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.213 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -66.78 -40.04 88.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.195 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.82 -38.16 85.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.194 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 59.7 tp -65.31 -39.59 92.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.179 173.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 91.24 35.28 7.11 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -142.58 163.53 32.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 111.147 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 94.2 p -86.55 167.35 14.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.178 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -65.03 120.97 71.43 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.222 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.88 -18.96 47.0 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.679 1.586 . . . . 0.0 111.184 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 80.92 34.61 26.78 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 80.5 mt -105.64 137.21 43.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.827 0.346 . . . . 0.0 111.187 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -93.76 160.47 14.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.237 173.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.9 p -60.67 156.63 16.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.208 -173.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 136.13 -176.3 20.35 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -86.93 136.55 32.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 111.173 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -123.01 153.98 39.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -119.17 148.67 42.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.226 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 44.3 tp -134.6 113.53 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.203 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -98.55 130.33 45.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.204 174.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.96 127.58 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.169 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -107.69 154.21 16.63 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -91.3 105.48 17.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 -175.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.705 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 90.6 mt -95.41 3.01 54.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.234 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . 0.705 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 52.5 t0 101.42 -117.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.203 -174.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -71.37 -9.1 57.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.229 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -119.77 173.76 6.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 175.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 75.4 m -126.92 147.47 50.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 29.8 t -104.64 118.91 37.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 242' ' ' LEU . 47.0 mt -96.1 113.15 24.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 176.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -105.51 110.41 22.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -95.26 133.42 39.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.217 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 87.1 mt -122.84 128.98 75.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.196 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.55 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 33.5 p30 -80.21 174.94 5.34 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -175.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' PRO . . . . . 0.55 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 53.4 Cg_exo -59.97 -24.46 76.46 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.678 1.585 . . . . 0.0 111.198 -175.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.29 -5.29 59.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.184 -174.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.67 18.78 56.01 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -117.49 150.46 38.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 0.0 111.214 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 73.9 p -76.73 160.75 29.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.181 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 85.9 mt -76.93 150.13 35.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.192 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 40.5 p -75.19 166.96 22.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -54.85 -40.41 69.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.227 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 99.4 p -68.89 -33.66 74.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.174 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -75.63 -35.52 60.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.209 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -76.18 -31.18 58.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.198 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.71 -38.42 83.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.235 174.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -65.42 -34.75 79.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.202 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.03 -20.35 65.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.215 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 76.7 t -56.87 -54.03 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.165 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.12 -35.83 82.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.191 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.7 -49.95 82.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.169 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -81.6 -28.55 33.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.221 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -57.78 -43.02 85.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.236 173.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -69.21 -43.49 73.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.184 175.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.92 -28.09 69.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.181 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -84.21 -37.62 21.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.242 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 84.8 p -70.61 -21.4 62.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.223 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.194 175.783 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.749 0.309 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 82.9 t -124.99 130.79 73.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.168 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -121.28 156.17 33.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.192 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.6 t -91.72 140.68 29.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.99 179.77 8.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.24 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -128.89 148.0 50.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.163 172.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 42.5 p30 -85.06 -170.02 2.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.209 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.01 -24.17 67.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.213 -171.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 61.6 p -97.34 -1.51 44.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.182 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.91 18.18 60.11 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.7 mt -91.46 157.28 42.48 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 0.0 111.192 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.555 ' HG3' ' HG3' ' A' ' 328' ' ' GLN . 76.6 Cg_exo -55.07 134.86 66.12 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.667 1.578 . . . . 0.0 111.261 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 67.9 ttp -148.81 149.04 30.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.222 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 83.2 mt -113.8 144.61 42.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.199 169.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 95.3 t -113.19 119.73 61.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.225 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.4 t -105.33 137.38 35.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.227 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.9 ttt180 -64.77 107.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.443 ' HA2' ' HD3' ' A' ' 247' ' ' PRO . . . 130.76 143.56 5.33 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.443 ' HD3' ' HA2' ' A' ' 246' ' ' GLY . 45.0 Cg_exo -58.55 167.73 4.77 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.732 1.621 . . . . 0.0 111.191 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -48.99 -46.99 44.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -62.99 -26.19 68.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.159 -173.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 81.3 t -85.29 -52.56 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.224 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 255' ' ' LEU . 74.0 t -73.58 -53.81 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.181 -173.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -56.27 -39.87 73.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 -172.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -73.86 -29.75 62.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -107.55 6.01 27.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.177 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.543 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 60.8 tp -65.48 -42.38 56.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.23 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 85.9 Cg_exo -51.75 -35.4 58.25 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.693 1.595 . . . . 0.0 111.188 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.94 79.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.11 -34.91 77.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.213 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.433 HD22 ' SD ' ' A' ' 264' ' ' MET . 81.0 mt -63.48 -41.76 98.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.186 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.56 -25.39 67.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.192 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -80.69 -20.07 43.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.21 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 31.6 m -105.16 9.82 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.204 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.64 20.22 58.63 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . 0.514 ' SD ' HG21 ' A' ' 278' ' ' VAL . 59.7 ttm -119.09 103.24 9.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.775 0.321 . . . . 0.0 111.213 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -93.65 129.08 40.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.166 -170.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.468 ' HA ' HG12 ' A' ' 278' ' ' VAL . 95.0 t -73.2 127.7 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.213 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 65.3 p -108.84 -27.88 9.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.219 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -162.71 166.31 24.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.237 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 82.8 p -161.41 153.78 20.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.208 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 85.1 m -133.92 112.0 10.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.185 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -72.86 -22.11 60.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 84.9 p -77.99 -12.41 59.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.178 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -116.87 -20.04 9.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.224 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.31 25.94 67.18 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -172.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -110.04 149.99 29.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.776 0.322 . . . . 0.0 111.187 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.42 ' HB3' ' HB2' ' A' ' 305' ' ' LEU . 56.7 ttm -140.07 136.76 33.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.196 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -110.59 125.6 53.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.197 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.514 HG21 ' SD ' ' A' ' 264' ' ' MET . 34.8 m -134.46 155.4 38.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.19 -169.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.0 m -117.92 125.06 49.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 172.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -113.15 137.61 51.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.209 -171.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -136.69 129.89 17.6 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.181 170.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.98 139.08 79.48 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.687 1.591 . . . . 0.0 111.269 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 64.3 mt -99.79 166.49 11.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.173 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 56.7 p -74.96 164.89 26.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.259 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -58.25 -39.3 78.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.21 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 93.9 p -70.29 -30.53 67.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.208 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.92 -43.58 92.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.215 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -71.63 -28.71 63.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.201 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -66.73 -40.53 88.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.194 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.98 -39.15 87.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.212 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.92 -39.0 90.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.188 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 90.3 39.93 5.89 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 -175.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -141.92 166.36 24.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.775 0.321 . . . . 0.0 111.208 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 82.8 p -99.43 -178.45 3.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.163 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -64.74 120.66 68.01 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.183 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.04 -22.94 47.05 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.728 1.619 . . . . 0.0 111.21 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.86 19.09 60.15 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 10.8 mp -101.29 140.28 35.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.228 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -99.33 159.56 14.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.184 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.3 t -60.16 139.99 57.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.181 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 153.15 -179.33 29.64 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -86.08 136.36 33.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.748 0.308 . . . . 0.0 111.244 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -121.15 149.05 43.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.426 ' HB3' ' HB ' ' A' ' 319' ' ' ILE . 87.7 tttt -110.72 122.13 47.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.212 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 276' ' ' MET . 62.8 mt -103.15 135.85 44.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.241 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -119.65 125.14 48.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.208 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 315' ' ' SER . 57.6 t -122.32 120.31 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -109.34 155.05 16.27 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -88.92 118.76 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 111.194 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.532 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 87.9 mt -95.45 11.41 32.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.225 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 37.1 t0 87.63 -64.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.157 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -101.81 -10.1 20.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.181 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 89.8 mmt-85 -137.69 176.57 8.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.217 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 50.3 m -119.99 136.59 54.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 307' ' ' VAL . 27.8 t -96.71 109.74 22.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 174.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 48.9 tp -111.72 124.0 51.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.182 -176.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -127.02 148.46 50.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.221 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -112.27 125.92 54.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -173.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 304' ' ' LYS . 92.5 mt -108.23 124.41 64.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.225 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.526 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 35.1 p30 -75.13 173.83 6.32 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.241 -174.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.526 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 51.8 Cg_exo -59.93 -25.18 78.79 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.73 1.62 . . . . 0.0 111.177 -176.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -80.18 -9.75 59.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.167 -173.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.58 17.17 42.97 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -120.42 162.01 20.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.797 0.332 . . . . 0.0 111.189 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 78.4 p -79.32 153.94 29.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.195 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 68.2 mt -76.47 158.43 31.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.197 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 41.0 p -76.76 167.05 22.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.199 -173.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.555 ' HG3' ' HG3' ' A' ' 240' ' ' PRO . 88.8 mt-30 -61.8 -35.04 77.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.21 174.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 98.9 p -71.51 -35.78 70.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.21 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -68.82 -41.95 77.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -67.61 -37.49 82.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.214 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -60.69 -37.41 81.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.195 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -66.7 -38.89 87.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.248 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 84.5 mt -68.19 -22.64 64.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.227 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.78 -56.75 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.169 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -67.98 -35.36 78.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.201 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.52 -46.53 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.179 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -79.66 -28.91 40.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.257 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -54.26 -42.07 69.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.221 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -76.17 -34.33 59.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.211 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.05 -40.82 95.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -74.02 -27.61 61.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.215 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 90.5 p -82.78 -27.83 30.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.215 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -62.68 124.84 84.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.237 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -53.91 130.28 38.45 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.701 1.6 . . . . 0.0 111.196 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 1.0 -14.531 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 . . . . . 0 CA--C 1.523 -0.071 0 CA-C-O 120.845 0.355 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 83.2 t -127.0 125.21 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.186 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -112.51 156.89 21.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.228 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 35.0 t -95.62 136.24 36.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.191 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.28 167.71 29.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.215 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -99.48 145.73 27.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 41.8 p30 -85.85 -169.9 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.35 -25.5 67.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.175 -172.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 68.6 p -97.58 -1.22 44.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.219 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.0 18.53 60.95 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 98.4 mt -94.0 158.09 36.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.753 0.311 . . . . 0.0 111.216 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.595 ' HG3' ' HG3' ' A' ' 328' ' ' GLN . 54.0 Cg_exo -55.06 139.3 80.02 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.696 1.598 . . . . 0.0 111.212 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.407 ' SD ' ' OG ' ' A' ' 315' ' ' SER . 64.5 ttp -156.08 149.88 25.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.172 -175.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 88.6 mt -111.89 143.91 42.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.203 172.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 94.2 t -118.08 120.94 66.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 176.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.01 140.03 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.181 -175.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -74.88 92.51 2.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.179 -174.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 153.59 156.07 7.46 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 173.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.4 157.87 38.79 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.728 1.618 . . . . 0.0 111.207 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.431 ' HB2' ' HB2' ' A' ' 309' ' ' ASP . 62.0 t80 -48.18 -47.05 35.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 176.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -63.34 -24.07 67.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.202 -174.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 90.2 t -88.44 -51.1 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.207 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 255' ' ' LEU . 72.6 t -74.42 -52.0 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.24 -174.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 87.9 t90 -55.12 -39.92 69.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.239 -174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -75.19 -31.69 61.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.193 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -99.02 -0.71 41.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.201 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.53 ' HB3' ' HD3' ' A' ' 256' ' ' PRO . 55.9 tp -69.64 -43.61 22.28 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 -176.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 255' ' ' LEU . 74.2 Cg_exo -53.2 -35.81 75.02 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.714 1.609 . . . . 0.0 111.147 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.56 -47.47 78.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.216 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.12 73.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.204 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 56.0 mt -67.64 -49.85 60.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.181 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.78 -31.75 69.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.171 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -60.76 -31.46 70.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.21 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.3 24.95 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.191 -171.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.65 23.34 50.65 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 170.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . 0.422 ' HB3' HG21 ' A' ' 278' ' ' VAL . 67.1 mtt -118.87 104.96 11.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.772 0.32 . . . . 0.0 111.227 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -96.7 112.23 24.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 95.7 t -69.62 127.84 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.234 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 79.6 p -103.84 -26.08 12.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.191 -174.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -165.12 162.26 20.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.157 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 86.0 p -159.48 154.34 24.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.191 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 91.6 m -132.08 109.91 10.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.184 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -72.54 -23.32 60.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.219 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 86.3 p -77.69 -12.7 60.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.199 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -119.56 -18.81 8.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.223 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.45 28.92 60.72 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -109.5 150.22 28.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.345 . . . . 0.0 111.196 -173.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 58.9 ttm -142.33 137.31 30.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.219 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -117.54 126.32 52.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.19 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' A' ' 264' ' ' MET . 10.5 p -138.77 135.65 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.179 -167.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 98.0 m -95.85 125.01 40.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.246 176.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -114.16 137.78 51.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.163 -172.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -132.62 127.58 20.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.203 169.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.03 137.6 76.71 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.765 1.643 . . . . 0.0 111.212 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 70.4 mt -99.23 163.85 12.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.21 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 58.7 p -71.55 163.26 28.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.174 -176.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.57 -38.69 75.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.194 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 90.9 p -69.64 -30.35 68.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.193 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.63 -43.96 92.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.254 175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -74.28 -26.45 60.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.184 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -67.56 -40.6 84.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.199 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -70.3 -35.1 73.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.21 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.87 -29.14 66.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 77.37 35.28 37.86 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -137.01 154.65 50.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.769 0.318 . . . . 0.0 111.182 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 36.1 t -70.45 142.16 52.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.209 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -64.72 117.21 36.09 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.214 175.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 156.83 62.34 Favored 'Trans proline' 0 C--N 1.327 -0.559 0 C-N-CA 121.696 1.597 . . . . 0.0 111.191 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -89.56 34.33 4.06 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 11.1 mp -100.32 139.92 35.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.762 0.315 . . . . 0.0 111.191 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -103.74 162.73 12.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.209 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.7 t -59.53 134.6 57.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 158.4 -178.97 34.41 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -86.82 133.42 33.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.804 0.335 . . . . 0.0 111.205 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -121.28 153.03 38.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.197 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -112.22 160.63 17.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.171 173.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 53.2 tp -144.98 128.82 17.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.173 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -109.75 122.77 48.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.199 170.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 47.7 t -116.48 126.9 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.199 -172.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -114.37 167.46 12.32 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . 25.1 t70 -107.08 104.4 14.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 111.185 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 313' ' ' ARG . 84.7 mt -86.1 59.95 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 175.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 310' ' ' LEU . 67.4 m-20 64.91 -104.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.189 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -93.93 16.02 15.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.234 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 310' ' ' LEU . 89.5 mmt-85 -131.6 166.14 22.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.174 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 58.2 m -118.37 138.79 52.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.203 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.407 ' OG ' ' SD ' ' A' ' 241' ' ' MET . 31.2 t -107.01 112.75 25.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.246 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 64.0 mt -101.76 113.59 26.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.193 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -105.72 102.4 11.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.165 170.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -86.97 135.11 33.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.219 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 79.5 mt -124.03 128.63 74.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.18 -172.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.517 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 30.8 p30 -72.7 173.32 5.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.189 -175.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.517 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 50.4 Cg_exo -60.45 -24.67 78.55 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.668 1.579 . . . . 0.0 111.24 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -81.69 -8.42 59.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 -175.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 88.75 24.6 32.32 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -121.09 143.82 48.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.809 0.338 . . . . 0.0 111.245 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 87.6 m -62.82 135.0 57.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.23 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 95.5 mt -59.91 155.25 16.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.217 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 69.4 p -83.23 165.97 18.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.247 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.595 ' HG3' ' HG3' ' A' ' 240' ' ' PRO . 89.2 mt-30 -61.61 -34.96 76.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.229 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 83.1 p -64.89 -25.65 67.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.189 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -90.01 -41.17 11.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -70.0 -36.52 75.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -57.95 -36.58 72.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.241 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -71.57 -35.74 70.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.191 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.07 -19.5 63.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 54.5 t -53.55 -53.78 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.173 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -66.49 -35.4 80.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.214 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 63.0 t -58.26 -50.18 79.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.168 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -86.17 -24.69 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.209 -176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -53.88 -49.55 68.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.181 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -76.53 -46.28 27.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.198 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.12 -36.46 81.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.208 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -72.54 -41.75 65.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.162 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 87.1 p -78.21 -15.33 58.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.194 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -109.26 153.58 42.6 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.193 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.46 143.53 77.2 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.717 1.611 . . . . 0.0 111.156 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 1.0 -14.496 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.412 ' HA ' ' HG3' ' A' ' 339' ' ' GLN . 69.5 m-20 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.822 0.344 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 97.1 t -130.92 135.17 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -129.99 161.72 30.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 -176.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 31.9 t -101.93 145.98 28.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.201 172.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -154.28 166.96 31.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.203 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.73 139.82 30.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.209 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -81.78 173.04 12.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.25 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -65.31 -23.32 66.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 60.0 p -82.85 -15.43 51.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.197 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.43 -4.52 64.39 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 98.0 mt -81.84 154.15 70.34 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.173 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.14 130.0 38.33 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.655 1.57 . . . . 0.0 111.259 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 63.1 ttp -130.01 139.64 51.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 43.1 tp -104.56 128.45 52.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.23 174.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 31.7 m -123.91 149.95 28.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.222 -173.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.41 145.62 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -74.86 84.33 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.2 -172.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 158.59 156.57 8.07 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 171.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.45 161.14 24.93 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.718 1.612 . . . . 0.0 111.234 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -48.8 -46.16 41.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.192 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -60.35 -30.68 69.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.167 -175.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 81.5 t -83.12 -52.47 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.225 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 255' ' ' LEU . 79.2 t -73.89 -50.17 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.24 -171.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 91.1 t90 -55.81 -37.39 68.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 -173.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -74.88 -30.93 61.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -96.89 -8.07 31.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.212 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.513 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 61.4 tp -67.45 -44.12 44.63 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 -173.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 90.9 Cg_exo -49.34 -40.4 43.85 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.658 1.572 . . . . 0.0 111.192 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.09 -43.25 95.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.252 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -68.0 -27.46 66.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.205 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.408 HD22 ' SD ' ' A' ' 264' ' ' MET . 93.2 mt -77.1 -39.61 48.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.203 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -63.03 -26.71 68.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.221 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -77.64 -14.86 59.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 35.9 m -113.78 15.8 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.219 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.16 14.45 71.8 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . 0.481 ' SD ' HG21 ' A' ' 278' ' ' VAL . 57.4 ttm -110.19 100.04 9.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 111.227 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -89.45 127.1 35.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 -171.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 278' ' ' VAL . 96.3 t -74.31 124.84 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.201 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 64.6 p -107.73 -26.63 10.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.2 -177.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -163.41 158.7 21.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.168 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 87.9 p -159.36 155.4 26.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.175 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 81.3 m -140.11 116.69 10.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.228 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -67.14 -38.73 86.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.24 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 96.6 p -73.54 -21.84 60.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.189 -170.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -113.83 -12.1 12.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.212 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 74.39 36.81 48.95 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -91.03 134.96 34.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 111.24 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 59.9 tpp -135.82 96.65 3.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 174.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -95.29 120.77 36.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.193 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.481 HG21 ' SD ' ' A' ' 264' ' ' MET . 35.2 m -132.32 155.56 41.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.241 -169.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 98.4 m -116.09 123.39 47.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.222 168.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -109.06 132.75 53.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.181 -170.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -129.01 126.51 23.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.195 170.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.08 141.0 80.52 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.703 1.602 . . . . 0.0 111.171 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 66.3 mt -98.32 164.0 12.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.224 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 59.5 p -75.56 164.79 25.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.193 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.17 -39.36 78.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 91.5 p -70.15 -29.87 66.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.198 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.52 -42.74 91.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.204 174.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -72.32 -29.77 64.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.188 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -65.6 -40.1 92.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.196 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.08 -45.34 85.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 62.8 tp -61.4 -41.01 96.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 97.68 34.57 5.45 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -140.09 172.35 12.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.319 . . . . 0.0 111.247 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 83.1 p -107.73 -175.29 2.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.179 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -60.81 120.39 52.99 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.87 -19.9 39.92 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.707 1.605 . . . . 0.0 111.218 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 85.34 11.76 74.64 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.3 mt -95.14 138.21 33.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 111.229 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -101.88 156.46 17.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.206 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 43.5 t -57.76 138.71 55.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.179 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 149.64 -178.94 26.82 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -81.95 143.06 31.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.775 0.321 . . . . 0.0 111.203 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -126.13 140.1 52.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.202 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -105.19 114.88 29.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.178 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 43.8 tp -110.73 120.62 43.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.23 -176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -98.12 131.17 44.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.232 171.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.15 117.64 54.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.202 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -105.79 154.86 16.97 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -92.17 114.65 27.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.763 0.316 . . . . 0.0 111.16 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.51 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 84.4 mt -93.7 9.92 35.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.232 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 34.5 t0 87.55 -64.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.208 175.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -99.62 -7.28 25.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.186 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -137.76 173.27 11.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 71.0 m -126.88 139.6 52.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 170.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 90.7 p -94.5 154.35 17.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 74.5 mt -129.32 115.63 17.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.184 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -115.08 104.53 11.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 174.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -92.4 133.13 36.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.193 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 85.9 mt -115.96 124.88 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.231 168.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.54 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 31.2 p30 -76.05 174.37 5.71 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.209 -172.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.54 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 64.0 Cg_exo -59.47 -25.44 78.65 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.688 1.592 . . . . 0.0 111.212 -175.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -84.34 -6.82 59.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.199 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.43 15.06 59.16 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -108.89 146.35 33.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.805 0.336 . . . . 0.0 111.22 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 74.9 p -67.25 149.97 49.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.461 ' HG ' ' HB2' ' A' ' 330' ' ' GLN . 13.9 tp -69.58 135.58 50.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.23 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 52.8 p -84.43 164.27 18.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.213 -168.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -54.98 -45.44 74.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.223 -174.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 97.3 p -63.02 -24.94 68.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . 0.461 ' HB2' ' HG ' ' A' ' 326' ' ' LEU . 74.7 mt-30 -88.72 -37.94 15.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.225 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -65.15 -37.45 87.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.179 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -72.84 -32.12 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.224 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -64.96 -33.07 75.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 94.3 mt -78.52 -7.94 58.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.24 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.06 -58.66 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.187 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -72.32 -33.45 67.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.239 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 68.5 t -63.95 -51.0 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.196 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -68.79 -41.29 78.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.18 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . 0.412 ' HG3' ' HA ' ' A' ' 229' ' ' ASP . 65.6 tt0 -54.55 -43.15 71.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -63.79 -41.13 97.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.186 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.79 -31.15 72.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.198 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -76.9 -34.64 57.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.151 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 83.5 p -77.04 -17.79 58.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.274 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -95.3 151.66 38.84 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.215 174.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.1 151.14 61.11 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.729 1.619 . . . . 0.0 111.204 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 0.999 -14.542 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.848 0.356 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.441 ' HB ' ' HG3' ' A' ' 339' ' ' GLN . 66.7 t -129.3 130.64 67.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -129.9 160.17 34.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.21 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 34.5 t -101.73 142.24 33.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.215 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -153.04 173.4 15.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.252 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -96.64 141.09 30.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.252 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -79.89 171.4 15.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.229 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.98 -25.62 67.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.166 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 61.7 p -83.55 -15.17 50.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.196 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.77 -5.56 58.31 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 95.3 mt -77.23 157.12 81.24 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.79 0.328 . . . . 0.0 111.19 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.476 ' HG3' ' HG3' ' A' ' 328' ' ' GLN . 51.2 Cg_exo -55.49 133.03 55.71 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.74 1.627 . . . . 0.0 111.211 177.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 62.2 ttp -133.67 144.56 49.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.254 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 74.5 mt -109.98 145.72 36.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.166 171.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 68.5 t -124.34 127.12 72.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 94.2 t -111.93 134.77 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.223 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -65.82 113.06 4.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.187 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 127.73 142.19 5.45 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -73.31 169.21 22.82 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.738 1.625 . . . . 0.0 111.228 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -48.53 -45.29 37.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.187 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -63.37 -27.09 69.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.236 -173.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 72.9 t -88.26 -56.88 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.177 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 255' ' ' LEU . 76.6 t -67.58 -54.66 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.199 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -55.61 -39.71 71.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.207 -169.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -68.0 -35.95 79.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -107.99 8.81 28.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.211 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.546 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 50.7 tp -68.4 -41.7 25.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.223 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 82.4 Cg_exo -51.17 -38.95 61.87 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.689 1.593 . . . . 0.0 111.18 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.08 -44.91 87.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.222 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.19 -36.0 82.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.185 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.95 -38.2 66.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.203 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -57.67 -36.31 71.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.215 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -64.91 -26.24 68.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.176 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 35.7 m -106.71 18.75 5.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.233 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 85.78 14.57 67.32 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . 0.442 ' SD ' HG21 ' A' ' 278' ' ' VAL . 58.1 ttm -111.9 99.92 8.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.764 0.316 . . . . 0.0 111.229 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.8 127.1 42.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.206 -171.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.421 ' HA ' HG12 ' A' ' 278' ' ' VAL . 98.0 t -72.61 127.98 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.227 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 73.8 p -108.21 -25.88 10.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.197 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -163.08 158.72 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 89.7 p -159.93 160.73 33.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.218 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 62.0 m -140.84 119.98 12.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 62.9 ttp180 -66.97 -43.52 82.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.182 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 96.9 p -73.33 -20.59 60.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.201 -169.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -112.41 -13.46 13.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 72.84 38.24 56.52 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -89.21 139.12 30.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 0.0 111.157 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 55.7 tpp -139.01 89.96 2.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.237 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -89.37 121.47 31.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.224 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.442 HG21 ' SD ' ' A' ' 264' ' ' MET . 34.6 m -129.99 153.63 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.239 -168.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.6 m -112.92 124.65 53.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.225 167.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -112.71 136.48 52.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.212 -171.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -134.69 128.73 19.07 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.22 171.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.17 140.48 81.0 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.643 1.562 . . . . 0.0 111.164 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 67.1 mt -99.67 163.9 12.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.239 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.3 p -73.47 163.13 28.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.186 -176.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.86 -35.3 72.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.241 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 87.9 p -71.42 -31.64 67.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.69 -43.08 94.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.189 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -72.5 -30.12 64.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.228 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -66.26 -40.2 90.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.172 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.19 -38.67 82.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.224 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.34 -36.28 81.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.214 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 94.72 19.16 32.62 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -174.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -115.71 -156.55 0.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.812 0.339 . . . . 0.0 111.194 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 10.7 t -147.84 -168.45 3.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.218 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -68.43 120.15 73.16 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.223 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.46 -15.03 25.04 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.686 1.591 . . . . 0.0 111.22 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 85.76 8.06 80.4 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.52 141.39 29.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.189 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -99.82 158.7 15.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.2 t -58.0 137.14 57.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.197 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 155.63 -179.65 31.42 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -87.03 138.23 31.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.325 . . . . 0.0 111.188 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -122.63 145.2 48.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.194 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -109.98 112.4 24.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.166 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 39.1 tp -105.73 120.06 40.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.235 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -92.25 128.18 38.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.173 170.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 52.7 t -115.09 122.79 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -116.25 157.2 15.17 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.77 120.28 34.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 0.0 111.165 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.524 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 88.2 mt -96.77 14.57 24.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.213 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 32.0 t0 87.61 -65.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -102.71 -10.42 19.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.213 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -139.16 176.7 8.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.218 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 58.7 m -119.83 138.05 53.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.231 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 23.7 t -100.06 128.59 46.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.182 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 68.4 mt -110.54 126.88 54.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.171 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -125.3 105.01 8.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -90.12 127.96 36.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.204 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 45.5 mm -108.89 127.66 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.253 170.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.53 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 26.3 p30 -75.72 174.17 5.94 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.226 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.53 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 71.9 Cg_exo -60.02 -26.07 81.43 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.716 1.611 . . . . 0.0 111.182 -173.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -83.29 -8.12 59.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.167 -174.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.73 15.13 58.63 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -105.94 146.9 29.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.799 0.333 . . . . 0.0 111.197 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 89.8 m -60.9 130.11 44.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.216 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 19.7 tp -63.24 134.71 56.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.166 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 56.7 p -81.29 164.75 22.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -166.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.476 ' HG3' ' HG3' ' A' ' 240' ' ' PRO . 88.2 mt-30 -63.75 -32.04 73.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.206 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 83.8 p -65.67 -18.11 65.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -107.85 -28.28 9.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.199 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -73.89 -42.28 60.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.227 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -62.04 -32.25 72.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.188 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -72.51 -35.02 68.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.238 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 38.5 mt -65.43 -32.39 73.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.195 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 58.0 t -52.6 -45.62 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -62.24 -45.47 93.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.196 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 5.3 m -78.82 -26.08 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -72.97 -43.96 61.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.214 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . 0.441 ' HG3' ' HB ' ' A' ' 230' ' ' VAL . 80.3 mt-30 -55.36 -44.75 76.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -65.38 -41.03 94.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.08 -36.69 85.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.192 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -79.55 -38.83 33.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.239 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 90.0 p -73.06 -25.83 61.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.259 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -110.67 149.98 41.09 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.223 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.81 150.54 55.97 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.698 1.598 . . . . 0.0 111.189 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 0.999 -14.533 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 48.3 p30 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.82 0.343 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 91.2 t -125.05 137.45 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -149.97 163.01 39.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.199 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 26.3 t -96.33 139.08 32.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.177 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -162.7 157.74 22.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.39 147.15 23.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.227 176.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -85.14 -166.81 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.221 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.97 -25.41 67.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 -172.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 63.0 p -97.41 1.01 48.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 -176.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 86.98 21.28 50.71 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 59.1 tp -99.62 114.44 65.61 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.35 . . . . 0.0 111.205 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.24 135.74 65.92 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.725 1.617 . . . . 0.0 111.221 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.3 163.93 39.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.193 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.7 tp -76.9 127.66 33.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.181 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.1 t -108.36 121.91 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.218 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.5 t -124.34 125.16 69.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.23 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -76.43 91.7 3.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 -172.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 172.46 161.2 22.53 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 172.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.17 156.15 52.11 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.646 1.564 . . . . 0.0 111.191 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.431 ' HB2' ' HB2' ' A' ' 309' ' ' ASP . 66.0 t80 -48.91 -45.89 42.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 176.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -63.95 -22.27 66.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.249 -175.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 91.8 t -91.22 -50.38 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.163 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 74.3 t -73.01 -46.95 50.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.184 -173.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -60.63 -40.14 90.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.232 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -71.61 -35.38 70.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.169 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -80.16 -25.57 39.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.185 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.624 ' HB3' ' HD3' ' A' ' 256' ' ' PRO . 49.7 tp -53.83 -48.67 92.84 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 -169.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 255' ' ' LEU . 90.0 Cg_exo -47.8 -44.47 26.75 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.671 1.581 . . . . 0.0 111.192 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.42 -40.84 93.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.195 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.42 -35.4 80.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.245 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 81.5 mt -67.39 -37.63 83.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.211 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.56 -26.45 68.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.211 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -92.64 1.59 57.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.201 -173.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 35.5 m -125.34 9.81 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.237 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 84.97 27.58 33.76 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 172.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 98.3 mtp -117.2 105.96 12.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.757 0.313 . . . . 0.0 111.239 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -87.75 118.11 27.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.218 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 90.9 t -70.28 126.64 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.211 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 67.1 p -106.23 -28.11 10.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.231 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -162.16 160.85 27.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.214 174.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 83.5 p -154.53 152.79 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.207 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 60.6 m -144.53 122.67 12.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -92.69 -19.98 21.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.242 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 88.8 p -75.75 -15.06 60.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.205 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -117.95 -20.64 8.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.245 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.02 48.86 10.48 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -145.96 175.24 10.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.335 . . . . 0.0 111.182 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.439 ' HB3' ' HB2' ' A' ' 305' ' ' LEU . 50.3 ttm -159.83 148.52 17.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.213 -175.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -116.81 121.22 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.192 174.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 45.4 t -138.53 131.29 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.202 -168.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 97.8 m -92.87 120.13 32.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.2 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -97.85 127.34 43.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.195 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -123.03 120.2 27.56 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.2 172.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.06 134.09 61.77 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.692 1.595 . . . . 0.0 111.188 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 68.5 mt -99.27 163.78 12.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.19 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 60.9 p -81.75 167.48 19.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.217 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -59.16 -32.68 70.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 85.2 p -69.81 -22.54 63.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.179 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -82.13 -39.57 23.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.203 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -74.24 -24.61 59.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.216 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -68.5 -40.2 80.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.203 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.72 -38.7 76.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.209 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 48.0 tp -67.95 -36.25 79.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.204 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 84.75 42.71 7.13 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -139.14 160.13 40.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 111.216 -174.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 87.8 p -94.28 162.62 13.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.212 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -41.26 120.96 1.98 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.247 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.22 -24.93 57.98 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.721 1.614 . . . . 0.0 111.172 -176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 81.86 15.63 74.75 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.37 143.36 26.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 0.0 111.205 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -100.35 145.23 28.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.211 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 46.3 t -54.34 139.08 37.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.204 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 143.65 -171.53 25.28 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -84.56 138.52 32.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 111.221 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -119.25 137.41 53.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.225 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.431 ' HB3' ' HB ' ' A' ' 319' ' ' ILE . 88.1 tttt -94.33 126.34 39.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.19 171.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.481 ' HB3' HD11 ' A' ' 316' ' ' LEU . 63.5 mt -108.13 134.75 50.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.243 -176.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -123.05 124.14 42.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.19 173.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.416 HG22 HD13 ' A' ' 316' ' ' LEU . 70.5 t -115.4 125.09 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.189 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -118.11 156.5 15.62 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 176.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . 18.2 t0 -102.63 108.52 19.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.752 0.311 . . . . 0.0 111.216 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 311' ' ' ASP . 83.5 mt -87.97 67.66 9.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.198 177.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 310' ' ' LEU . 65.4 m-20 64.93 -102.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.24 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -89.23 -8.19 54.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -118.34 175.05 5.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.194 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 74.5 m -132.24 159.35 39.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.203 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 87.8 p -133.04 149.53 52.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.215 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.481 HD11 ' HB3' ' A' ' 305' ' ' LEU . 37.1 tp -133.07 118.06 18.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.165 -175.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -100.22 140.21 34.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.233 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' A' ' 326' ' ' LEU . 46.1 m-85 -108.52 131.25 55.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.233 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 304' ' ' LYS . 85.9 mt -116.48 119.32 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.235 168.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.571 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 30.2 p30 -78.14 175.85 4.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.172 -171.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.571 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 67.9 Cg_exo -59.45 -25.65 79.31 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.748 1.632 . . . . 0.0 111.175 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.88 -6.72 59.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 88.67 14.47 61.31 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -98.96 142.72 30.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.73 0.3 . . . . 0.0 111.242 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 81.4 p -78.67 162.61 26.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.178 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 318' ' ' PHE . 25.3 tp -62.55 131.7 49.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.267 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 66.4 p -87.74 164.92 15.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.18 177.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -61.55 -47.75 84.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 73.8 m -55.9 -42.71 76.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.224 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -64.99 -49.22 71.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -63.48 -34.57 78.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.171 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.84 -40.37 97.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -68.48 -34.12 75.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.216 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.74 -13.73 61.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.206 -175.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 74.1 t -55.83 -58.46 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.226 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -66.28 -34.96 79.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.68 -49.86 82.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.227 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -87.25 -24.52 24.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.213 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -55.22 -49.99 70.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.191 171.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -67.07 -36.55 82.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.213 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -70.17 -42.34 72.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.23 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -75.69 -27.78 58.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.156 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 72.8 m -81.24 -22.37 38.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.218 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -58.46 125.86 77.23 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.224 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.25 128.9 26.89 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.686 1.591 . . . . 0.0 111.226 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 0.999 -14.533 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.795 0.331 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 96.9 t -120.84 138.87 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.193 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -130.29 163.04 27.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.226 176.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 40.7 t -92.85 140.37 29.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.182 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -146.69 175.83 10.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.202 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -119.58 144.32 47.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.238 174.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 42.2 p30 -88.63 -172.04 3.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.177 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -69.0 -19.21 64.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.188 -172.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 59.8 p -95.84 -7.37 37.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.183 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 92.89 6.49 63.5 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 240' ' ' PRO . 99.4 mt -87.43 145.45 37.53 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.783 0.325 . . . . 0.0 111.219 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 239' ' ' LEU . 54.6 Cg_exo -58.99 140.27 94.6 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.724 1.616 . . . . 0.0 111.192 -176.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -148.21 172.05 14.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.2 173.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 92.0 mt -108.89 150.49 27.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.195 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.9 149.43 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.221 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.78 138.71 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.203 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -71.9 74.08 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.169 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 174.94 164.44 29.7 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -76.25 159.83 36.49 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.718 1.612 . . . . 0.0 111.181 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -52.0 -44.28 64.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -63.42 -23.35 67.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.192 -171.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.16 -52.51 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.203 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.15 -52.94 55.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.204 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -57.71 -42.49 83.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.155 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -67.08 -34.7 78.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.185 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -100.0 4.55 44.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.211 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.528 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 46.6 tp -68.73 -43.39 28.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.217 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 85.9 Cg_exo -51.84 -36.91 64.85 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.73 1.62 . . . . 0.0 111.226 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.19 -45.54 91.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -66.27 -36.93 84.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 49.0 mt -63.31 -43.82 96.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.158 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.67 -20.19 66.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -93.52 -5.71 48.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.222 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 31.5 m -115.24 2.18 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.199 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 98.44 21.29 17.5 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 67.1 mtt -116.98 104.38 11.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 111.193 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -89.01 120.52 30.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.76 124.91 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.203 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 71.8 p -104.69 -25.37 12.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.216 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -164.99 160.62 19.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.226 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 84.7 p -162.89 157.67 21.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.179 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 68.3 m -143.23 121.06 11.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.217 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -73.26 -45.9 53.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.222 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 87.0 p -66.72 -21.07 66.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.202 -172.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -106.69 -21.81 12.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.213 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 75.61 42.59 26.3 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -128.14 160.6 31.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.801 0.334 . . . . 0.0 111.217 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 59.7 ttm -158.27 149.77 21.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.23 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -125.93 128.7 47.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.187 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.59 146.61 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.166 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 97.4 m -102.6 119.29 38.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.221 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -107.52 137.17 46.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.191 -172.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -136.96 129.08 17.01 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.225 169.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.01 140.4 79.93 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.702 1.602 . . . . 0.0 111.215 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 56.5 mt -100.63 165.32 11.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.155 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.1 p -73.01 163.62 27.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.24 -37.37 74.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.156 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 89.5 p -71.25 -30.95 66.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.53 -42.41 92.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.222 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -71.55 -29.88 65.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.198 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -66.09 -39.95 90.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.206 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.92 -41.16 87.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.199 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.46 -41.88 98.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.213 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 97.48 35.6 5.15 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -143.64 160.27 40.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 111.141 -174.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 88.1 p -85.1 171.47 12.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.237 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -64.92 120.04 63.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.218 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -69.14 -21.03 36.95 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.76 1.64 . . . . 0.0 111.197 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.09 30.22 55.63 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 47.4 tp -106.4 133.44 51.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 111.188 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -86.4 164.75 16.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.236 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.0 p -68.72 164.71 21.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.191 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 145.36 172.12 15.52 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -91.75 109.32 20.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.747 0.308 . . . . 0.0 111.186 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -103.82 146.74 28.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -169.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -90.81 129.81 36.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.201 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.418 HD21 HD21 ' A' ' 255' ' ' LEU . 41.5 tp -123.19 119.93 31.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.219 -176.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -112.19 145.54 39.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 43.5 t -135.12 134.81 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.198 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -134.21 172.66 21.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -115.59 112.78 22.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 0.0 111.182 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.558 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 93.3 mt -83.37 0.52 45.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.177 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 34.0 t0 88.41 -64.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.178 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -76.4 -15.23 59.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.213 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -164.74 173.83 11.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.156 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 38.5 t -100.67 151.64 21.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.218 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 97.6 p -131.87 153.77 49.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.192 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.404 ' HB2' HD11 ' A' ' 305' ' ' LEU . 4.3 pp -150.59 156.47 41.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.218 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -149.21 136.5 20.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.179 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -102.13 138.49 39.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.202 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 85.4 mt -124.33 130.43 73.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.188 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -54.72 157.19 5.6 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.268 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.43 -25.67 49.72 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.681 1.587 . . . . 0.0 111.237 175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.84 0.8 57.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.222 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.83 32.01 10.51 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -124.42 121.6 35.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.802 0.334 . . . . 0.0 111.178 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 6.1 t -49.12 150.99 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 9.7 mp -62.53 151.5 37.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.158 165.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 69.6 p -85.14 161.83 19.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -57.25 -38.8 74.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.219 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 85.5 p -65.15 -26.03 68.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.197 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -88.72 -41.48 12.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.233 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -66.83 -41.22 87.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.242 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -57.52 -34.31 68.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.222 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -73.52 -36.79 65.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.202 173.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 67.9 mt -68.32 -20.11 64.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.182 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 55.9 t -54.13 -55.46 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.194 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -68.74 -34.97 76.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.84 -49.0 86.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.188 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -75.41 -37.95 60.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.211 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -53.57 -44.32 69.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.22 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -65.13 -41.27 94.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.197 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.52 -32.24 73.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.243 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -76.43 -29.33 56.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.209 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 72.2 p -76.99 -16.13 59.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.186 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -74.26 158.5 85.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.198 171.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -54.96 140.14 79.42 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.728 1.619 . . . . 0.0 111.166 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 1.0 -14.497 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.2 129.51 53.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.204 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -150.54 155.26 39.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 87.6 p -87.21 158.8 19.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.215 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -166.56 155.75 11.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.165 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -93.24 135.25 34.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.212 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 47.9 p30 -86.57 -165.81 1.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.215 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -65.15 -24.58 67.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.202 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 65.9 p -98.13 -2.3 40.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.201 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 86.46 11.28 72.08 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 32.4 tp -78.31 123.88 85.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 0.0 111.218 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.85 120.5 8.24 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.686 1.59 . . . . 0.0 111.223 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 67.9 mmm -129.79 160.04 34.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.223 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 33.6 tp -107.79 124.03 49.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.212 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.8 t -106.39 125.3 62.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 89.3 t -107.97 133.77 51.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.186 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -68.71 102.08 1.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 145.43 154.13 6.07 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.46 154.92 38.69 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.658 1.572 . . . . 0.0 111.208 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.442 ' CD1' ' O ' ' A' ' 248' ' ' PHE . 1.2 t80 -54.99 -45.45 75.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 178.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.56 -25.81 67.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.244 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.72 -49.03 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 255' ' ' LEU . 62.8 t -66.48 -39.55 84.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.177 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -54.57 -33.16 59.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.205 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -65.57 -34.96 79.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.226 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -108.95 4.88 23.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.193 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.568 ' N ' ' HD2' ' A' ' 256' ' ' PRO . 63.0 tp -64.36 -52.1 56.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.225 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 255' ' ' LEU . 42.7 Cg_endo -67.21 -24.8 43.7 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.697 1.598 . . . . 0.0 111.211 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.13 -49.69 71.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.192 171.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.19 -38.12 89.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 48.0 mt -62.4 -44.89 95.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.15 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.33 -33.05 74.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.199 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -71.79 -23.62 61.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.23 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 25.3 m -103.66 -0.26 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.226 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 107.03 -2.15 35.44 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 169.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 64.2 mtt -89.76 90.75 8.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 0.0 111.224 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -72.77 111.45 7.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 95.7 t -68.02 131.34 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 65.5 p -109.46 -30.98 7.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.246 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -168.65 161.21 11.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.197 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 39.9 t -147.05 125.21 12.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.239 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 92.8 m -93.81 115.05 27.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.255 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 92.0 mtm180 -80.58 -22.42 40.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.228 -173.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 89.9 p -79.35 -15.28 58.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.192 -177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -119.77 -19.92 7.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.246 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 74.88 42.91 29.31 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -129.74 118.07 21.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 0.0 111.203 -171.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 59.7 ttm -111.58 131.89 54.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.239 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -103.13 133.77 47.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.17 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 19.5 m -132.71 147.37 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.195 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.0 m -98.47 115.22 28.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.255 166.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -93.57 115.07 27.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.191 -171.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -110.52 105.37 57.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.189 166.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -54.9 142.13 76.09 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.694 1.596 . . . . 0.0 111.216 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.28 153.47 28.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.195 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.7 p -75.22 167.92 20.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.23 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -55.38 -43.66 75.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.255 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 91.3 p -70.82 -31.24 67.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.193 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.58 -36.83 83.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 176.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -69.63 -29.89 67.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.219 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -71.48 -37.96 71.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.195 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.37 -41.86 79.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 55.8 tp -67.52 -39.93 85.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.208 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 87.99 40.96 6.44 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.408 ' HB1' ' HA ' ' A' ' 337' ' ' VAL . . . -140.56 159.91 41.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 111.214 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 89.1 p -77.19 165.59 24.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.202 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -103.63 108.54 59.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.197 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.79 169.44 21.18 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.723 1.615 . . . . 0.0 111.18 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -90.19 3.33 82.27 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 96.1 mt -53.71 176.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.772 0.32 . . . . 0.0 111.204 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -143.58 176.24 9.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.192 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 85.1 p -74.29 161.81 29.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.194 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 143.5 -177.66 22.16 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -91.24 104.94 17.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.799 0.333 . . . . 0.0 111.247 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -99.23 151.31 21.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.185 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -117.69 137.25 52.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.194 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 316' ' ' LEU . 37.5 tp -121.93 106.93 11.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.23 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -93.36 121.53 34.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.168 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.49 127.31 70.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.192 -172.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -111.44 158.41 14.35 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -101.89 118.71 37.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.34 . . . . 0.0 111.229 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 89.6 mt -110.85 77.45 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.191 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.7 -108.54 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -100.9 28.71 5.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.165 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -134.24 151.82 51.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.25 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 57.8 m -109.62 128.59 55.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.151 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 32.7 t -106.4 111.42 23.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.19 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.419 ' HB3' HD11 ' A' ' 305' ' ' LEU . 69.7 mt -98.18 123.35 42.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.191 -172.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -109.35 100.37 9.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.187 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -86.06 132.31 34.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.217 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 66.7 mt -124.6 124.27 67.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.224 -171.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -59.72 155.81 38.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.185 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -61.0 -18.63 58.8 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.663 1.575 . . . . 0.0 111.182 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -78.56 -11.94 59.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.189 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.73 14.53 43.15 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -119.06 152.77 35.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.804 0.335 . . . . 0.0 111.232 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 62.6 p -77.87 160.14 28.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.194 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 9.9 mp -70.35 142.39 52.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.229 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 69.9 p -81.45 164.58 21.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.199 -173.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -55.17 -36.97 66.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 76.9 p -62.57 -25.99 68.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.195 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -100.32 -29.24 12.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.196 -175.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -73.11 -24.25 60.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -80.33 -15.17 57.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.197 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -89.46 -29.47 18.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.188 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 88.3 mt -74.22 -10.34 59.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.162 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 6.0 m -66.74 -24.66 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.202 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -97.83 -32.01 11.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.234 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.408 ' HA ' ' HB1' ' A' ' 293' ' ' ALA . 53.5 t -60.23 -49.59 83.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.191 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -84.52 -33.62 23.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.187 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 66.9 tt0 -55.36 -45.82 76.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.214 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -64.72 -38.23 90.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.234 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.42 90.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.238 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -74.41 -30.21 61.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.179 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 90.1 p -85.57 -20.85 28.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.157 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -64.05 125.74 88.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.182 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -53.91 129.8 36.03 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.668 1.578 . . . . 0.0 111.191 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 0.999 -14.532 0 N-CA-C 111.236 -0.745 . . . . 0.0 111.236 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.848 0.356 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.403 HG12 HG22 ' A' ' 244' ' ' VAL . 23.8 m -132.32 160.65 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.17 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -156.51 157.25 35.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.215 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 30.1 t -90.69 141.17 29.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.227 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -161.75 155.08 21.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.233 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.76 144.87 25.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.181 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 46.4 p30 -85.08 -164.66 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.218 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -65.01 -25.86 68.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.253 -172.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 53.8 p -95.45 -1.04 51.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.52 18.39 60.37 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 54.2 tp -90.72 115.85 65.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.164 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.67 130.37 38.35 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.711 1.607 . . . . 0.0 111.162 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -144.74 176.26 9.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.206 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 50.8 tp -102.88 127.09 50.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 99.8 t -110.47 125.52 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 314' ' ' SER . 47.8 t -99.22 137.56 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 176.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -80.64 80.0 7.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.201 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 170.04 159.47 15.99 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -53.06 136.17 60.61 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.673 1.582 . . . . 0.0 111.198 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -59.72 -27.82 66.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.249 -172.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -67.05 -40.71 87.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.179 173.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 68.1 t -68.85 -43.79 82.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.211 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 79.5 t -69.07 -40.54 80.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.233 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -55.1 -35.22 64.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.203 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -75.16 -33.16 61.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -97.33 -11.34 24.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.21 -172.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.526 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 57.0 tp -70.72 -43.6 15.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.175 -172.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 88.7 Cg_exo -51.26 -39.94 61.69 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.726 1.618 . . . . 0.0 111.21 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.13 -44.53 96.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.175 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.15 -39.55 93.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.21 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.78 -42.38 97.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.207 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -67.32 -22.97 65.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.184 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -93.28 -6.04 48.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.196 -174.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 29.4 m -111.17 -3.1 10.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.237 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 101.92 8.05 46.0 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 66.4 mtt -96.35 88.34 4.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 111.18 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.5 120.76 11.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.216 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.412 ' HA ' HG12 ' A' ' 278' ' ' VAL . 88.2 t -73.38 122.83 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.22 -175.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 60.3 p -110.45 -28.06 8.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.194 -175.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -161.39 155.82 22.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.209 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 40.8 t -162.09 115.92 1.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.199 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 86.8 m -125.43 112.16 15.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.213 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -75.26 -23.1 57.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.199 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 84.2 p -74.78 -16.29 60.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.216 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -118.3 -14.11 9.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.191 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 72.72 29.94 64.66 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -116.13 111.52 20.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 0.0 111.242 -169.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.4 ' SD ' HD23 ' A' ' 255' ' ' LEU . 95.1 mtp -115.84 152.81 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.2 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -142.88 135.02 27.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.192 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 266' ' ' VAL . 34.2 m -135.14 158.79 41.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.268 -175.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 99.4 m -110.07 118.62 36.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.186 165.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -95.8 127.44 41.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 -173.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -121.35 122.96 27.86 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.218 167.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -54.84 136.86 73.7 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.714 1.609 . . . . 0.0 111.192 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 77.1 mt -91.19 157.53 17.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.226 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.8 p -75.21 165.24 25.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.185 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -54.77 -43.88 73.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.19 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 91.8 p -69.03 -31.06 69.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.215 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.63 -40.45 95.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.22 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -70.59 -30.2 66.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.158 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -69.36 -39.64 77.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.198 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.62 -39.81 80.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.208 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.6 -45.0 84.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.183 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 97.84 34.7 5.37 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -142.64 155.8 44.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.231 -175.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 94.0 p -80.57 159.63 25.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.197 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -71.34 119.87 76.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.224 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.38 -15.02 25.24 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.687 1.591 . . . . 0.0 111.247 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 77.79 29.35 55.0 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 98.1 mt -93.91 143.29 26.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 0.0 111.208 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -90.09 163.81 14.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.206 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 82.9 p -69.64 160.67 31.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.225 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 145.57 178.63 21.24 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 174.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.57 132.74 34.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 0.0 111.173 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -122.37 149.55 43.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.202 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.86 154.91 23.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.174 174.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.556 HD13 ' C ' ' A' ' 305' ' ' LEU . 3.2 tm? -139.61 111.24 7.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.211 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 317' ' ' GLN . 62.5 tp60 -92.44 120.71 33.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.175 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 92.8 t -87.57 126.78 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.169 175.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -87.31 161.77 32.95 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 175.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -97.59 87.45 4.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 111.172 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 313' ' ' ARG . 97.7 mt -113.65 142.83 45.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 175.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -70.34 -49.98 43.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.206 -172.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -111.08 4.65 19.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.213 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 310' ' ' LEU . 89.4 mmt-85 -138.5 171.71 13.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.17 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . 0.417 ' HB3' ' HB ' ' A' ' 244' ' ' VAL . 46.3 t -128.24 114.82 17.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 171.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 11.3 t -81.32 113.63 19.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.183 175.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 73.0 mt -105.65 98.62 8.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.187 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 306' ' ' GLN . 62.7 tt0 -88.93 99.01 12.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.2 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -84.01 132.38 34.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 86.4 mt -125.05 129.54 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.189 -173.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.521 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 31.4 p30 -75.6 173.46 7.05 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.164 -173.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.521 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 52.9 Cg_exo -59.94 -26.25 81.82 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.641 1.561 . . . . 0.0 111.264 -175.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -81.56 -8.5 59.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.191 -175.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.24 24.1 27.64 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -119.79 139.31 52.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.761 0.315 . . . . 0.0 111.222 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 74.3 m -65.08 137.39 57.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.223 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 88.4 mt -61.86 147.44 46.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.185 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 60.1 p -82.19 168.48 17.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.177 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -52.88 -41.95 64.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.173 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 89.4 p -64.96 -26.18 68.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.182 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -91.55 -23.13 20.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.215 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -85.07 -29.95 24.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.214 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -65.5 -36.87 85.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.176 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -64.79 -34.77 79.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.167 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.24 -13.96 60.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.235 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.16 -58.39 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.21 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.43 -35.01 79.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.204 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.84 -51.65 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.237 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -78.12 -30.68 49.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.216 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -52.76 -45.4 67.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.166 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -70.01 -39.19 75.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.178 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.19 -35.04 79.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.218 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -77.4 -24.78 50.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 65.5 p -76.99 -18.2 58.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.165 175.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -74.76 151.73 86.86 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.03 135.56 69.25 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.643 1.562 . . . . 0.0 111.217 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 1.0 -14.486 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.772 0.32 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 10.0 p -147.05 146.8 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.207 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -146.51 169.07 19.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.209 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 29.0 t -100.95 142.07 32.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.196 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -155.64 161.05 40.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -86.02 144.95 27.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.179 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 43.5 p30 -92.87 -171.59 2.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.162 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -69.86 -18.33 63.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.176 -173.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 70.8 p -95.62 -7.1 38.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.186 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.93 7.48 64.3 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 99.4 mt -93.63 148.83 36.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.787 0.327 . . . . 0.0 111.164 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.06 141.6 48.56 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.733 1.622 . . . . 0.0 111.182 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -143.82 163.38 33.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.234 175.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 316' ' ' LEU . 36.6 tp -103.82 114.22 28.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.163 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.86 123.28 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.182 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 96.6 t -100.11 135.64 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.235 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -76.12 74.49 2.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.212 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 168.83 157.64 11.77 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 173.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.63 157.68 36.0 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.699 1.6 . . . . 0.0 111.209 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.408 ' HA ' HG22 ' A' ' 251' ' ' VAL . 50.5 p90 -65.23 -20.26 66.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.205 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -69.87 -28.49 65.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.217 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 75.2 t -85.1 -39.21 13.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.173 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' A' ' 248' ' ' PHE . 14.7 m -67.26 -17.77 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -67.13 -13.71 62.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.182 173.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -105.35 -27.95 11.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.195 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.29 -42.58 36.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.546 ' N ' ' CD ' ' A' ' 256' ' ' PRO . 82.3 mt -72.18 -41.47 8.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.182 -165.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 255' ' ' LEU . 87.8 Cg_exo -48.26 -42.73 33.24 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.654 1.569 . . . . 0.0 111.199 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -88.59 -42.24 12.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -41.44 97.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.185 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.43 -48.79 78.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.19 -36.87 76.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.181 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -87.56 3.06 49.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.216 -172.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 34.2 m -119.03 14.26 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.202 172.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 104.64 -1.76 42.32 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 168.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 73.1 mtm -108.96 85.28 2.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.766 0.317 . . . . 0.0 111.179 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -68.27 122.07 17.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.218 -175.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 278' ' ' VAL . 91.3 t -70.53 124.51 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.22 -176.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 72.4 p -109.58 -25.78 10.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -162.47 162.35 27.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 32.1 t -162.61 136.44 6.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.165 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 89.4 m -123.25 117.98 26.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.217 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -74.31 -35.56 63.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 94.5 p -65.51 -21.31 66.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.205 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -107.97 -21.62 12.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.193 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 72.14 38.28 59.38 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -129.35 128.52 43.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.207 -169.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 90.7 mtp -117.51 147.98 42.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.201 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -120.98 130.14 53.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 266' ' ' VAL . 33.8 m -131.12 153.43 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 -174.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 85.9 m -106.35 122.93 47.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.223 167.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -101.68 129.62 47.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.223 -171.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.4 124.94 27.05 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.186 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.76 130.25 39.43 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.698 1.599 . . . . 0.0 111.197 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . . . . . . . . . 78.5 mt -96.92 155.26 16.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.214 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 56.1 p -73.53 163.83 27.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.198 -176.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.08 -36.69 70.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 89.1 p -71.45 -30.89 66.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.241 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.56 -41.9 92.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.199 175.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -73.36 -29.19 62.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.213 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -66.78 -40.04 88.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.195 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.82 -38.16 85.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.194 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 59.7 tp -65.31 -39.59 92.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.179 173.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 91.24 35.28 7.11 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -142.58 163.53 32.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 111.147 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 94.2 p -86.55 167.35 14.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.178 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -65.03 120.97 71.43 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.222 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.88 -18.96 47.0 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.679 1.586 . . . . 0.0 111.184 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 80.92 34.61 26.78 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 80.5 mt -105.64 137.21 43.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.827 0.346 . . . . 0.0 111.187 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -93.76 160.47 14.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.237 173.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.9 p -60.67 156.63 16.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.208 -173.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 136.13 -176.3 20.35 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -86.93 136.55 32.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 111.173 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -123.01 153.98 39.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -119.17 148.67 42.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.226 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 44.3 tp -134.6 113.53 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.203 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -98.55 130.33 45.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.204 174.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.96 127.58 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.169 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -107.69 154.21 16.63 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -91.3 105.48 17.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 -175.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.705 ' O ' ' CB ' ' A' ' 311' ' ' ASP . 90.6 mt -95.41 3.01 54.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.234 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . 0.705 ' CB ' ' O ' ' A' ' 310' ' ' LEU . 52.5 t0 101.42 -117.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.203 -174.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -71.37 -9.1 57.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.229 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -119.77 173.76 6.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 175.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 75.4 m -126.92 147.47 50.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 29.8 t -104.64 118.91 37.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 242' ' ' LEU . 47.0 mt -96.1 113.15 24.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 176.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -105.51 110.41 22.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -95.26 133.42 39.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.217 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 87.1 mt -122.84 128.98 75.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.196 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.55 ' HB2' ' CD ' ' A' ' 321' ' ' PRO . 33.5 p30 -80.21 174.94 5.34 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -175.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.55 ' CD ' ' HB2' ' A' ' 320' ' ' ASP . 53.4 Cg_exo -59.97 -24.46 76.46 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.678 1.585 . . . . 0.0 111.198 -175.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.29 -5.29 59.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.184 -174.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.67 18.78 56.01 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -117.49 150.46 38.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 0.0 111.214 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 73.9 p -76.73 160.75 29.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.181 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 85.9 mt -76.93 150.13 35.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.192 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 40.5 p -75.19 166.96 22.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -54.85 -40.41 69.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.227 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 99.4 p -68.89 -33.66 74.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.174 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -75.63 -35.52 60.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.209 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -76.18 -31.18 58.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.198 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.71 -38.42 83.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.235 174.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -65.42 -34.75 79.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.202 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.03 -20.35 65.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.215 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 76.7 t -56.87 -54.03 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.165 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.12 -35.83 82.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.191 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.7 -49.95 82.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.169 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -81.6 -28.55 33.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.221 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -57.78 -43.02 85.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.236 173.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -69.21 -43.49 73.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.184 175.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.92 -28.09 69.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.181 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -84.21 -37.62 21.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.242 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 84.8 p -70.61 -21.4 62.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.223 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -94.5 159.28 34.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.194 175.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.98 141.97 85.7 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.685 1.59 . . . . 0.0 111.241 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 C--O 1.0 -14.53 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.72 . . . . . . . . 1 1 . 1 stop_ save_